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II Abstract 
The work described herein is concerned with Lewis acidic triarylboranes for synthetic 
and catalytic transformations where the influence of different substitution pattern and 
substituents were crucial in determining the resulting reactivity. Chapter 1 will provide a 
general introduction into acidity and will lay the theoretical foundation for the ensuing 
chapters. Chapter 2 introduces the boranes utilised in this work and will give literature 
examples describing reactivities of the currently known boranes. Besides providing 
several crystal structures, this chapter will discuss the Lewis acidity of these boranes. 
Chapter 3 explores the hydroboration of imines catalysed by tris[3,5-bis(trifluoromethyl)-
phenyl]borane. By testing a variety of various Lewis acids further insight into the 
mechanism of this hydroboration is gained. Chapter 4 further investigates borane imine 
adducts and the impact of the adduct formation on the electronic transitions within the 
imines. The photoactive adducts are then explored as vapochromic materials towards 
various solvent vapours. Chapter 5 focuses on the formation of pyrones, dihydropyrones 
and isocoumarins catalysed by tris(pentafluorophenyl)borane. A cross over experiment 
reveals the nature of this cyclisation reaction. Chapter 6 investigates the radical 
character of a frustrated Lewis pairs and their resulting reactivity. A novel protocol for a 
radical Heck-type reaction is provided and the mechanism was investigated. Finally, 
Chapter 7 will show the ambiguity between 1,1-carboboration and 1,3-haloboration in the 
reaction of propargyl esters with dichlorophenylborane. 
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1 General introduction 
1.1 Lewis acids 
According to Brønsted and Lowry, acidity concerns the movement of protons and is 
based on the reaction of a compound with water to form an oxonium-ion (H3O+) as shown 
in Scheme 1 (I).1 
 
Scheme 1: (I) Reaction of a Brønsted acid base pair (hydrogen chloride and water) (II) General adduct 
formation of a Lewis acid with a Lewis base 
The ions forming in aqueous hydrogen chloride are not the result of the dissociation of 
hydrogen chloride into a chloride anion and a proton, rather the result of an acid base 
reaction between water and hydrogen chloride. 
According to Brønsted and Lowry an acid is a substance which can produce hydrogen-
ions in solution.2 In 1923, G. N. Lewis expanded the definition of acids and bases.3 
Similar to the reaction of a proton with water, other electron pair acceptors can show this 
behaviour. Lewis theory considers the movement of electrons rather than protons where 
a Lewis acid (electron pair acceptor) and a Lewis base (electron pair donor) can combine 
to form an adduct (Scheme 1, II).3 
R. G. Pearson showed that just like Brønsted acids and bases, which are defined by 
acidity and basicity, Lewis acids and bases can be categorised according to their 
properties. Therefore he introduced the principle of hard and soft acids and bases 
(HSAB).1 He distinguished compounds small in size with a high positive oxidation state 
as hard Lewis acids and compounds large in size and/or low oxidation states are defined 
as soft Lewis acids (Table 1).  
Table 1: Classification of hard and soft Lewis acids4 
Hard Borderline Soft 
H+, Li+, Be2+, Al3+, BF3, 
NC+ 
Fe2+, Pb2+, Bi3+, Ni2+, BMe3, 
GaH3 
CO, Ag+, Au+, Hg2+, BH3, 
Br2 
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Polarisability is stronger in soft rather than hard Lewis acids. The principle also states 
that acids show greater affinity for bases of the same class and vice versa. The character 
of the adduct bond is typically more ionic the harder both Lewis acid and base are. 
1.2 The Gutmann Beckett method 
Initially to quantitatively describe the electrophilicity of solvents Gutmann and co-workers 
introduced the acceptor number (AN). In 1975, they used 31P nuclear magnetic 
resonance (NMR) spectroscopy to measure the shift of triethylphosphineoxide (TEPO) 
in the presence of various solvents (Table 2).5 
 
 
Scheme 2: Reaction of TEPO with aprotic (1) and protic (2) solvents 
Scheme 2 shows that TEPO can interact with both Lewis (1) as well as Brønsted acids 
(2). In both cases the oxygen atom operates in TEPO as the nucleophile and either 
donates electron density into the free orbital of the electron accepting Lewis acid (1), or 
gets protonated and must share one of its valence electron pairs (2). In both cases the 
adjacent phosphorus atom experiences a reduction in electron density depending of the 
strength of the (Lewis) acid. The resultant reduced electron density and the resulting 
deshielding of the phosphorus atom causes a downfield shift in the 31P NMR spectrum. 
Based on this shift, the AN can now be determined as shown in equation (1). 
(1) 	𝐴𝑁 = %𝛿!"#$%& − 41* ∙ , '(()*.',-,'- 
Equation (1) is the difference between the downfield shift of the mixture of acid and TEPO 
and the value 41 in the equation corresponds to the 31P NMR shift of TEPO in hexane 
as a weak acid. This difference is multiplied by a constant with the difference of the 31P 
NMR shift of TEPO in antimony (V) pentachloride (δ = 86.14 ppm) as a very strong Lewis 
acid and again the shift in hexane (δ = 41 ppm) in the denominator. This creates a scale 
for Lewis acidity, with an acceptor number of zero corresponding to hexane, and an 
acceptor number of 100 corresponding to SbCl5 (Table 2).5 Lewis acids with an acceptor 
number higher than a 100 are considered super acids. 
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Table 2: AN of different solvents5 
Solvent AN 
Hexane 0 
Diethyl ether 3.9 
Tetrahydrofuran (THF) 8.0 
Benzene 8.2 
Acetone 12.5 
Pyridine 14.2 
Dimethylformamide (DMF) 16.0 
SbCl5 100.0 
In 1996, Beckett and co-workers expanded the Gutmann method to determine the acidity 
of boranes.6 They probed the borane catalysed polymerisation of epoxide monomers, 
and found that the Lewis acidity of these catalysts was a crucial factor in these 
polymerisation reactions. Beckett et al. suggested that an excess of the Lewis acid 
should be present to make sure the equilibrium is shifted far to the right-hand side 
(Scheme 3).  
 
Scheme 3: Equilibrium shifted far towards the adduct of TEPO and Lewis acid. 
Initially, measurements were in THF at a concentration of 0.7 mol/l. Britovsek and co-
workers reduced the concentration to 0.1 mol/l and changed the solvent to benzene-d6 
to prevent polymerisation of the THF in the case of strong Lewis acids.7 All Lewis acidities 
measured in this work were carried out after Britovsek’s protocol in either CDCl3 or 
benzene-d6. 
1.3 Reactivity of Lewis acids 
Research into Lewis acid catalysed reactions have experienced an uninterrupted 
expansion in recent decades and researchers are constantly providing new Lewis acid 
chemistry with more versatile, selective and reactive catalysts, as evidenced by 
literature.8 These Lewis acid mediated reactions can be classified into two groups 
(Scheme 4). 
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Scheme 4: Different types of Lewis acid mediated reactions. LA: Lewis acid 
In group A (Scheme 4), the complex between substrate and Lewis acid leads to the 
product with the Claisen rearrangement being the most prominent example (Scheme 5).9 
 
Scheme 5: Comparison of a Lewis acid and thermally promoted Claisen rearrangement 
In group B (Scheme 4), the complex formed between substrate and Lewis acid is stable 
enough to react with a variety of reagents to form the desired product. Here the Lewis 
acid activates the substrate towards reaction with a second reagent. The Diels-Alder 
reaction between an unsaturated carbonyl dienophile Lewis acid complex and a diene is 
a renowned reaction in this class (Scheme 6).10 
 
Scheme 6: SnCl4 catalysed Diels-Alder reaction (major:minor 20:1) 
 
1.4 Lewis acidic boron compounds 
As with the other group 13 elements, boron atoms possess three valence electrons. 
Covalently bonded to a monovalent group X its composition is BX3. The geometrical 
structure of these compounds is planar with a sp2-hybridised boron-centre and an XBX-
angle of 120°. In this configuration the boron atom only has an electron sextet and seeks 
one of three possible pathways to saturate its valence shell (Scheme 7). 
Substrate
LA
Substrate LA Product (Claisen Rearrangement)
Substrate
LA
Substrate LA Product
Reagent (Diels-Alder, Aldol, Ene, Friedel-
Crafts, Esterification, Micheal 
Reaction)
Group A
Group B
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Scheme 7: Three possible pathways of boranes to achieve neon configuration. D: Electron donor 
If the substituents at boron have free electron pairs (Scheme 7, a) a pπpπ-bond is formed 
by back donation of a valence electron pair of the fluorine-atom into the vacant p-orbital 
of the boron-centre. In cases when the substituents do not have any available electron 
pairs (Scheme 7, b) a dimerisation and a formation of a 2-electron-3-centre bond can 
occur as in B2H6. Apart from these two pathways to gain noble gas configuration, there 
is also an intermolecular option by adduct formation with a Lewis basic donor molecule 
(Scheme 7, c). In all cases, there is a transformation of an sp2-hybridised boron atom to 
an sp3-hybridised species. The Lewis acidity of boron halides towards several nitrogen 
(e.g. triethylamine) and oxygen (e.g. diethyl ether) bases is BF3<BCl3<BBr3. 11 This trend 
is unexpected when one considers the decrease in electronegativity moving down the 
periodic table. One generally accepted explanation for this trend is the stronger back 
donation from fluorine compared to chlorine.12 This increased back donation reduces the 
availability of the otherwise empty p-orbital on the boron atom to accept an electron pair 
from a base.11 However, Politzer and co-workers could show in computational studies 
that the overlap integral of the boron 2p and the fluorine 2p orbitals is actually smaller 
than the corresponding integral for boron 2p and a chlorine 3p orbital. And when a boron 
trihalide acts as a Lewis acid it assumes tetrahedral configuration upon adduct 
formation.13 As the bond angle between the boron and the halogen atom decreases, the 
bond lengths increase accordingly. Due to the large charge and the small size of the 
fluorine atom it gets close enough to the boron atom to form a strong polar bond with 
good orbital overlap.14 In BCl3 the boron-halogen bond is longer and not so strong 
compared to fluorine (there is a greater mismatch in orbital size). Therefore, more energy 
is required to distort a BF3 moiety from planarity compared to a BCl3 moiety. Surprisingly 
towards softer Lewis bases the trend is inverted.15 In these interactions the Lewis acid is 
barely distorted from its planar geometry, so the strength of the acid-base interaction 
depends only on the charge of the boron atom which is larger in BF3 than in BCl3.13 
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Cationic boron compounds are another uprising field in Lewis acid catalysed 
chemistry.16,17 These boron compounds have an oxidation state of (+III) but vary in their 
coordination number (Figure 1). 
 
Figure 1: Cationic boron compounds with an oxidation state of +III sorted by Lewis acidity (CN: 
coordination number) 
The acidity and therefore the reactivity increases with decreasing coordination number. 
The boron centre is covalently bonded to two R-groups and is also stabilised with up to 
two ligands L connected via a dative bond. The most Lewis acidic borinium ions are sp-
hybridised with two vacant orbitals, addition of one Lewis base to this species generates 
the sp2-hybridised borenium cation of intermediate Lewis acidity. Addition of a second 
Lewis base then generates the sp3-hybridised boronium cation which, as a consequence 
of its neon configuration, is not Lewis acidic. These cations are commonly prepared by 
removal of anionic ligands (Scheme 8).18 
 
Scheme 8: Borenium synthesis by fluoride abstraction 
1.5 Frustrated Lewis pairs 
In 1942, Brown et al. showed that 2,6-lutidine and trimethylborane do not form the 
expected acid-base complex as would be expected by Lewis’ definition of acid base 
pairs. However, they did not probe further into this unquenched potential between these 
two compounds (Scheme 9, top).19 More than a decade later Wittig and Tochtermann 
showed that these hindered Lewis pairs can add across unsaturated bonds (Scheme 9, 
bottom).20,21 
NN
B
FMes Mes
MeMe Me3SiOTf
PhCl, 12 h
reflux
-FSiMe3
NN
BMes Mes
MeMe NN
BMes Mes
MeMe
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Scheme 9: First literature examples of sterically hindered Lewis pairs and their addition across unsaturated 
carbon-carbon bonds 
In 2006, Stephan and co-workers further investigated this unquenched reactivity.22 An 
initial reaction of tris(pentafluorophenyl)borane (BCF) with the sterically demanding 
disubstituted Mes2PH yielded the phosphonium-fluoroborate (A) through an SNAr 
reaction. A subsequent reaction of A with chlorodimethylsilane gave the phosphonium-
hydridoborate (B) (Scheme 10). 
 
Scheme 10: Reaction of dimesitylphosphine and BCF and a subsequent reaction with chlorodimethylsilane 
The resulting colourless compound B is stable at room temperature as well as air-stable. 
Heating the zwitterionic compound B to 150 °C leads to dehydrogenation and forms the 
neutral compound C (Scheme 11). The high steric demand around the phosphorus and 
boron-atom prevents dimerisation or oligomerisation making this intramolecular Lewis 
acid base pair sterically frustrated. This “frustrated Lewis Pair” (FLP) as defined by 
Stephan et al. readily reacts with H2 under 1 atmosphere (1 atm) of dihydrogen to give 
hydridoborate B again (Scheme 11).22 
N
Me
Me
B
MeMe
Me
+ no adduct formation
Brown (1942)
Wittig (1959)
Tochtermann (1966)
BPh3
PPh3 BPh3
PPh3
NaCPh3
BPh3
BPh3
Ph3C
Na
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Scheme 11: The first metal-free activation of hydrogen by an FLP 
The reaction shown in Scheme 11 was the first example of reversible, hydrogen-
activation system using a metal-free compound. Since then a range of FLPs have been 
developed including intermolecular FLPs (Scheme 12).23 
 
Scheme 12: Reversible binding of H2 by an intermolecular FLP 
The ability of these compounds to activate dihydrogen reversibly led to FLPs being used 
in metal-free hydrogenation catalysis. Similar to metal catalysed hydrogenations, carbon 
compounds such as enamines or CO2 can be reduced to the corresponding amine or 
formic acid respectively (Scheme 13).24,25 
 
Scheme 13: Hydrogenation of an enamine and CO2 by an activated FLP 
The ability to activate small molecules does not stop at dihydrogen but there are plenty 
of literature examples of other molecules such as C-C π-bonds,26 CO227 or N2O28 that 
will make use of the unquenched reactivity of the frustrated Lewis pair (Scheme 14). 
Mes2HP BH(C6F5)2
F F
F F
B
150 °C
-H2
H2 (1 atm)
25 °C
Mes2P B(C6F5)2
F F
F F
C
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Scheme 14: Activation of various small molecules with intermolecular FLPs 
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2 Introduction of the boranes synthesised in this work 
This chapter will introduce the boranes utilised in this Thesis. Here literature examples 
for the synthesis and the utilisation of the known boranes tris(pentafluorophenyl)borane, 
tris[3,5-bis(trifluoromethyl)phenyl]borane and tris(2,4,6-trifluorophenyl)borane are given. 
Besides these literature known boranes Chapter 2 will describe the synthesis of three 
novel triarylboranes (Tris(3,4,5-trifluorophenyl)borane, tris(3,4-dichlorophenyl)borane 
and tris(4-fluorophenyl)borane) and compare their crystal structures with known 
examples. Finally, a comparison of the acidity determined via the Gutmann-Beckett 
method will try to show a correlation between the substitution patterns of these 
homoleptic triarylboranes and their acceptor number.  
2.1 Tris(pentafluorophenyl)borane 
To highlight some of the main points in Chapter 1, boranes have unique features as 
Lewis acids owing to their vacant p-orbital and are very tunable towards their hardness 
and softness by simply varying the substituents attached to boron. There have been 
extensive studies by Piers,29 Stephan,30 Paradies31 to name a few to broaden the field of 
borane Lewis acids and their reactivity. One of the most frequently used boranes is 
tris(pentafluorophenyl)borane (BCF). This borane was initially synthesized in 1964 by 
Park and coworkers through lithiation of pentafluorophenylbromide (1a) in pentane 
followed by addition of a boron trichloride solution and two fold sublimation of the crude 
material to give BCF as a pure white solid (Scheme 15) with an acidity comparable to 
BF3 (AN = 76).32  
 
Scheme 15: Initial synthetic route for BCF 
The approach used in this thesis circumvents lithiation of 1a to avoid potential benzyne 
formation and ensuing risks formed from elimination of LiF (Scheme 16). 
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Scheme 16: Formation of benzyne derivative through LiF elimination 
The Grignard reagent 1d of 1a is less prone to α-elimination and thereby safer to use 
(Scheme 17).33 
 
Scheme 17: Alternative synthetic access to BCF 
Another advantage of this synthetic approach is that the yields from the Grignard route 
are improved compared to the lithiation method (85%). It must be mentioned that in order 
to attain a pure borane, a third sublimation step is required to remove the etherate adduct 
that forms with BCF. This ether adduct can be clearly distinguished by a signal at around 
40 ppm in 11B NMR spectra compared to a broad singulett at 60 ppm for the free BCF. 
The strong Lewis acid BCF was found by Park to readily form adducts with NH3, NMe3, 
pyridine and PPh3.32 It was later used stoichiometrically as an activator component for 
homogeneous metallocene Ziegler-Natta olefin polymerisation in which the Lewis acid 
removes a methyl group from the zirconium pre-catalyst to generate the active catalyst 
[Cp2ZrMe]+ (Scheme 18).34 
 
Scheme 18: Homogeneous Ziegler-Natta olefin polymerisation 
In more recent literature, BCF has found applications in various other chemical 
transformations. It catalyses the reduction of unsaturated bonds such as aldehydes,35 
ketones,35 esters,35 imines,36 olefins37 and amides38 with the assistance of silanes 
(Scheme 19). 
  
Cp2ZrMe2 B(C6F5)3 Cp2ZrMe B(C6F5)3Me+
Cp2ZrMe B(C6F5)3Me
H2C CH2n H2
C
H2
CCp2Zr CH3n
B(C6F5)3Me
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Scheme 19: Hydrosilation of various unsaturated organic compounds 
Mechanistic studies by Piers and coworkers showed that initially a borane/silane adduct 
is formed, thereby increasing the electrophilicity of the silicon-atom. Nucleophilic attack 
of the Lewis basic substrate at the δ+ silicon centre aids in the displacement of the 
hydridoborate yielding the activated substrate. (Scheme 20).39 Following nucleophilic 
attack and the formation of the borate anion there are two possible pathways for the 
formation of the reduced product (Scheme 20, path a or b). Deuterium labelling 
experiments however pointed towards path b.39 This pathway shows that the borane is 
not just needed for the initial formation of the silylium cation but also plays an important 
role in the transfer of the hydride anion. 
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Scheme 20: Mechanism of the hydrosilylation of ketones, aldehydes, esters and imines 
Computational studies show that the lowest unoccupied molecular orbital (LUMO) of the 
borane/silane adduct lies along the Si-H-B axis (Scheme 21).40 A large orbital lobe trans 
to the Si-H bond is likely the preferred site for nucleophilic attacks and explains the 
nucleophilic attack from the substrate in the reaction in Scheme 20. 
 
Scheme 21: Nucleophilic attack of the LUMO of the borane/silane adduct 
Another important feature of BCF is its steric bulk preventing adduct formation with 
sterically demanding bases. By increasing the rigidity of the substituents, the tendency 
to interact with soft Lewis acids is increased. This is observed in several π-bond 
activations observed in literature and discussed later in this Thesis (Scheme 22).41–43 
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Scheme 22: π-Activation of unsaturated systems by BCF 
2.2 Tris[3,5-bis(trifluoromethyl)phenyl]borane 
Although there are extensive studies on borane catalysed hydrosilylations,44 there is little 
literature evidence of another hydroelementation reaction namely hydroboration. 
Oestreich and co-workers showed that tris[3,5-bis(trifluoromethyl)phenyl]borane (1f) is 
more suitable for hydroborations than BCF.45 1f was first synthesised by Ashley and co-
workers in 2012 using iPrMgCl as a transfer Grignard reagent in reaction with boron 
trifluoride etherate and an ensuing sublimation in vacuo (Scheme 23).46 
 
Scheme 23: Synthesis of BArF3 by Ashley et al.47 
Oestreich used the same procedure to access triarylborane 1f with slightly lower yields 
(62%). The Lewis acidity was found to be slightly higher than BCF (AN = 84 compared 
to 76) and 1f was found to be less sterically demanding due to the lack of ortho-fluorine-
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atoms. Like BCF, 1f is also able to activate hydrogen in the presence of sterically 
demanding bases like tetramethylpiperidine (TMP).48  
2.3 Tris(3,4,5-trifluorophenyl)borane 
As part of this thesis, the novel borane tris(3,4,5-trifluorophenyl)borane (1h) was 
synthesised and fully characterised. As with 1f, it is also devoid of ortho-fluorine atoms 
(Scheme 24).  
 
Scheme 24: Synthesis of 1h 
As this species lacks ortho-fluorine atoms, the lithiation 1g cannot result in the elimination 
of LiF to form explosive benzyne species (see Scheme 16) even though the yields could 
be improved by using a transfer Gringard reagent like iPrMgCl. The crystal structure of 
1h shows a similar paddlewheel structure to other triarylboranes (Figure 2).48 
 
Figure 2: Comparison of the crystal structures of 1h and 1i. Protons omitted for clarity. Thermal ellipsoids 
set at 50% probability. Carbon: black, fluorine: green, boron: pink 
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Interestingly 1h was found to have a slightly higher Lewis acidity than BCF (AN = 79) 
even though it bares fewer electron withdrawing fluorine-atoms. As discussed in Chapter 
1 the reduction in steric demand in ortho-position may allow TEPO, a hard Lewis base, 
to form an adduct with 1h and the lack of ortho-substituents facilitates the resultant 
tetrahedral structure.  
2.4 Tris(2,4,6-trifluorophenyl)borane 
Among the homoleptic triarylboranes another borane utilised in this work is tris(2,4,6-
trifluorophenyl)borane (1i, Figure 2). This represents a Lewis acid with the same steric 
demand as BCF but with fewer electron withdrawing fluorine atoms, explaining the 
reduced Lewis acidity (AN = 69). It was first synthesised by Alcazaro et al. using again a 
transfer Gringard reagent in the first step followed by the reaction with boron trifluoride 
etherate to give 1i in a very good yield (Scheme 25).49  
 
Scheme 25: Synthesis of 1i 
This lower acidity while having the same steric demand as BCF has proven to have some 
unique catalytic features.50 Our group could show that 1i can be used to catalyse the 
hydroboration of alkynes, aldehydes and secondary aldimines using pinacolborane 
(HBpin) (Scheme 26).51 
 
Scheme 26: Hydroboration reactions catalysed by 1i 
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2.5 Tris(3,4-dichlorophenyl)borane & tris(4-fluorophenyl)borane 
As part of this Thesis two more triarylboranes (tris(3,4-dichlorophenyl)borane and tris(4-
fluorophenyl)borane) were synthesised and fully characterised (Scheme 27). 
 
Scheme 27: Synthesis of homoleptic triarylboranes 1l & 1n 
As expected 1l has the lowest Lewis acidity of the fluorinated triarylboranes (AN = 66) 
used in this work having the fewest fluorine substituents. Interestingly, 1n has a very high 
acceptor number of 78 even though it bares only two chlorine atom which are less 
electron withdrawing than fluorine. This is intermediate between BCF (AN = 76) and the 
3,4,5-fluorinated borane 1h (AN = 79). If the only influencing factors were sterics and 
negative inductivity, we would expect a lower acidity for 1n but the acceptor number 
indicates a similar acidity compared to 1c and 1h. This indicates that backdonation in 
the form of a positive mesomeric effect is responsible for the overall acidity of the borane. 
1l and 1n could both be crystallised by sublimation and their structures determined. The 
crystal structures of both compounds show the expected paddlewheel structure as found 
for other boranes (Figure 3).  
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Figure 3: Crystal structure of 1l and 1n. Protons omitted for clarity. Thermal ellipsoids set at 50% 
probability. Carbon: black, chlorine: light green, fluorine: green, boron: pink 
2.6 Summary 
As part of this thesis a range of boranes have been synthesised and their Lewis acidity 
determined by the Gutmann-Beckett method (Figure 4). However, further investigations 
are needed to quantify the contributions of inductive and mesomeric effects of the 
substituents towards the overall acidity.  
 
Figure 4: Comparison of the Lewis acidities of various boranes52 
As Figure 4 shows there is only a slight difference between 1l (AN = 66) and 
triphenylborane (BPh3, AN = 65) it can be concluded that the effect of the fluorine-
substituent on the para position instead of a proton in terms of acidity is negligible. As 
already mentioned, 1h is more Lewis acidic than 1c towards TEPO. It can be concluded 
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that the increase in steric bulk and the inability to assume a tetrahedral structure has a 
greater effect on the Lewis acidity, than the additional negative inductive effect added by 
the two fluorine-atoms in ortho-position. By comparing 1n to 1h we can show that the 
positive mesomeric effect of the F-atom must have an influence on the acidity since 
reducing the number of substituents from 3 (1h) to 2 (1n) with a lower electronegativity 
(F = 3.98, Cl = 3.16) equals in almost the same acidity. This argument is supported by 
the acceptor number of 1f (AN = 84) since in the case of trifluoromethyl substituents 
there is no mesomeric stabilisation. Overall, we can see that slight changes in the 
substitution pattern of these triarylboranes can have big effects towards reactivity and 
acidity. This will be shown in greater detail in the following chapters of this Thesis. 
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3 Hydroboration of ketimines 
3.1 Introduction 
As previously mentioned in Chapter 2, hydroborations are a well-studied 
hydroelementation reaction with many applications.53–57 In recent years many groups, 
besides ourselves, have shown examples of borane catalysed hydroborations.51,58,59 In 
this chapter, the metal-free hydroboration of imines to amines is discussed as a 
straightforward way of preparing amines. Currently the majority of known hydroboration 
protocols however use metal catalysts.60–64 This limits the use of the resulting amine 
products for human consumption (e.g. food products or pharmaceuticals) without costly 
purification due to regulations by international bodies.65 The use of non-metal catalysts 
has the benefit of avoiding an intense purification step. 
The hydroboration of aldimines was described in Chapter 2 and can be catalysed by the 
less Lewis acidic borane tris(2,4,6-trifluorophenyl)borane (1i). Unfortunately, this 
reactivity of 1i could not be expanded to ketimines.51 One of the few protocols of boron 
catalysed ketimine (2.1) hydroboration was described by Crudden and co-workers using 
BCF and 1,4-diazabicyclo[2.2.2]octane (DABCO).58 The addition of a base is needed to 
facilitate the hydride abstraction to form the hydridoborate [HB(C6F5)3]- and to stabilise 
the formed borenium cation [Bcat]+ (Scheme 28) which represents the actual catalytically 
active species (Scheme 30). 
 
Scheme 28: Formation of a base-stabilised borenium cation with BCF 
Without the presence of a stabilising base, BCF is known to decompose HBpin to B2pin3 
and several unidentified compounds by Lewis acid-promoted ring opening.66 Crudden et 
al. showed that this in situ formed borenium cation [Bcat]+ is the actual active species and 
capable of catalysing the hydroboration of imines (2.1) with HBpin (Scheme 29).58  
 
Scheme 29: Hydroboration of imines with HBpin catalysed by [Bcat]+ 
To probe the reactivity of this DABCO-stabilised cation, [Bcat]+ was generated with 
tetrakis(perfluorophenyl)borate [B(C6F5)4]- as a more innocent counter anion (Scheme 
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30, top) and successfully tested as a catalyst (6 examples, 18-96%). To prove that the 
hydride used to produce the borate anion [HB(C6F5)3]- cannot participate in side reactions 
towards ketimines (2.1), stoichiometric amounts of the imine were mixed with the 
hydridoborate salt and only traces of the desired amine could be isolated. 
 
Scheme 30: (Top) generation of [Bcat]+[B(C6F5)4] (bottom) stoichiometric reaction of [Bcat]+[HB(C6F5)3]- with 
imine 2.1 to amine 2.2 
The proposed mechanism of this reaction suggests that the hydridoborate is not the 
catalyst of the reaction, but rather the generated borenium cation [Bcat]+ (Scheme 31).58  
 
Scheme 31: Mechanism of the hydroboration catalysed by [Bcat]+ 
The aforementioned mechanism suggests that the initial heterolysis of the hydridoborane 
HBpin by BCF is only required to generate the catalytically active cation [Bcat]+. This 
indicates that a stronger electrophile is needed to activate ketimines (2.1) to make them 
prone for hydroboration towards pinacolborane. 
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As recently shown by Oestreich and co-workers 1f is a very efficient hydroboration 
catalyst for alkenes without the addition of a base using pinacolborane whereas BCF is 
not (Scheme 32).45 
 
Scheme 32: Hydroboration of alkenes with HBpin catalysed by 1f 
As Scheme 32 shows, this reaction only works at elevated temperatures and mechanistic 
studies revealed that the actual catalytic species is not 1f but rather a borohydride that 
is formed from a ligand exchange reaction at 80 °C. This forms the catalytically active 
species 2.4a and 2.4b in situ (Scheme 33). 
 
Scheme 33: Catalytic cycle of the alkene hydroboration with HBpin 
Scheme 33 depicts the catalytic cycle for this hydroboration reaction. An initial ligand 
metathesis forms the catalytically active mono- or diarylborane 2.4a and 2.4b. These 
species can now undergo a concerted 1,2-syn-addition of the B-H-bond across the 
unsaturated C-C-bond in a highly regioselective manner. A second ligand metathesis 
replaces the BArF3-n-moiety with a Bpin group and the in situ generated electron deficient 
hydroborane 2.4a or b is regenerated to form the desired hydroborated product. 
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3.2 Aims of this work 
The results by Oestreich described above encouraged us (in collaboration with 
Oestreich) to test if 1f is also a possible catalyst for the reduction of ketimines without 
the help of an additional base.  
3.3 Results 
In this study the model ketimine substrate 2.1a was tested towards its reactivity with 
HBpin using various boranes catalysts. In addition, the isoelectronic trityl cation in 
[Ph3C]+[B(C6F5)4]- was also tested as a potential catalyst (Scheme 34, Table 3). 
 
Scheme 34: Hydroboration of 2.1a under various conditions 
Table 3: Optimisation of the Lewis acid catalysed hydroboration of 2.1a under various conditions 
Entry 
 
Lewis acid Catalytic 
loading (mol%) 
Time 
 (h) 
Solvent Conversiona 
(%) 
1 none - 18 neat 0 
2 BPh3 2.0 18 neat 0 
3 B(C6F5)3 2.0 18 neat 36 
4 1f 2.0 18 neat 100 
5 1f 0.3 18 neat 100 
6 [Ph3C]+[B(C6F5)4]- 10.0 18 neat 0 
7 HB(C6F5)2 3.0 18 neat 5 
8 2.4a·SMe2 3.0 18 neat 100 
9 1f 1.0 1 benzene 58 
10 1f 1.0 1 toluene 30 
11 1f 1.0 1 PhCF3 37 
12 1f 1.0 1 CH2Cl2 34 
13 1f 1.0 1 1,2-Cl2C2H4 37 
14 1f 1.0 1 neat 35 
15 1f 1.0 18 benzene 100 (87) 
16 B(C6F5)3 5.0 6 benzene <5 
17 BCl3 20.0 18 benzene 27 
18 BF3·OEt2 20.0 18 benzene 99 
a Conversion determined by gas chromatography (GC) analysis. Number in brackets represents isolated yield of free 
amine after hydrolysis and purification by flash chromatography on silica gel. 
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The less Lewis acidic BPh3 (entry 2, Table 3) shows no activity and to confirm results by 
Crudden et al. BCF was tested (entry 3, 16). Even after 18 h only 36% conversion could 
be observed. Entry 6 shows that trityl has no observable conversion towards the model 
system. This is notable as trityl is isoelectronic to the borane (entry 6). HBArF2 (2.4a) was 
tested as a dimethylsulfide adduct (entry 8) and showed high catalytic (100% GC 
conversion) activity at a catalyst loading of 3 mol% after 18 h. Interestingly the BCF 
equivalent of 2.4a (Piers’ borane, HB(C6F5)2, entry 7) was found to be appreciably less 
effective as a catalyst and gives only 5% conversion after 18 h. Boron trihalides were 
also tested (entry 17 and 18). At low catalyst loadings the conversion using 
borontrichloride or borontrifluoride is negligible, but raising the catalyst loading to 20 
mol% produced the target amine almost quantitatively with boron trifluoride (entry 18). 
When using the less stable and more Lewis acidic boron trichloride, only 27% conversion 
could be observed (entry 18). Borane 1f showed the highest conversion with catalyst 
loadings as little as 0.3 mol% after 18 h (entry 5). We decided to use 1 mol% as the 
catalyst loading for further studies since lower catalyst loadings would increase the 
inaccuracy on the used scale system. The solvent was then varied to determine the most 
suitable solvent system (entries 9-14) and with 58% conversion after 1 h benzene 
showed the most promising results (entry 9). This gave us our final optimal conditions of 
18 h at room temperature with a catalyst loading of 1 mol%. These conditions gave 
quantitative conversion determined via GC chromatography and after workup 87% of the 
hydrolysed amine could be isolated (entry 15). With the optimal conditions in hand, a 
scope of this hydroboration reaction was assessed (Scheme 35).  
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Scheme 35: Hydroboration of imines catalysed by 1f in the presence of HBpin (isolated yields) 
A variety of R1 groups were tested. Neither electron deficient trifluoromethyl substituted 
phenyl-rings (2.3d and 2.3e), nor electron rich methyl substituted phenyl rings in R1 
position (2.3f) proved to be problematic and gave yields between 84% and 95%. Also, 
para- and meta-substituted phenyl bromides (2.3b and 2.3c) showed good yields of 77% 
and 96% respectively. Replacing the phenyl ring with a 1- or 2-napthyl moiety (2.3g and 
2.3h) did not reduce reactivity and excellent yields of 92% and 99% respectively could 
still be observed. Adding both electron withdrawing trifluoromethyl on the para-position 
of the N-phenyl ring (R3) (2.3i) as well as the electron donating methoxy substituent (2.3j) 
reduced the yield to 30% and <5% respectively. When using the sterically less 
demanding benzyl as an N-protecting group (2.3k), comparable isolated yield (83%) to 
the model substrate 2.3a (87%) was observed. Similar results were observed with 2.3l 
which posessed a tosyl-protecting group. Increasing the steric bulk in R2 position by 
introducing either an ethyl- (2.3m) or a phenyl-moiety (2.3n) did not influence the reaction 
and very good yields (83% and 94% respectively) could be be obtained. The more 
reactive aldimines showed very good yields as well (86%) even when the steric bulk was 
increased from a phenyl- (2.3o) to a benzhydryl-protecting group (2.3p).  
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To gain a better understanding of this mechanism several stoichiometric reactions were 
undertaken. Neither the 1H nor the 11B NMR spectrum showed any changes upon mixing 
with the model substrate 2.1a with stoichiometric amounts of HBpin. But adding an 
equivalent of 1f to a solution of 2.1a in dichloromethane-d2 (CD2Cl2) revealed a clear 
downfield shift in the 11B NMR spectrum indicating the formation of an imine-borane 
adduct (Ia, Scheme 36). 
 
Scheme 36: Stoichiometric reaction of 2.1a with 1f and a subsequent reaction with HBpin 
The addition of an equivalent of HBpin led to a quantitative formation of the desired 
product 2.2a after 17 h, with the catalyst crashing out of solution after completion of the 
reaction. No formation of hydroboranes 2.4a or 2.4b or formation of the second product 
(2.4c) of the ligand metathesis could be observed while monitoring this reaction via 
heteronuclear 1H, 11B or 19F NMR spectroscopy. Secondly no hydridoborate anion of 1f 
[HBArF3]-, and no borenium cation formed by hydride abstraction of HBpin could be 
observed in the 11B NMR spectra making a borenium catalysed mechanism highly 
unlikely, in contrast to Crudden’s work.58 For comparison we repeated the experiment 
with stoichiometric amounts of BCF as the borane in the first step. (Scheme 37).  
 
Scheme 37: Stoichiometric reaction of 2.1a with BCF and 1 equivalent of HBpin 
Again, borane imine adduct Ib was readily formed after mixing BCF with imine 2.1a in 
CD2Cl2 as observed in the 11B NMR spectrum. But the addition of an equivalent of HBpin 
did not lead to the desired product and even after 44 h only traces of amine 2.2a could 
be observed via 1H-NMR spectroscopy. As discussed in Chapter 1 the ortho-fluorine 
substituents of the triarylborane reduces the ability to assume the resulting tetrahedral 
structure facilitating the adduct formation between sterically less demanding boranes 
and Lewis bases. To support this hypothesis borane 1h was prepared and it was tested 
catalytically and stoichiometrically in the hydroboration of model substrate 2.1a (Scheme 
38). 
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Scheme 38: Stoichiometric (top) and catalytic reaction (bottom) of 2.1a and tris(3,4,5-
trifluorophenyl)borane (1h) with HBpin (*NMR-conversion) 
Indeed 1h showed excellent conversions in the hydroboration of the model substrate 
2.1a to give the desired amine 2.2a. As seen with 1f and BCF, 1h initially forms an adduct 
with the imine when mixed in CD2Cl2 as observed via 11B NMR spectroscopy. But only 
resembles the sterically less demanding borane 1f in the follow up reaction with HBpin 
to form amine 2.2a.  
These results of this study can be summarised by the mechanism shown in Scheme 39. 
 
Scheme 39: Possible catalytic cycle of the hydroboration catalysed by 1f 
The initial step of the reaction is adduct formation between the borane catalyst and imine 
substrate to give I. This activated imine has a lower energy LUMO compared to the free 
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imine and a proximate HBpin molecule reduces adduct I via transition state II. The now 
weakened Lewis adduct III is replaced by an unreduced imine (2.1) to complete the 
catalytic cycle.  
3.4 Summary & Outlook 
To sum up the findings of this chapter, triarylboranes that are less hindered (i.e. lacking 
substitution in the ortho position), such as 1f and 1h, show reactivity in the hydroboration 
of imines where BCF fails. As discussed in Chapter 1, this is a “group B” Lewis acid 
mediated reaction where a complex is formed first between the Lewis acid and substrate 
and a second reagent then forms the desired product. 
In further studies, it could be shown that heating up a mixture of HBpin and 1h in toluene-
d8 to 80 °C for 12 h gives one of the products connected to the ligand metathesis 
described in Scheme 40 to form 2.4d. 
 
Scheme 40: Ligand metathesis of 1f with HBpin to form 2.4d 
This can indicate a further similarity to 1f making 1h also a possible pre-catalyst to reduce 
olefins by formation of the mono and di-substituted hydroboranes in situ. Further studies 
are ongoing in our group to look at using borane 1f in metal-free catalytic hydroboration 
reactions.  
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4 Photophysical studies of B(C6F5)3 imine adducts 
4.1 Introduction 
As discussed in Chapter 2 and 3, borane Lewis acids have been shown to form adducts 
with a variety of unsaturated moieties, including aldehydes, ketones, aldimines as well 
as ketimines.51,67 The electron accepting ability of these trivalent boranes can induce 
large electronic dipoles, which are able to promote intramolecular donor-acceptor 
charge-transfer (ICT). There has been several examples showing this photochemical 
feature (Figure 5). 68–72 
 
Figure 5: Borane containing compounds experiencing donor-acceptor ICT68,72 
Bazan and co-workers showed that BCF causes modifications in the photoactivity of 
already photoactive molecules by forming strong Lewis acid/base adducts.68 Recent 
findings by Nieto and co-workers showed that the interaction of BCF with tolane 
derivatives bearing a carbonyl moiety in ortho- or para- position (Scheme 41) has an 
effect on the photophysical properties of the aldehyde.71  
 
Scheme 41: Preparation of borane-carbonyl adducts 4.2 by Nieto et al. 
At low concentrations (c≤10-5mol/l), a solution of these adducts 4.2 displayed the same 
photophysical features as the initial free aldehydes 4.1. However, it was found that 
increasing the concentration would cause a new local maximum to arise in the UV 
spectrum. Exciting this new maximum revealed the emissive features of these adducts 
4.2. By modifying the Ar-substituent of 4.2 with electron donating and withdrawing 
moieties, a range of emission maxima from 437 nm to 613 nm could be created. Similar 
emission maxima were observed in the solid-state of adducts 4.2. Nieto and co-workers 
attribute this new absorption band to a lowering in the LUMO level of the aldehyde 4.1 
by formation of an adduct with BCF. The spatial distribution of this LUMO is concentrated 
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around the carbonyl-group showing the direct influence of the carbonyl-borane adduct 
formation (Figure 6). 
 
Figure 6: Representation of the LUMO orbital of 4.2a by DFT calculation 71 
4.2 Aims of this work 
These results encouraged us to probe the change of emission of these aldehyde-adducts 
with boranes (Figure 7) other than BCF to see how the steric and electronic effects of 
the borane alter the photophysical properties of the aldehyde. We were interested to see 
if there was an observable trend between the acidity of the borane and the emission 
maximum of the aldehyde-borane adducts.  
 
Figure 7: Boranes used to probe the aldehyde-borane adduct formation 
4.3 Synthetic results 
A variety of literature known aldehydes were synthesised and their ability to form adducts 
with the boranes in Figure 7 was investigated via 11B NMR spectroscopy (Figure 8).  
  31 
 
Figure 8: Adduct formation of aldehydes 4.1 with 1c, 1i and BPh3 (left) and synthesised aldehydes 4.1a-c 
isolated yield in brackets (right) 
It was found that compound 4.1a can only form an adduct with the strongest Lewis acid 
1c and a downfield shift was observed for the borane in the 11B NMR spectrum upon 
adduct formation. Weaker Lewis acids BPh3 and 1i only showed 11B NMR signals of the 
free acid indicating no adduct formation. The more Lewis basic and electron rich methoxy 
substituted compounds 4.1b and 4.1c could form an adduct with the less acidic borane 
1i, but again BPh3 showed neither a shift in the 11B NMR spectrum nor a visible change 
upon mixing aldehyde and borane in CDCl3. To increase the donor ability and hereby 
facilitate the adduct formation with the weaker Lewis acid BPh3, the aldehydes 4.1b and 
4.1c were transformed to their corresponding aldimines with Ph, iPr and nBu-protecting 
groups (Scheme 42). 
 
Scheme 42: Synthesis of aldimines 4.2a-4.2f via a condensation reaction 
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All reactions gave the desired imine product. The low yields (17-57%) were attributed to 
the use of molecular sieves (3Å) in the synthesis, and the resulting difficulties in 
extraction for the purification. When the drying agent was changed to magnesium 
sulphate (MgSO4) the isolated yield was increased to 85% (4.3f). As with the aldehydes, 
the imines 4.3 were tested towards their adduct formation with boranes 1c, 1i and BPh3 
via 11B NMR spectroscopy (Figure 9).  
 
Figure 9: Adduct formation of imines 4.2 
The nBu-protecting group has the least steric demand of the synthesised imines 4.3, and 
forms adducts with all three tested boranes regardless of whether the tolane derivative 
is ortho (4.3c) or para (4.3f) substituted. The sterically more demanding isopropyl group 
showed no adduct formation with BPh3, the least acidic of the three boranes.73 
Compounds 4.3b and 4.3e shifted the singlet of 1c and 1i downfield in the 11B NMR 
spectra upon mixing in CDCl3, indicating the formation of an adduct in these cases. The 
sterically most demanding group of the three introduced protecting groups was the 
phenyl moiety. Here, only 1c was able to form an adduct with the compounds 4.3a and 
4.3d whereas both BPh3 and 1i showed no shift in the 11B NMR spectra when added to 
a solution of imine in CDCl3. To study the structural properties of this adduct further, 
compound 4.4a was crystallised by slow evaporation of a saturated chloroform/hexane 
solution. The crystal structure is depicted in Figure 10.  
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Figure 10: Solid-state crystal structures of 4.2d (left) and 4.4a (right). Thermal ellipsoids set to 50% 
probability. H atoms omitted for clarity. C: black, N: blue, O: red, B: pink, F: green 
The crystal structure of 4.4a proved to be the expected adduct. Compared to the initially 
reported BCF aldehyde adduct 4.2d, the torsion angle between the two phenyl rings 
increased from 26.16° to 42.60°. This indicates that, at least in the solid-state, the system 
is not fully delocalised. The boron nitrogen distance is 1.613(3) Å and ca. 0.02 Å lower 
than similar motifs described in literature.29 A typical covalent boron nitrogen bond is ca. 
1.39 Å74,75, which is much shorter than the observed distance in the crystal structures in 
Figure 10. The α-carbon of the protecting group has a distance of 3.00 Å to the 
neighbouring carbon atom of the (pentafluoro)phenyl group explaining why the more 
sterically demanding imines 4.3a and 4.3d were less likely to form adducts with the less 
Lewis acidic boranes 1i and BPh3.  
4.4 Photophysical results 
In preliminary studies, we compared the UV-vis spectra of imines 4.3c and 4.3f since 
both demonstrated promising adduct formation within the range of the tested 
triarylboranes. Both had two absorption bands around 300 nm. But only the UV-vis 
spectra of 4.3c showed an additional peak at 390nm. Based on these results the borane 
imine adducts of 4.3f were chosen for further studies to elucidate the solution-state 
electronic properties of these adducts via UV-vis absorption (Table 4, Figure 11), and 
luminescence spectroscopies (Table 5, Figure 16). 
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Table 4: Absorption and molar absorptivity (ε) of imine 4.3f and various borane adducts 
 
Borane Compound Absorption/nm (ε/dm3·mol-1·cm-1) 
none 4.3f 
313 
(29,800) 
329* 
(24,200) 
 395 (4,000) 
BPh3 4.4b 
281 
(46,300) 
308* 
(22,300) 
329* 
(17,000) 
390 
(14,000) 
1i 4.4c 
312 
(28,600) 
328* 
(23,000) 
 
387* 
(10,000) 
1c 4.4a 
312 
(24,500) 
330* 
(13,200) 
 397 (7,400) 
1h 4.4d 
294 
(32,800) 
317* 
(19,100) 
332* 
(16,800) 
381 
(16,800) 
BF3·OEt2 4.4e 
317 
(21,300) 
332* 
(18,000) 
 
401 
(14,000) 
BCl3 4.4f 
289 
(44,300) 
  
399 
(23,900) 
BBr3 4.4g 
289 
(54,200) 
  
402 
(24,000) 
*: Shoulder 
An increase in molar absorptivity of the lowest energy band could be observed in all 
adducts 4.4 compared to the free imine (Figure 11).  
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Figure 11: UV-vis absorption spectra of 4.3f and its adducts 4.4 in CHCl3 solution 
This increase in molar absorptivity was most pronounced in 4.4g. In luminescence 
studies, these solutions were excited at 330 nm and 400 nm correlating with the two 
absorption bands. While the excitation at 330 nm gave two emission peaks at around 
380 nm and 500 nm, excitation at 400 nm only yielded the lower energy emission at 
around 500 nm. The results of the energetically lower excitation are displayed in Figure 
12. 
 
Figure 12: Steady-state emission spectra of 4.3f and adducts in CHCl3 solution (λex=330 nm, c=10-5 M) 
The emission intensity clearly increases upon adduct formation (Figure 12), and the 
highest intensity is observed with adduct 4.4d. Here, the boranes that are more sterically 
hindered or less favourable towards tetrahedral configurations 1i, 1c and BF3, form 
adducts with lower emission intensities compared to borane imine adducts of 1h, BCl3, 
BBr3. A reason why the adduct of 1h and imine 4.3f has the highest intensity can be 
explained by the presence of heavier halogens on the boron halides (BBr3 & BCl3). These 
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heavier halogen moieties facilitate intersystem crossing that leads to an excited triplet 
state. With emission from the triplet state being slow it is highly quenched by other 
processes.76 That may also be the reason why the emission intensity of adduct 4.4g is 
lower than 4.4f. In Table 5 the numerical values of the emission maxima are listed.  
Table 5: Steady-state emission maxima of 4.3f and its adducts 4.4 
Borane Compound Emission/nm 
none 4.3f 490 
BPh3 4.4b 491 
1i 4.4c 493 
1c 4.4a 501 
1h 4.4d 490 
BF3·OEt2 4.4e 496 
BCl3 4.4f 493 
BBR3 4.4g 495 
 
With both the lowest energy absorption and emission band in hand the direct relation of 
bathochromic or hypsochromic shift versus Lewis acidity determined by the Gutmann-
Beckett method could be plotted (Figure 13). With compound 4.3f the acceptor number 
of the solvent CHCl3 is visualised instead.5  
 
Figure 13: Difference in the lowest energy absorption and emission band of 4.3f and adducts 4.4 and the 
acidity of the respective borane 
To represent these shifts, the difference of the lowest energy absorption and emission 
band between adduct 4.4 and free imine 4.3f was formed. These two values are plotted 
against the acceptor numbers of boranes in adducts 4.4. In Figure 13, no trivial trend can 
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be observed, indicating that the change in absorption and emission is dependent upon 
various factors.  
As already mentioned, adducts 4.2 displayed photophysical activities only at 
concentrations over 10-5 mol/l. Literature attributes the concentration dependency with 
the formation of dimers of 4.2 that are the actual active species.71 Adducts 4.4 
demonstrate activity even below this concentration and it could be argued that even 
monomers of 4.4 are photophysically active.  
Additionally, solvatochromic studies revealed a clear sensitivity of the emission band at 
500 nm towards solvent polarity and, among the tested solvents, the least polar hexane 
displayed the most hypsochromical shift (Figure 14). This sensitivity to the polarity of the 
solvent can therefore be assigned to a transition with a significant intramolecular charge 
transfer contribution.  
 
Figure 14: Solvatochromic fluorescence spectra of 4.4f (λex=400 nm) 
The stability of adduct 4.4a towards air was further studied and after exposing a solution 
of 4.4a in CHCl3 to air for 10 minutes the fluorescence intensity of the charge transfer 
emission band at 500 nm was observed over time. Interestingly, even after 2 h there was 
still half of the emission intensity detectable (Figure 15). 
 
  38 
 
Figure 15: Time based steady-state emission plot of a 10-5 M solution of 4.4a in CHCl3 (λex=400 nm, 
λem=500 nm) 
Within these studies the solid-state stability towards light, air and moisture as well as the 
solvatochromic fluorescence changes encouraged us to further explore the application 
of this species as a potential vapochromic material. These materials change colour upon 
exposure to volatile organic compounds, offering a low-cost technology for the detection 
of analytes.77 The initial solid-state film fluorescence spectra of both 4.3f and 4.4a are 
clearly distinguished from each other and 4.4a only shows emission at the lowest energy 
band even when exited at 330 nm (Figure 16). Both emission maxima experience a 
bathochromic shift compared to their respective chloroform solutions.  
 
 
Figure 16:Solid-state film fluorescence spectra of 4.3f and 4.4a (λex=330 nm) 
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4.5 Vapochromic results 
To test the vapochromic potential towards various solvents, a 25 mM solution of 4.4a 
was prepared and thin filter strips were impregnated with 4.4a and dried under vacuum. 
These strips were suspended in a vial over various undried solvents and the change in 
fluorescence of these strips was recorded photographically when excited at 365 nm 
(Figure 17). 
 
Figure 17: Experimental setup for the vapochromic studies (λex=365 nm) 
 
 
Figure 18: Photographical results of the setup described in Figure 17 with 4.4a permeated filter strips 
excited at 365 nm (I) none (II) hexane (III) toluene (IV) Et2O (V) THF (VI) methanol (MeOH) 
The blank sample depicted in Figure 18 (I, left) is in a closed vial under a nitrogen 
atmosphere. A second sample was left out to further probe the stability of these adducts 
towards air and moisture but even after 2 days there is hardly any difference observable 
between these two samples (Figure 18, right). As expected, hexane (II) as the weakest 
Lewis base alters the colour of the fluorescence the least in the first 30 min. Toluene (III) 
quenches the intensity of the fluorescence, but still the yellow-green colour of the initial 
adduct is visible after 30 min. Here π-π interaction between the solvent and the imine 
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could create more non-radiative relaxation pathways, thereby quenching the 
fluorescence intensity of the filter strips. The more coordinating aprotic solvents (IV) and 
(V) have a stronger influence on the filter strips colour. The better donor THF quenches 
most of the visible fluorescence after 5 min. Et2O first turns the strips into a blue colour 
that resembles the emission wavelength of the free imine suggesting IV is forming an 
adduct with 1c and breaking the adduct 4.4a. With VI the same trend can be observed 
within the first 5 minutes but after 30 min the colour turns into a slightly darker blue. In 
an attempt to gain deeper insight into these processes the solvent vial was replaced with 
a dry vial and the changes were monitored (Figure 19). 
 
 
Figure 19: Photographical results of the filter strips over time (λex=365 nm) (I) none (II) hexane (III) toluene 
(IV) Et2O (V) THF (VI) MeOH 
Surprisingly, after being quenched by the solvent vapor the fluorescence of IV and V 
were the quickest recover to the original adduct color after drying the strips. This 
suggests the adduct between 4.3f and 1c was reformed after evaporation of the 
coordinating solvent. With methanol there is observed fluorescence, but the blue colour 
implies that reformation of the initial imine-borane adduct does not take place.  
4.6 Discussion of vapochromic results 
Parkin and co-workers could show that an adduct of 1c and water has the same acidity 
in acetonitrile (MeCN) as hydrochloric acid making it incompatible with bases which 
irreversibly deprotonate the adduct to give the corresponding hydroxytriarylborate 
(HOBAr3).78 With VI being a protic solvent this deprotonation of the adduct of methanol 
and 1c by the imine could also be an explanation for the slight change in the blue colour 
after 30 mins compared to the light blue after 5 mins (Scheme 43). 
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Scheme 43: Possible decomposition pathways of 4.4a with methanol (top) and 1c with water (bottom) 
Compared to the coordinating solvents, the non-coordinating solvents (Figure 19, II and 
III) cannot recover the lost fluorescence here. The inability to form an adduct with 1c 
makes the unprotected borane more susceptible to attacks from moisture present in the 
undried solvents (Scheme 43, bottom).  
4.7 Summary & Outlook 
In conclusion, a number of imines 4.3 could be synthesised, and their borane adducts 
4.4 were characterised spectroscopically. The sterically least demanding nBu-protecting 
group proved to be the most promising in terms of adduct formation. The ICT character 
of this electronic transition could be identified and the stabilisation by the borane 
increased the intensity the lowest energy emission and absorption band. The stability of 
the adduct 4.4a especially in the solid-state allowed the exploration of the vapochromic 
properties with a small range of solvents. The results suggest that these adducts indeed 
could be used to design new vapochromic materials by tuning the charge transfer 
fluorescence properties. 
After understanding this vapor induced phenomenon on a mechanistic level these 
materials could be utilised to detect volatile organic compounds. Here, an optimised 
borane-imine adduct could form the base of a sensor to detect and differ between 
different solvent vapors. This would give an alternative to absorbing the vapors onto an 
absorbent for later extraction and chromatographic analysis, making this process faster 
and more cost efficient.  
 
Scheme 44: Gold and platinium based vapochromic materials described in literature.79–81 
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Also most of the literature known vapochromic materials (examples in Scheme 44) have 
a metal center with the majority being Pt(II) or Au(I) based77, making this metal-free 
alternative even more cost effective. 
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5 B(C6F5)3 promoted cyclisation of substituted alkynyl 
esters, ethers, and acids 
5.1 Introduction 
Lactones are omnipresent structures in naturally occurring or biologically active 
compounds. Within this group pyrones, isocoumarins and dihydropyrones are a 
reoccurring motive (Figure 20).82,83 
 
Figure 20: Examples of lactones 
They find uses in many pharmaceutical compounds as antiviral84, anti-inflammatory85, 
antibiotic86, and antispasmoidic87 drugs. They possess purgative properties88 and have 
proven to be effective antimicrobial agents.89,90 Also, these compounds are considered 
nonsteroidal antagonists to enzymes and display affinity to enzymes like the androgen 
receptor91 (AR), a DNA-binding transcription factor controlling development and 
maintenance of the male sexual phenotype. Another example is the pregnane X 
receptor92 (PXR) a nuclear receptor whose primary function is to sense the presence of 
foreign toxic substances. Notably, 2-pyrones have proven to be effective inhibitors for 
enzymes like the HIV-1 protease93 essential for the viral replication in the HI-virus and 
serine proteases94. Displayed in Figure 21, is thunberginol A, an immunosuppressant 
isocoumarin derivative, that can be extracted from fermented leaves of Hydrangea 
macrophylla (Figure 21).95 
 
Figure 21: Structure of Thunberginol A (left). Picture of hydrangea macrophylla (right) 
With ubiquitous applications, the synthesis of these heterocycles is of great interest. 
Literature has provided many intermolecular examples such as the ring expansion of β-
lactones or metal catalysed cascade reactions of propiolic acids or esters with 
alkynes.96,97 Another well studied approach is an inverse Diels-Alder-type reaction 
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described by Boger, Mullican and Yamashita.98,99 Here, we will discuss a Lewis acid 
promoted intermolecular cyclisation of alkynyl esters (Scheme 45). 
 
Scheme 45: Intermolecular cyclisation of alkynyl esters promoted by Lewis acids 
First reports by Gandour and co-workers in 1984 utilised in situ generated bromonium 
ions to promote this 6-endo-dig cyclisation.100 The Lewis basic bromide anion formed in 
the generation of the cation promotes the abstraction of the alkyl ester group R1 (Scheme 
46).  
 
Scheme 46: Bromine promoted cyclisation of alkynyl esters by Gandour and co-workers 
Larock et al. expanded this scope by utilising various p-block Lewis acids in agreement 
with the mechanism proposed by Gandour (Scheme 47).101 
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Scheme 47: Chloro-oxycarbonylation by Larock and co-workers 
One of the latest examples of this non-metal promoted cyclisation with a consecutive 
dealkylation by a halide anion was described by Blum and co-workers (Scheme 48).102 
 
Scheme 48: Stoichiometric reaction of alkynyl esters with B-chlorocatecholborane 
Again, this stoichiometric reaction between B-chlorocatechol borane and alkynyl ester is 
in agreement with the mechanism described by Gandour and Larock. One of the few 
examples of a stoichiometric transition metal promoted cyclisation was accomplished by 
Katzenellenbogen and co-workers (Scheme 49).103 
 
Scheme 49: Mercury(II)acetate promoted cyclisation by Katzenellenbogen et al. 
Like the stoichiometric reactions described previously, a soft Lewis acid HgOAc2 is used 
to promote the 6-endo-dig cyclisation, resulting in an isocoumarin derivative with a 
mercury chloride in the 4-position. Here two equivalents of copper chloride are used in a 
reaction with the isocoumarin mercurial to give the desired product. Catalytic examples 
are rare, however the Blum group has described a dual catalytic system (Scheme 50).104 
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Scheme 50: Catalytic carbo-oxycarbonylation described by Blum et al. 
Instead of using a base to dealkylate the cationic intermediate, Blum utilises a secondary 
palladium catalyst that selectively complexes the allylic ester groups, and a subsequent 
carbodemetallation forms the final product. Another approach by Takaki and co-workers 
uses catalytic amounts of bismuth triflate to cyclise the alkynyl ester starting material 
(Scheme 51).105 
 
Scheme 51: Bismuth catalysed reaction by Takaki et al. 
These α-substituted benzyl esters form a zwitterionic cyclised bismuthate intermediate, 
which is then replaced by the ester group via an intramolecular 1,5-migration (Scheme 
52). 
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Scheme 52: Mechanism postulated by Takaki and co-workers 
It should be noted that the uncyclised esters can be activated via a s-activation of the 
carbonyl group and via a π-activation at the unsaturated carbon-carbon bond. The other 
examples utilised soft Lewis acids to activate the soft Lewis basic centre. In contrast, 
Takaki describes an initial dual activation of both the carbonyl, as well as the alkyne 
group, almost using the oxygen-atom as a directing anchor to bring bismuth in the vicinity 
of the olefinic bond. 
 
Scheme 53: Reaction by Melen et al. to generate pyrylium borate zwitterions 
Initial results within our group showed that BCF is capable of the initial π-activation, but 
without an additional base to abstract the alkyl-ester group, the product of these 
cyclisations is a stable zwitterionic pyrylium borate and no catalytic turnover is possible 
(Scheme 53).106 
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5.2 Aim of this work 
Inspired by the work of Takaki107 and co-workers the aim of this work was a BCF 
promoted cyclisation of esters and acids and if possible to reintroduce the liberated 
borane into the reaction cycle and make this a catalytic reaction (Scheme 54).  
 
Scheme 54: Cyclisation reactions promoted by 1c studied in this chapter 
5.3 Synthesis of the starting material and their reaction with B(C6F5)3 
To study the reactivity of BCF towards varying ester groups within these alkynyl esters, 
access to their free acids was crucial. Here 5.1 was chosen as the model backbone to 
probe the reactivity described in Scheme 54. 
 
Scheme 55: Synthetic route to free acid 5.8 
In accordance with a literature procedure,105 methyl isobutyrate 5.7a was deprotonated 
with lithium diisopropylamide (LDA) and an ensuing reaction with 3-bromopropyne yields 
ester 5.7b in 84% yield. The terminal alkyne 5.7b is then cross coupled to an aryl halide 
via a Sonogashira type protocol to give methylester 5.8a and is then saponificated using 
sodium hydroxide in methanol to yield the desired product 5.9a in excellent yields (99%) 
(Scheme 55). Here, first studies revealed that stoichiometric amounts of BCF are 
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capable to cyclise free acids 5.9 (Scheme 56). This is unusual as typically boranes are 
unstable with respect to acidic substrates (See Chapter 4). 
 
Scheme 56: Hydro-oxycarbonylation of 5.9a promoted by BCF 
This reactivity in Scheme 56 encouraged us to synthesise a scope of free acids 5.9 to 
see the limitations of this hydro-oxycarbonylation (Scheme 57). Generally, the yield in 
the saponification step of this reaction was excellent, the electron rich ortho (5.9h) and 
para (5.9b) methoxy substituted acids showed a drop in yield in the first step of the 
reaction though. This trend could be further observed with compound 5.9c with an 
electron donating methyl group in para position. 1-Naphtyl substituted acid 5.9i showed 
a drop in conversion in the first step yielding 33% of the desired product. Electron neutral 
(5.9a) as well as electron deficient systems 5.9d, 5.9f and 5.9g gave good to excellent 
yields between 69 and 95% over both steps of the reaction. 
 
 
Scheme 57: Scope of synthesised carboxylic acids 5.9. Isolated yield after 2 steps in brackets 
  50 
With a range of acids to hand, these were reacted with stoichiometric amounts of BCF 
in CDCl3 at room temperature (Scheme 58). 
 
Scheme 58: Reaction of synthesised acids 5.9 to give dihydropyrone derivatives 5.4. Isolated yield in 
brackets. 
In Scheme 58 clear trends are observable. In the ortho position substituted carboxylic 
acids 5.9g, 5.9h and 5.9i do not give the desired product, so a steric demand close to 
the triple bond is responsible for the hindrance in this borane promoted cyclisation. Also, 
reducing the electron density in the phenyl ring with a fluoride (5.9f) or trifluoromethyl 
(5.9d) substituent in the para position quenches the reactivity of the free acid towards 
this Lewis acid promoted cyclisation. Following this we then turned out attention to ester 
starting materials. In an esterification step, acids 5.9a and 5.9d were reacted with various 
alcohols. Groups able to stabilise a carbocation were introduced to see if this showed an 
increase in reactivity, especially for the more deactivated esters of 5.9d, that did not 
show any activity towards BCF as a free acid (Scheme 59). 
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Scheme 59: Steglich esterification of acids 5.9a and 5.9b with various alcohols. Isolated yields in brackets. 
DMAP: 4-Dimetylaminopyridine, DCC: N,N’-Dicyclohexylcarbodiimide 
The Steglich108 esterification was used to introduce alkyl (5.1a), allyl (5.1b), benzyl (5.1c 
and 5.1d) and benzhydryl (5.1e-j) ester groups. The yield of this esterification step is 
between 13% and 64% and esters 5.1a-j could be isolated. Again, in a stoichiometric 
reaction with BCF the reactivity of these different ester groups was tested (Scheme 60). 
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Scheme 60: Stoichiometric cyclisation reaction of esters 5.1 to give dihydropyrones 5.4. NMR conversion 
with isolated yields in brackets a24h reaction time  
It can be shown that the isopropyl ester 5.1a, with only a positive inductive effect, does 
not show any reactivity towards BCF. Also, the allyl group that could stabilise a possible 
cationic leaving group with only one resonance structure does not yield the desired 
product. Benzyl esters 5.1c and 5.1d did form the desired esters after 24 h reaction time 
with excellent yields. The best performance was displayed by the benzhydryl derivatives 
5.1e-j with reaction times of 30 mins. Interestingly, trifluoromethyl-substituted esters 5.4b 
and 5.4f-h did give similar results to the less electron deficient esters 5.4a and 5.4c-e, 
indicating that an increase in the stability of the leaving group increases reactivity 
towards BCF to the otherwise non-reactive carboxylic acid 5.9d.  
Access to these cyclised dihydropyrones encouraged us to widen the scope even further 
to also access cyclised pyrones 5.5 and isocumarins 5.6. Therefore esters 5.2 and 5.3 
were synthesised via their free acids. 
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Scheme 61: Synthesis of carboxylic acids 5.12. Isolated yields in brackets. 
The acid group of iodobenzoic acid 5.11a was first protected with a methyl substituent 
and the resulting benzoate 5.11b reacted with arylacetylenes109 to give esters 5.12. After 
saponification in methanol, carboxylic acids 5.13 could be isolated in very good yields 
(Scheme 61). Again, Steglich’s protocol was used to introduce benzhydryl groups, as 
well as an ethylphenyl group (5.3g) to expand the scope of esters even further (Scheme 
62). This esterification step yielded desired products 5.3a-g in good to excellent yields 
(68% to 97%). 
 
Scheme 62: Steglich esterification of acids 5.12. *isolated yields 
The final group of esters containing and alkene functionality were then also synthesised 
via the free acid of 5.2 (Scheme 63). The benzhydrylic esters showed the fastest reaction 
in the initial stoichiometric reaction (Scheme 60) so esters 5.2 were synthesised with 
halide substituted benzhydrols as alcohols. Free acid 5.15a again was synthesised via 
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a Sonogashira coupling of iodoacrylate with phenylacetylene110 and a subsequent 
saponification (Scheme 63). 
 
Scheme 63: Synthesis of acid 5.15a and esters 5.2. *isolated yields 
The esters were then tested in the 1:1 stoichiometric cyclisation reaction with BCF. 
 
Scheme 64: Reactions of acids 5.12 & 5.15 and 5.2 & 5.3 with stoichiometric amounts of BCF. In situ NMR 
conversion with isolated yield in brackets. a 24 h reaction time 
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Even after 24 h free acids 5.12 only showed around 50 percent conversion determined 
via in situ 1H NMR spectroscopy. Compound 5.15a did not deliver the desired pyrone 
and as already shown in the first example the reactivity increases when the acid’s proton 
is replaced with benzhydrylic ester groups. All cyclised benzhydryl esters 5.2a-c and 
5.3a-f show very good isolated yields of the corresponding cyclised lactone (81% to 
92%).  
 
Figure 22: Crystal structure of isocumarin 5.16a and dihydropyrone 5.4c. Protons omitted for clarity. 
Thermal ellipsoids set at 50% probability. Carbon: black/grey, boron: pink, fluorine: green, oxygen: red 
5.16a and 5.4c could both be crystallised and structurally characterised. The structures 
shown in Figure 22 give another proof of connectivity. There are no unexpected features 
within these structures. The isolated structure could confirm that the final cyclised 
product does form an adduct through its carbonyl oxygen atom with BCF, which could 
be of hindrance if this reaction is to be used catalytically.  
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5.4 Results of the catalytic reaction with B(C6F5)3 
To probe this system for its catalytic activity, compound 5.1e was chosen as the model 
substrate. Indeed, running the reaction with 10 mol% BCF instead of stoichiometric 
amounts only gave 10% conversion, showing that the final lactone borane adduct is 
stable at room temperature. Increasing the reaction temperature to 70 °C however gave 
the desired product quantitively (Table 6, entry 6). 
Table 6: Scope of the catalytic reaction of 5.1e with various boranes and solvents 
 
Entry Catalyst Solvent Loading (mol%) Conv. (%)a 
1 BPh3 CDCl3 10 <5 
2 B(2,6-F2C6H3)3 CDCl3 10 <5 
3 B(2,4,6-F3C6H2)3 CDCl3 10 <5 
4 BF3∙OEt2 CDCl3 10 7 
5 B(C6F5)3 CDCl3 10 >95 
6 B(C6F5)3 CDCl3 5 >95 
7 B(C6F5)3 CDCl3 1 >95 
8 B(C6F5)3 THF 10 52 
9 B(C6F5)3 1,4-Dioxane 10 54 
10 B(C6F5)3 Toluene 10 >95 
11 B(C6F5)3 Et2O 10 >95 
12 B(C6F5)3 CH2Cl2 10 >95 
13 B(C6F5)3 CH2Cl2 5 >95 
aIn situ NMR Conversion determined via 1H NMR spectroscopy 
Reducing the Lewis acidity quenches the reactivity, and triaryl boranes with fewer 
fluorine atoms on the aryl rings show no conversion (Table 6, entry 1, 2 and 3). The 
equally acidic but sterically less demanding boron trifluoride gives only 7% conversion 
after 6 h (Table 6, entry 4). Reducing the catalyst loading does not affect the reaction 
and with even as little as 1 mol% BCF quantitative conversion can be observed after 6 h 
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via 1H NMR spectroscopy (entry 6 & 7). A scope over various solvents revealed that 
more coordinating solvents such as 1,4-dioxane (entry 9) and THF (entry 10) only 
convert 50% of the alkynylester 5.1e to the desired lactone 5.17a. Diethyl ether (entry 
11), dichloromethane (entry 12) and toluene (entry 10) all show similar activity compared 
to chloroform. Here a complexation of the more coordinating solvents with BCF is 
suspected to be the reason for the drop in conversion. To ensure that especially the 
cyclisations of acids 5.9, 5.13, 5.15 is not a Brønsted acid promoted reaction, acid 5.9b 
was chosen as a model substrate and was reacted with catalytic amounts of two 
Brønsted acids (Table 7). 
Table 7: Carboxylic acid 5.9b in reaction with proton sources 
 
entry Brønsted acid Conv. (%) 
1 CF3CO2H <5 
2 CF3SO3H <5 
 
As shown in Table 7, both triflic acid (Table 7, entry 2) as well as trifluoroacetic acid 
(entry 1) do not display any reactivity in the tested conditions and hereby making a proton 
promoted cyclisation more unlikely. The stoichiometric scope (Scheme 64) already 
showed that not all tested compounds show the same high reactivity as model substrate 
5.1e, which dissuades from using 1 mol% catalyst loading, but instead supports the use 
of a 5 mol% loading. This catalytic loading is still half of what Takaki and co-workers 
reported in their bismuth catalysed cyclisation reaction of these alkynylesters.105 The 
solvent of choice was CH2Cl2, which showed high conversion and facilitated solvent 
removal after the reaction due to its low boiling point. Entry 13 on Table 6 was chosen 
as the standard conditions for the catalytic scope. With the optimal conditions 
determined, the substrate scope was then examined (Scheme 65). 
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Scheme 65: Catalytic scope with optimised conditions. In situ NMR conversions are given, isolated yields 
in brackets. a 120 h reaction time b 10 mol% catalyst loading c 16 h reaction time d 24 h reaction time e 48 h 
reaction time 
Again, electron deficient alkynyl esters and acids are less reactive and only the 
benzhydryl esters display any reactivity towards the model system and, even after 120 
h reaction time, only 27% product 5.17d could be isolated. Here the conversion 
stagnates after about 60 h pointing towards an unwanted side reaction of BCF with ester 
5.1j. This trend continues with the less reactive free acids, here only the electron rich 
methoxy substituted acid 5.9b shows the desired product in tested conditions. A 
comparison between cyclised products 5.17h-j and 5.17k-m can confirm these findings. 
The more electron rich methyl substituted esters 5.3d-f are quantitively converted to the 
desired product after 6 h. However, the less electron rich esters 5.3a-c need increased 
catalyst loading (10 mol%) and reaction time (24 h) to give the cyclised isocumarin 
derivates 5.17h-j in very good yields. Another trend that could be observed in the 
stoichiometric reactions was that benzyl ester 5.1c is less reactive compared to 
benzhydrylesters 5.1e-g. This is again confirmed in the catalytic scope and even after 
120 h reaction time only 33% of the cyclised product 5.17c could be isolated. With 
ethylphenyl ester 5.3g quantitative conversion could be achieved, but the reaction time 
needed to be increased to 48 h. Model substrate 5.1e and its halide derivatives 5.1f and 
5.1g gave the products 5.17a and 5.17f-g in excellent yields (90-95%). Pyrone formation 
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is slightly slower and an increase in reaction time (16 or 24 h) is needed to isolate pyrone 
derivatives 5.17n-p in good yields.  
5.5 Mechanistic studies and discussion 
To gain further insight into this cyclisation reaction, a crossover experiment was 
conducted to see whether this reaction is inter- or intra-molecular. By mixing two 
differently substituted esters and observing the reaction via 1H NMR spectroscopy, 
should give rise to either four different products in case of an intermolecular reaction, or 
only two products in the intramolecular case (Scheme 66). 
 
Scheme 66: Crossover reactions of esters 5.1 to form cyclised dihydropyrones 5.4 
Indeed, both crossover reactions A and B result in a mixture of four products. This speaks 
for an intermolecular reaction, and the liberation of the ester group as a carbocationic 
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species. This is in agreement with the reactions carried out in this work. The more 
stabilised the formed carbocation is, the higher the reactivity of the initial alkynyl ester. 
These results were confirmed via 1H NMR spectroscopy (Figure 23). 
 
Figure 23: Stacked 1H NMR spectra of crossover A and single crude reactions to form products 5.4 with 
1,4-dioxane as an internal standard in a sealed capillary 
The resulting spectra of both crossover reactions gave 4 signals in the 5 ppm region of 
the 1H NMR spectrum. Comparing these four signals with the individual peaks resulting 
from the stoichiometric reaction of esters 5.1 with BCF reveal that each peak represents 
one of the cyclised products 5.4c, 5.4e, 5.4f and 5.4h. Here it is noteworthy to mention 
that the bismuth promoted cyclisation by Takaki and co-workers only gives two products 
when conducting a crossover experiment.105 This suggests that there must be 
differences in the mechanism between these two cyclisation reactions. The collected 
results allow for two different pathways for the mechanism to take place (Scheme 67). 
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Scheme 67: Possible mechanistic pathways for the cyclisation reaction 
As already discussed in Chapter 1, BCF is capable to activate both σ-Lewis basic and 
π-Lewis basic centres. In Scheme 67, the left catalytic cycle represents the σ-pathway. 
An initial oxygen-borane adduct (I) is formed, facilitating the exit of the ester group as a 
carbocation. In a second step (II), the liberated carbocation can now induce the 
cyclisation reaction and give the cyclised product as a borane adduct (III). A second 
possible pathway (π-pathway) is the activation of the unsaturated bond (IV) and an 
ensued 6 endo-dig cyclisation to give pyrylium borate V similar to that observed in the 
Melen group previously. Now a carbocation is liberated and in a carbodeboronation 
reaction (VI) the final product is formed, and the catalyst is reintroduced into the cycle. 
Observing the reaction over time shows the presence of a signal in the 11B NMR 
spectrum at around -16 ppm, characteristic for vinyl borates, 106 that vanishes towards 
the end of the reaction. This could point towards the π-pathway, but also throughout the 
reaction a big signal at around 0 ppm is observable in the 11B NMR spectra of this 
reaction, a region characteristic for boron-oxygen adducts.106 Thus, the true catalytic 
cycle is still not fully understood.  
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5.6 Summary & Outlook 
In conclusion, this is the first example of carbo- and hydro-oxycarbonylation promoted 
by a non-metal catalyst in the literature. Showcasing a highly efficient and fast C-C and 
C-H-bond formation at relatively mild conditions. Further studies are needed though to 
determine whether one of the two proposed pathways is correct or a different more 
complex mechanism is the actual pathway of the studied cyclisation reaction. With this 
method, biologically active pyrones, dihydropyrones and isocumarins can be 
synthesised with a very straight forward protocol giving access to potential 
pharmaceutical compounds without the use of metal catalysts and hereby saving a costly 
purification step.  
 
 
Scheme 68: (top) Copper promoted 5-endo-trig reaction by Gevorgyan et al.111 (bottom) Gold promoted 5-endo-dig 
reaction by Hu et al.112 
Here, other cyclisation reactions promoted by coinage metals shown in Scheme 68 could 
be of interest as well. Gevorgyan111 and co-workers could show that allene substituted 
pyridines can be cyclised by a copper catalyst to give pyrrole derivates and the group 
around Hu112 discussed the cyclisation of an unsaturated cyclic ketone system to give a 
furan derivative. Both reactions are quite similar to the reaction discussed in this chapter 
and could be promoted by BCF. The reaction of Hu et al. needs an additional hydride 
source in form of an Hantzsch ester, which could quench the reactivity of the borane 
catalyst. But both systems are promising and could expand the BCF promoted cyclisation 
reactions and replace precious metals in synthetic transformations.  
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6 FLP mediated Heck-type reaction 
6.1 Introduction 
The Mizoroki-Heck reaction is a ubiquitous tool to create important structures in natural 
products, pharmaceuticals, materials and agrochemicals.113 It was first described by 
Mizoroki and colleagues in 1971 (Scheme 69).114 
 
Scheme 69: General reaction of the Mizoroki-Heck reaction 
In the following year Heck et al. proposed the first full mechanism (Scheme 70).115 
 
Scheme 70: Mechanism of the Mizoroki-Heck reaction 
The alkene insertion starts with an oxidative addition of the aryl or vinyl halide on to the 
palladium catalyst. The now oxidised palladium catalyst reacts with an alkene to form 
complex III. The following β-hydride elimination then gives the arylated alkene and 
hydridopalladium halide IV. Finally, a reductive elimination step promoted by the added 
base regenerates the Pd(0) catalyst I by quenching the hydrogen halide. In recent years, 
radical processes have been developed performing this Heck-type reaction (Scheme 
71). 
 
Scheme 71: General reactivity of radical Heck-type reaction 
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These reactions are mainly, with a few exemptions,116,117 promoted by transition 
metals.118–120 As mentioned earlier, the cost of removing residual catalysts in products for 
human consumption has a significant impact on total production costs, and is strictly 
regulated by international bodies.121 In addition, residual metal catalysts can act as 
charge carrier traps or photoquenchers strongly affecting the intrinsic properties in 
products for the modern electronics industry, making metal-free approaches highly 
desirable.122  
Recent findings by Stephan123 and Erker124 proved that negatively charged BCF radicals 
can be generated by trapping the resulting anion with benzoquinone (Scheme 72). 
 
Scheme 72: SET BCF reduction of benzochinones by Stephan and Erker. TEMPO: (2,2,6,6-
Tetramethylpiperidine-1-yl)oxyl 
Erker’s example is using oxidative radicals like TEMPO or trityl, whereas Stephan 
showed that the FLP consisting of BCF and PMes3 has radical character due to a single 
electron transfer (SET) equilibrium (Scheme 73). 
 
Scheme 73: SET equilibrium of FLP pair BCF/PMes3 
This equilibrium is greatly shifted to the left-hand side of the reaction shown in Scheme 
73 and the resulting borane radical anion has a very short life time. Therefore, a FLP 
mixture of BCF and PMes3 shows nearly no activity in electron paramagnetic resonance 
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(EPR) spectroscopy.123 Mixing this FLP with a benzoquinone derivative results in a 
dianion and a phosphine radical cation, which can be clearly detected via EPR 
spectroscopy.  
6.2 Aim of this work 
As discussed in Chapter 5, BCF can be used in the intramolecular cyclisation of alkynyl 
carboxylic acids and esters to generate pyrones, dihydropyrones and isocoumarins. In 
this catalytic reaction BCF is shown to be able to liberate a benzhydryl cation (Scheme 
74).  
 
Scheme 74: Cyclisation reaction discussed in Chapter 5 
With Stephan’s and Erker’s recent findings in hand, the possibility to liberate a 
benzhydryl radical utilizing the BCF radical anion generated via SET equilibrium (as 
shown in Scheme 73), instead of the two-electron diamagnetic pathway (discussed in 
Chapter 5), is explored (Scheme 75).  
 
Scheme 75: Reactivity probed in this work 
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6.3 Results 
6.3.1 Synthesis of starting materials 
To probe if a carbon radical can be liberated instead of a carbocation, esters 6.1a and 
6.1b were synthesised in a simple one step esterification from commercially available 
starting materials to give the products in reasonable yields (Scheme 76). 
 
Scheme 76: Synthesis of esters 6.1 
6.3.2 Reactivity of Esters 6.1 with (frustrated) Lewis base pairs 
Upon mixing 6.1a with the FLP Mes3P/B(C6F5)3 in chloroform-d1 a strong purple 
colouration (Absmax = 571 nm), that is characteristic for the radical cation of Mes3P, could 
be observed initially. The deep purple colour turned into a clear orange solution after 12 
h at room temperature, or 4 h in a 70 °C oil bath. A doublet (1JPH = 478 Hz) in the 31P 
NMR spectrum indicated the presence of a P-H-bond and, after slow evaporation of the 
reaction mixture, a crop of colourless crystals suitable for X-ray diffraction could be 
harvested (Figure 24). The product was found to be a phosphonium borate salt 
[RCO2B(C6F5)3][HPMes3]. This confirmed the expected reactivity of the borane radical 
anion with the carbonyl oxygen atom of ester 6.1a (Scheme 74). However, this raised 
several questions. 1) Where did the benzhydrol moiety end up and 2) where did the P-H 
proton come from? 
O
O
F3C
F
F
O
O
F3C
6.1a (85%) 6.1b (61%)
F3C
Cl
O R
1OH
pyridine
F3C
O
O
6.1
R1
  67 
 
Figure 24: Isolated compound 6.2a C: black, O: red, B: peach, F: green, P: orange. Thermal ellipsoids set 
to 50% probability. H atoms omitted for clarity 
Further purification of the solution, following filtration to remove the salt, via column 
chromatography revealed the second product of this reaction to be the homocoupled 
benzhydryl ester moiety dimer 6.2b as a white solid. This dimer could be recrystallised 
in a CHCl3/n-hexane mixture to give colourless needles suitable for X-ray diffraction 
(Scheme 77). 
 
Scheme 77: Homocoupled product of the liberated carbon radical C: black; F: green. Thermal ellipsoids 
set to 50% probability. H atoms omitted for clarity 
The identification of products 6.2a and 6.2b from the reaction mixture, as well as the 
observation of a deep violet coloured reaction suggested that the generation of a carbon 
radical was successful. Dimerisation of the radical would then lead to the homocoupled 
product.  
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To investigate if this reaction was limited to mesityl phosphine a range of aromatic and 
aliphatic phosphines were tested in this reaction, but all other phosphines displayed a 
two-electron diamagnetic reaction pathway. This could be confirmed by monitoring the 
reactions in situ by multinuclear NMR spectroscopy. In the 1H NMR spectra, a doublet of 
the non-aromatic benzhydrol proton with J ̴ 16-20 Hz was observed corresponding to a 
2JPH coupling (Figure 25). In addition, a 6JPF long-range coupling was also observed with 
6JPF ̴ 4.0 – 4.5 Hz in the 31P NMR spectra. 
 
Figure 25: Reaction of 6.1a with BCF and various phosphines and stacked zoomed spectra of the 
reactions in the region of the benzhydrylic proton (pink) 
Stephan and co-workers already showed that tri-tert-butylphosphine displays a different 
reactivity and forms a diamagnetic encounter complex with BCF.123 With the results in 
Figure 25, the list of diamagnetic phosphine/BCF encounter complexes was expanded. 
6.3.3 EPR results 
After confirming that solely mesityl phosphine displays a different reactivity, with a 
suspected radical intermediate, EPR spectroscopy measurements were undertaken to 
verify the reactivity proposed in Scheme 75. Stephan and co-workers could observe a 
very small signal in a solution of BCF/PMes3, which was even more pronounced when 
the boron atom was replaced with an aluminium atom. The very small signal described 
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by Stephan et al. could not be observed in the EPR spectra upon mixing BCF and PMes3 
in CDCl3. In contrast, the reaction mixture of 6.1a with the B(C6F5)3/PMes3 FLP showed 
a strong doublet signal in the room temperature EPR spectrum (Figure 26).  
 
Figure 26: CW EPR spectrum (T = 298 K) of 6.1a and PMes3/BCF. Modulation amplitude 2.0 G, 
microwave power = 2.5 mW. Black (experimental), red (simulated) 
The measured giso value of 2.0072 and isotropic 31P hyperfine coupling constant of 670 
MHz (238.5 G) are comparable with those reported previously for the phosphonium 
[Mes3P]+• radical cation.123 When reacting 6.1b with the FLP mixture a second smaller 
signal could be observed due to the carbon based radical (Figure 27). Unfortunately, the 
poor resolution of the spectrum shown in the inset to Figure 27 arising from a low 
concentration of radicals precludes accurate determination of the hyperfine coupling, to 
assign this signal to a fluorenyl radical. However, a preliminary simulation suggests the 
presence of one large proton coupling (aiso » 63 MHz) arising from the methylene proton, 
and a second smaller coupling arising from the two equivalent protons at the 1-position 
on the aryl rings (aiso » 9 MHz) (Figure 28). These values are similar to those previously 
reported on the 9-hydroxyfluorenyl radical.78  
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Figure 27: CW EPR spectrum (T = 298 K) of 6.1a and PMes3/BCF. Modulation amplitude 2.0 G, 
microwave power = 1.6 mW. Black (experimental), red (simulated) 
 
Figure 28: CW EPR spectrum (T = 298 K) of 6.1a and PMes3/BCF. Modulation amplitude 2.0 G, 
microwave power = 1.6 mW. Black (experimental), red (simulated) 
The difference between the two ester moieties suggests that the fluorenyl radical has a 
longer lifetime than the benzhydryl radical and is therefore also observable in the EPR 
spectrum. However, in both cases, the presence of radicals could be confirmed.  
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6.4 Radical Heck-type reaction and mechanism 
In a bid to determine the hydrogen source of the protonated phosphonium cation in 6.2a, 
the reaction of 6.1b with the FLP BCF/PMes3 was probed. Indeed, under anhydrous 
conditions in CDCl3, a doublet was observed in both the 1H and 31P spectra due to 1JPH 
coupling. This suggests that the substrate must be acting as the hydrogen source in an 
unwanted side reaction and not the solvent. Addition of one equivalent of water or D2O 
however proved a good 1H or 2H source displaying a 1:1 doublet and 1:1:1 triplet in the 
31P NMR spectra due to 1JPH (478 Hz) and 1JPD (74 Hz) coupling respectively.125 Using 
C6D6 as a solvent acted as a poor 2H source whereas toluene-d8 acted as a better 2H 
source, showing triplet/doublet ratio of 4:1 in the 31P NMR spectrum (Figure 29). 
 
Figure 29: Stacked 31P spectra to determine the quenching source of the phosphonium radical 
Using a solvent as a sacrificial hydrogen source showed us that C-H-bond activation is 
possible but did not significantly increase the yield of homocoupled product 6.2b (36% 
in toluene). Instead of using the solvent as a hydrogen source, a more atom efficient way 
to quench the formed radical cation of Mes3P was sought. By adding styrene to the 
reaction, terminal alkenes could be activated in the β-position to give the hetero-coupled 
product 6.4a as the E-isomer (Scheme 78).  
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Scheme 78: Reaction of ester 6.1a with FLP BCF/PMes3 in the presence of an excess of styrene 
Indeed, the reaction delivered the desired product 6.4a as the E-isomer probably due to 
the steric demand of the benzhydryl group. An excess of styrene is necessary, as using 
only one equivalent reduces the yield by about 50% (11% isolated yield). In an attempt 
to improve the yield of the reaction, a scope of 6.1b with 4-fluorostyrene over various 
solvents showed that THF was the most promising and 84% of the expected product 
6.4b was isolated (Scheme 79). Chloro- and bromo-benzene as well as 1,2-
dichloroethane (DCE) showed yields similar to chloroform at around 40%. Acetonitrile 
showed no observable conversion at all. 
 
Scheme 79: Optimised reaction of 6.1b with 4-fluorostyrene and FLP BCF/PMes3 
The observed strong purple colouration is much fainter in THF, indicating that there are 
fewer radical cations of Mes3P released, leading to an increased reaction time from 3h 
in CDCl3 to 7h in THF. When following this reaction via 19F NMR spectroscopy, fewer side 
products were observed in THF. The high affinity of THF to form an adduct with B(C6F5)3 
is likely responsible for the increased reaction time and reduced number of radicals per 
time unit, as it gives the formed radicals less chance to homocouple or be quenched via 
other undesirable pathways. 
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Scheme 80: Scope over various styrenes in reaction with esters 6.1 and the FLP BCF/PMes3. Isolated 
yield in brackets 
Scheme 80 displays a range of styrenes in reaction with esters 6.1, with 4-fluorostyrene 
showing the best yields with both esters 6.1a and 6.1b. Generally, 9-fluorenol ester 6.1b 
gave higher conversions than the benzhydryl ester 6.1a, indicating that longer life times 
of the formed radical directly translates to higher yields in the coupled product. Chlorine 
substituted alkenes 6.4f and 6.4j experience a drop in yields to 41% and 50% 
respectively. This can be attributed to unwanted side reactions of radicals with heavier 
halides. Similar to the products generated from styrene (6.4a and 6.4g), electron rich 
substituted styrenes yield products 6.4d, 6.4h and 6.4i at around 50%, meanwhile only 
6.4c has a slightly lower yield (36%).  
With these results in hand the following mechanism can be postulated (Scheme 81). The 
reaction can be divided in three steps where the individual steps resemble the general 
reactivity of radical promoted Heck-type reactions (Scheme 71). The reaction begins with 
a radical initiation. The created radical is then added onto the unsaturated bond, and a 
final oxidation and elimination step restores the unsaturated bond. In metal-catalysed 
radical alkenylations, the formation of the carbon radical is the rate determining step. The 
high affinity of the formed radical borane anion to the carbonyl oxygen atom of ester 6.1 
makes this step very fast. To reduce the amount of free BCF in the reaction mixture, and 
to slow down the initial radical formation, the coordinating solvent THF was used. After 
the radical initiation step, the formed carbon radical is added reductively onto the double 
bond to give the Markovnikov product. Next, the trimesityl phosphonium radial cation can 
eliminate a hydrogen and reoxidise the radical intermediate to give the final alkenylated 
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product 6.4. This also explains why the FLP itself shows no reactivity towards styrene 
when tested in a control reaction in CDCl3.  
 
Scheme 81: Possible mechanism of the alkenylation reaction 
Interestingly, α-methyl-styrene exhibits an additional alternative reaction pathway 
generating two products (Scheme 82). 
 
Scheme 82: Reaction of 6.1a with α-methyl-styrene. Ratio determined via 19F NMR spectroscopy of the 
isolated mixture in brackets 
The major product of this reaction is not the expected E-isomer 6.5b but rather 
compound 6.5a, indicating that there was an elimination at the α-methyl moiety rather 
than the β-position. This is plausible looking at the elimination and oxidation steps 
(Scheme 83). 
 
Scheme 83: Elimination and oxidation step of the reaction of 6.1a with α-methyl-styrene and the FLP 
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Eliminating a hydrogen-atom of the α-methyl group has less steric demand (major 
product) and with [Mes3P]+• being quite sterically demanding, eliminating the β-hydrogen 
atom is the unfavourable process (minor product). 
6.5 Summary & Outlook 
In conclusion, it could be shown that the Mes3P/B(C6F5)3 FLP can be utilised as a 
powerful metal-free tool for C-C bond formation via a radical pathway without using 
controversial solvents like DCE or CCl4.126 The synthesised alkenes show high 
stereoisomeric purity yielding solely the E-isomer. Simple and commercially available 
starting materials are used, and good functional group tolerance is observed. Further 
studies into widening the scope as well as mechanistic studies are ongoing in our group. 
This novel single electron reactivity of frustrated Lewis pairs is slowly expanding and is 
in its naissance.127 Recent findings by Müller128 and co-workers (anie 2018) have shown 
that other than BCF also silylium ions (SiR3)+ display the same single electron transfer 
equilibrium (Scheme 84). 
 
Scheme 84: SET equilibrium between silylium cations and sterically demanding phosphanes 
Here further studies are needed to categorise Lewis acids and explore the ones identified 
as capable of this SET in their reactivity.  
 
Scheme 85: Direct alkenylation of simple unactivated alkanes with styrenes by Wei et al.129 
This expanded library of radical anions could be capable of other C-H-activations (e.g. 
Scheme 85). 
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7 1,3-Haloboration vs. 1,1-carboboration 
7.1 Introduction 
As shown in this work so far, borane Lewis acids exhibit affinity towards unsaturated π-
bonds and can activate them. By reacting these electron deficient systems with olefins, 
a highly desirable boron centre can be introduced into organic compounds, making it 
available for metal catalysed cross coupling reactions.130–134 In 1963, Lappert and co-
workers first described the addition of boron trichloride and phenyl substituted derivatives 
across a terminal alkyne (Scheme 86).135  
 
Scheme 86: Reactivity of BCl3, PhBCl2, Ph2BCl with terminal alkynes by Lappert and co-workers 
Two different reactivities could be observed. Boron trichloride reacts with two equivalents 
of a terminal alkyne to form alkene III. Here, two 1,2-additions across the unsaturated 
bond take place to form the chloroborated product III. When the Lewis acidity of the 
reacting borane is reduced by the introduction of a phenyl group, a different alkene II can 
be isolated. Again, a 1.2-chloroboration can be observed but instead of a second 
chloroboration, a 1,2-carboboration takes places, and a B-Ph bond is added across the 
unsaturated terminal alkyne. Further reduction of the Lewis acidity by introducing another 
phenyl group into the borane chloride leads to a single carboboration of the terminal 
alkyne to give product I. In later studies, Lappert and colleagues mixed these boranes 
with norbornadiene yielding similar results (Scheme 87).136 
 
Scheme 87: Chloro- and carbo-boration of norbornadiene 
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The two weaker Lewis acids, Ph3B and Ph2BCl, showed no reactivity towards 
norbornadiene, but PhBCl2 and BCl3 result in a 2,6-substituted products (IV and V). The 
possible resonance structures make this substitution pattern plausible, with BCl3 
resulting in the chloroborated product V, and PhBCl2 yielding the carboborated product 
IV (Scheme 87).  
 
Scheme 88: Reversibility of the haloboration reaction 
Through the addition of pyridine to 1,2-haloboration product VI, Lappert and co-workers 
could also show that the haloboration reaction can be reversible (Scheme 88).135 
However, this addition reaction is not limited to a 1,2-substitution pattern. Wrackmeyer 
and co-workers described the first 1,1-carboboration by reacting BEt3 with activated 
alkynes (Scheme 89).137  
 
Scheme 89: 1,1-carboboration of activated alkynes 
With silyl, germyl, stannyl and plumbyl-groups, activated alkynes undergo a 1,1-
carboboration, formally inserting a vinylidene isomer into one of the B-C bonds. 
Mechanistically, this insertion proceeds differently (Scheme 90). 
 
Scheme 90: Mechanism of the 1,1-carboboration in scheme 86 
As shown in Scheme 90, the 1,1-carboboration of the activated alkynes is a two-step 
reaction. First, the borane adds to the substrate, then rearrangement of the zwitterionic 
intermediate yields the product. However, to migrate the terminal R-group of un-activated 
alkynes, more electrophilic boranes are required. When reacting BCF with terminal 
alkynes, Erker and co-workers could observe a migration of a C6F5-group (Scheme 
91).138 
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Scheme 91: 1,1-carboboration of unactivated alkynes 
This reaction delivers both the E and Z isomer as the 1,1-carboborated products. 
Irradiating the reaction mixture with UV light gives the Z-isomer as the main product. This 
reaction is not limited to transferring the perfluorinated phenyl ring, as other groups have 
been reported to be transferred (Scheme 92).139 
 
Scheme 92: 1,1-Carboboration of 1-pentyne 
7.2 Aim of this work 
These results encouraged further investigation of electron deficient boranes in reactions 
with unsaturated system to achieve benzannulations and cyclisations, amongst 
others.140 Results within our group gave an insight into the reactivity of propargyl 
carbamates and other propargyl amides and esters (Scheme 93).141 
 
Scheme 93: Reactions of propargyl carbamates with BCF 
After the initial work of Lappert and co-workers, the commercially available PhBCl2 did 
not have the same focus as other Lewis acidic boranes. Based on results within our 
group, the reactivity of simply accessible propargyl esters with commercially available 
borane PhBCl2 was probed and was the attention of this study.  
7.3 Synthesis of starting materials 
To study this reactivity a scope of esters 7.1 was synthesised (Scheme 94). With the 
exception of ester 7.1e, all products 7.1 could be isolated with good yields. Compound 
7.1a was chosen as a model substrate for the unsubstituted propargyl esters 7.1a-d.  
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Scheme 94: Esterification of acyl chlorids with propargyl alcohol derivatives. Isolated yields in brackets 
7.4 Reactivity of PhBCl2 and esters 7.1 
The 1:1 stoichiometric reaction of ester 7.1a with PhBCl2 led to the clean formation of a 
single product 7.2a as observed using heteronuclear NMR spectroscopy in CDCl3 after 
8 h (Scheme 95).  
 
Scheme 95: Model substrate 7.1a in the reaction with stoichiometric amounts of PhBCl2. 1H NMR 
conversion in brackets 
Multinuclear NMR spectroscopy (HSQC, HMBC) suggested product 7.2a from the 
reaction of 7.1a with PhBCl2. Varying the solvent did not influence the reaction, and when 
model substrate 7.1a and PhBCl2 was mixed in C6D6, toluene-d8, CH2Cl2 and PhCl, the 
same reactivity was displayed, and full conversion could be observed within 8-9 hours. 
Additionally, trialling other boron reagents such as BCl3 were unsuccessful with a mixture 
of products observable in multinuclear NMR spectroscopy. To gain more insight into the 
formation of 1,3-haloborated product 7.2a, compound 7.1a was deuterium labelled with 
D2O in the presence of commercially available Lewis basic resin WA30 (Scheme 96).142 
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Scheme 96: Mild deuteration of terminal alkyne 7.1a. Isolated yield in brackets 
After successfully labelling compound 7.1a with a deuterium atom at the terminal alkyne 
position, the reaction of 7.1h with PhBCl2 was monitored via 1H and 2H NMR 
spectroscopy and compared to the non-deuterated reaction, as depicted in Scheme 95 
(Figure 30). 
 
Figure 30: 1H and 2H NMR spectra of haloborated products 7.2a and 7.2b 
During the course of the reaction, the alkyne signal (δ = 2.3 ppm) of 7.1a diminishes and 
a new signal at around δ = 6.5 ppm appears. This signal is absent in the 1H NMR 
spectrum of the reaction mixture of 7.1h and PhBCl2. However, a signal at ca. δ =6.5 
ppm can be observed in the 2H NMR spectrum. This clearly identified the fate of the non-
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aryl protons in the final product. A scope of other unsubstituted propargyl esters 7.1b-d 
gave similar results (Scheme 97). 
 
Scheme 97: Scope for the 1,3-haloboration reaction of propargyl esters to give producs 7.2 
Electron deficient esters 7.1b-d display the same reactivity to form the 1,3-haloborated 
products and slow evaporation of a saturated solution of the reaction mixture of 7.2d in 
CH2Cl2/hexane produced a crop of crystals suitable for X-ray diffraction. The resolved 
structure confirmed the spectroscopic data (Figure 31). 
 
Figure 31: Solid-state structure of compound 7.2d. Thermal ellipsoids set to 50% probability. H atoms 
omitted for clarity. C: black, O: red, B: pink, Cl: green, N: blue 
It is important to mention that the Z-isomer was observed in all cases, and there was no 
adduct formation between the carbonyl oxygen and the vinyl borane visible in the 11B 
NMR spectrum. When the sterically more demanding dimethyl-substituted esters 7.1e-g 
were reacted with PhBCl2, a different reactivity was observed in which a carboboration 
reaction took place (Scheme 98).  
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Scheme 98: 1,1-Carboboration of esters 7.1 to give alkenes 7.3. Isolated yield in brackets 
Again, slow evaporation of a saturated reaction mixture of 7.3a in a CH2Cl2/hexane 
solution produced a number of colourless crystals suitable for X-ray diffraction (XRD) 
(Figure 32). 
 
Figure 32: Solid-state structure of compound 7.2d. Thermal ellipsoids set to 50% probability. H atoms 
omitted for clarity. C: black, O: red, B: pink, Cl: green 
The determined structure is in agreement with the results of multidimensional NMR 
spectroscopy (HSQC, HMBC) of the isolated product 7.3a. This reactivity resembles the 
1,1-carboboration of propargyl carbamates with BCF described in Scheme 93. Here the 
11B NMR spectrum gives the expected signal at around 0 ppm, reminiscent of a boron-
oxygen adduct (see Chapter 3).  
7.5 Mechanism 
In contrast to Lappert et al. results, it is not the Lewis acidity that influences if a carbo- 
or halo-boration pathway is chosen, but also the steric demand and electronic effects of 
the substrate at the α-position of the ester group. 
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Scheme 99: Possible mechanism for both elementoborations 
As with the first step in Scheme 93, a 1,2-trans-oxyboration initiates the reaction to form 
zwitterionic species A. Subsequently, ring opening takes places. If the α-position of the 
ester group is unsubstituted (R = H) a chloride ion is transferred to it, but if there is steric 
demand present in the α-position (R = Me) this transfer is hindered, promoting a 1,1-
carboboration by migrating the phenyl group of the dioxolium borate zwitterion A.  
7.6 Summary & Outlook 
In summary, the ambiguity between these two elementoboration first described by 
Lappert et al. could be confirmed, and as an additional factor other than Lewis acidity 
the steric demand of the olefin can have an impact of the favoured pathway. This method 
can provide highly functionalised alkenes with both a boron functionality, as well as a 
newly formed carbon-carbon bond or halogen suitable for further reactivity. 
In future work the isolation of the generated 1,3 haloborated products should be one of 
the major focuses as well as further reactivity with the generated products to yield 
compounds interesting for industrial or pharmaceutical purposes. 
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Scheme 100: Expanding the reactivity of propargyl esters with borane Lewis acids 
Also, in connection with Lapperts135,136 work the reactivity of these propargyl esters with 
Ph2BCl should be probed and the differences in reactivity studied, to see whether the 
change in substitution pattern und acidity of the Lewis acid also generates a different 
reactivity. 
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8 Conclusions 
Lewis acids are very versatile reagents and catalysts as shown throughout this Thesis. 
In particular, triaryl boranes have proven to be capable of many transformations. Chapter 
2 emphasised the importance of the substitution pattern of these triaryl boranes and how 
steric demand can reduce the Lewis acidity of these electron deficient boron centres. As 
a first result of this chemistry, Chapter 3 showed that triaryl boranes unsubstituted in the 
ortho-position can be used to reduce ketimines catalytically, while triaryl boranes with 
fluorine atoms in ortho position failed to do so.143 A novel Lewis acid was synthesised for 
mechanistic studies and showed great activity. Therefore, making further hydroboration 
studies with this 3,4,5-substituted triaryl borane highly desirable. Here, the scope may 
be expanded to olefins with initial studies suggesting a ligand metathesis at elevated 
temperature indicating the presence of a highly reactive hydridoborane species (HnBArF2-
n). The tendency to form imine borane adducts was utilised in Chapter 4 to lower the 
LUMO of photo physically active aldehydes and imines.144 Here, the 
tris(pentafluorophenyl)borane adduct of an nBu protected imine proved to be a viable 
indicator to differ between coordinating and non-coordinating, as well as protic and 
aprotic, solvents. These results could be first steps towards photo-physically active 
borane stabilised indicators for different applications. When increasing the steric demand 
in ortho-position of these triaryl boranes the activation of π-basic centres can be 
observed. In Chapter 5 this was used to cyclise alkynyl esters to form pyrones, 
dihydropyrones and isocoumarins.145,146 A slight variation of the starting material could 
give a facile metal-free access to biologically active molecules, making this reactivity 
especially interesting for the pharmaceutical industry. In Chapter 6, a single electron 
transfer reduction of BCF gave the corresponding radical anion. A similar ester motif as 
in Chapter 5, in reaction with the formed radical borane anion, liberates a carbon based 
radical capable of reacting with styrene derivatives to give the formal Heck product. 
Further expanding this reactivity can be of great interest since the majority of Heck 
protocols is metal catalysed and, as discussed in this Thesis, metal-free approaches are 
enticing for various reasons. Finally, Chapter 7 showed the influence of steric hindrance 
in the reactivity of propargyl esters and the haloborane PhBCl2.147 An increase in steric 
demand of the substrates drives the reaction towards a 1,1-carboboration rather than a 
1,3-haloboration product. Both reactions give a highly functionalised organic compounds 
with two functional groups introduced. To summarise these results, this work has 
showcased various novel reaction pathways and mechanisms and suggests that borane 
promoted transformations provide an efficient alternative to metal-based reactions.  
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9 Experimental 
9.1 General procedure 
All synthetic procedures and manipulations were performed either in a glove box with a 
N2-atmosphere or under N2 using standard Schlenk like techniques. The solvents were 
either used straight from the solvent purification system MB SPS-800 (toluene, CH2Cl2, 
MeCN, methanol, DCE, 1,4 dioxane, hexane, pentane) or distilled after stirring over 
sodium/benzophenone (Et2O), potassium (THF) or calcium hydride (CHCl3). All solvents 
were stored over molecular sieves (3 Å). Deuterated solvents were not further purified 
but also stored over molecular sieves (3 Å). Purchased chemicals were used as 
received. Imines in Chapter 3 were supplied by Oestreich and co-workers. 1H, 11B, 13C, 
19F, 31P NMR spectra were recorded on Bruker Avance 300 or 500 and on Bruker Avance 
II 400. 13C spectra were recorded as proton uncoupled spectra. NMR spectra are 
referenced to BF3·OEt2 (11B), CFCl3 (19F), H3PO4 (31P) or the respective NMR solvent in 
the 1H NMR spectrum if not stated differently. Chemical shifts are expressed as parts 
per million (ppm) downfield shift of the respective NMR solvent. Signals are described 
as follows: s = singlet, d = doublet, t = triplet, q = quartet, pent. = quintet, sext. = sextet, 
sept. = septet, m = multiplet and br. = broad. Coupling constants are given in Hertz (Hz). 
Shimadzu IRaffinity-1 photospectrometer was used to measure IR-spectra. Intensities 
are described as follows: s = strong (>80%), m = medium (>60%), w = weak (<60%) and 
br. = broad. Waters LCT Premier/XE and Water GCT Premier was used to do mass 
spectroscopic measurements. The continuous wave (CW) X-band EPR measurements 
were performed on a Bruker EMX spectrometer utilizing an ER4119HS resonator, using 
100 kHz field modulation, 1.0 mW microwave power and <1G amplitude. Simulations of 
the EPR spectra were performed using the Easyspin software package running within 
the Mathworks® MatLab® environment. Melting points were measured using a 
Gallenkamp apparatus and are reported uncorrected. Quartenary carbons adjecent to a 
boron atom are omitted due to broadening. 
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9.2 Lewis acidic boranes utilised in this work 
9.2.1 Synthesis and characterisation of boranes 1 
9.2.1.1 Synthesis of borane 1c 
 
 
1c was synthesised using literature procedure by Lancaster and co-workers.33 
Magnesium turnings (1.18g, 49 mmol, 1 equiv) were suspended in Et2O (100 ml) and 
C6F5Br 1a (6.06 ml, 49 mmol, 1 equiv) was added dropwise slowly at 0 °C. The reaction 
was allowed to stir for 3 h and warmed to room temperature and it turns dark brown. The 
resulting solution is transferred via filter cannula to a stirred solution of BF3·OEt2 (2 ml, 
16 mmol, 0.33 equiv) in toluene (100 ml). The excess Et2O solvent was removed under 
vacuum leaving the mixture as a toluene solution. The mixture was heated making sure 
the temperature does not rise over 100 °C overnight. After cooling to room temperature 
all volatiles were removed under vacuum leaving a bright brown solid residue. The brown 
cake was subjected to a three-fold sublimation (120 °C, 1 x 10-3 bar) giving the desired 
product 1c as a white solid. Yield: 7.05 g, 13.77 mmol, 85%. The spectroscopic data 
agrees with literature established values.33 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 
59.6 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: - 127.73 (br. s, 6F, o-F), -142.46 
(br. s, 3F, p-F), -159.83 (br. s, 6F, m-F). 
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9.2.1.2 Synthesis of borane 1f 
 
1f was synthesised using literature procedures by Ashley and co-workers.47 iPrMgCl 
(12.15 ml, 24 mmol, 2 M, 1 equiv) was added slowly to a Schlenk flask charged with 1-
bromo-3,5-bis(trifluoromethyl)benzene 1e (3.6 ml, 24 mmol, 1 equiv) in THF (100 ml) at 
-20 °C. The reaction was allowed to warm to 0 °C for 30 minutes before being cooled to 
-50 °C. Now BF3·OEt2 (1 ml, 8 mmol, 0.33 equiv) was added dropwise. The mixture was 
warmed to room temperature and after one hour all volatiles were removed under 
vacuum. The amber oil was extracted using a toluene/pentane mixture (1:1, 3 x 40 ml). 
The extract was dried under vacuum. The greyish solid residue was sublimed (100 °C; 
1 x 10-3 bar) to give 1f as a white solid. Yield: 3.27 g, 5.02 mmol, 62%. The spectroscopic 
data agrees with literature established values.47 1H NMR (400 MHz, CDCl3, 298K) δ/ppm: 
8.22 (s, 3H, p-H), δ 7.99 (s, 6H, o-H). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 68.8 (s, 
br). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: −63.4 (s, CF3).  
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9.2.1.3 Synthesis of borane 1h 
 
1-Bromo-3,4,5-trifluorobenzene 1g (3.5 ml, 29.4 mmol, 1 equiv) was dissolved in 
diethylether (50 ml). The resulting solution was stirred and cooled to –78 °C, and a 
solution of nBuLi (20 ml, 1.47 M, 29.4 mmol, 1 equiv) was added slowly. The resulting 
yellow solution was stirred for 2 h and turned white. To the still cool mixture, BF3·OEt2 
(1.2 ml, 9.8 mmol, 0.33 equiv) was added dropwise and, after stirring for another 2 h, the 
cooling setup was removed. The reaction was stirred overnight, the solvent was then 
removed in vacuo, and the resulting solid was sublimed at 120 °C under vacuum yielding 
pale yellow oily crystals that were washed with pentane (3 x 3 ml), dried, and resublimed 
to afford 1h (as a pale-yellow crystal. Yield: 0.65 g, 16%, 1.56 mmol. 1H NMR (400 MHz, 
CDCl3, 298K) δ/ppm: 7.07 (t, 3JHF = 7.4 Hz, 6H). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 151.3 (ddd, 1,2,3JCF = 254.0, 9.6, 2.7 Hz, m-C), 143.0 (dt, 1,2JCF = 260.9, 15.0 Hz, 
p-C), 136.5–136.0 (m, C-B), 122.0 (dd, 2,3JCF = 13.6, 5.4 Hz, o-C).33 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 64.6 ppm. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -133.2 (d, 
3JFF = 20.1 Hz, m-F), -152.4 (t, 3JFF = 20.1 Hz, p-F). HRMS (TOF EI) m/z calculated for 
[C18H6F9B]+: 404.0413, found: 404.0529. 
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9.2.1.4 Synthesis of borane 1i 
 
 
1i was synthesised using literature procedures by Alcazaro and co-workers.49 1-Bromo-
2,4,6-trifluorobenzene (2.87 ml, 24.3 mmol, 1 equiv) was dissolved in THF (50 ml) and 
cooled to -20 °C. At this temperature iPrMgCl (4.0 ml, 8.1 mmol, 1 equiv, 2M in THF) 
was added dropwise. The reaction mixture allowed to warm up to 0 °C and after 1 h 
cooled to -50 °C. At this temperature BF3·OEt2 (1.00 ml, 8.1 mmol, 0.33 equiv) is added 
dropwise. After stirring for an hour the mixture was allowed to warm to room temperature. 
All volatiles were removed under vacuum and the resulting solid was subject of a two-
fold sublimation (120 °C, 1 x 10-3 bar) to give 1i as a white solid. Yield: 3.27 g, 5.02 
mmol, 62%. The spectroscopic data agrees with literature established values.49 1H NMR 
(500 MHz, CDCl3, 298 K) δ/ppm: 6.64 (t, 3JHF = 8.3 Hz, 6H, m-H). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 58.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -95.75 (d, 
4JFF = 10.4 Hz, 6F, o-F), -100.31 (t, 4JFF = 10.4 Hz, 3F, p-F). 
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9.2.1.5 Synthesis of borane 1l 
 
1-bromo-4-fluorobenzene (46) (3.72 ml, 34.1 mmol, 1 equiv) was suspended in Et2O at 
–78 °C and nBuLi (15 ml, 37.5 mmol, 1.1 equiv) was added dropwise and the reaction 
mixture was allowed to stir at –78 °C for 3h. BF3·OEt2 (1.4 ml, 11.37 mmol, 0.33 equiv) 
was added to the reaction mixture dropwise and the reaction mixture was allowed to 
warm to room temperature overnight. Removal of all volatiles in situ and a three-fold 
sublimation of the remaining solid (120 °C, 1 × 10–3 mbar) afforded the desired borane 
1l as a white solid. Yield: 2.74g, 9.28 mmol, 82%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.64 -7.57 (m, 2H), 7.13 – 7.21 (m, 2H). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 65.2 (s, 1B). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -107.79 (s, 1F). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 165.5 (d, 1JCF = 253.0 Hz, 3C, p-C), 141.0 (d, 3JCF = 8.4 
Hz, 6C, o-C), 138.8 (br. s, 3C, B-C), 115.0 (d, 2JCF = 20.0 Hz, 6C, m-C). HRMS (ESI) m/z 
calculated for C18H12F3B [M+H]+: 296.0984, found: 296.0996. 
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9.2.1.6 Synthesis of borane 1n 
 
A solution of 4-bromo-1,2-dichlorobenzene (2.74 g, 12.1 mmol, 1 equiv) in diethylether 
(50 ml, dry) was cooled to -78° C under nitrogen and nBuLi (4.9 ml, 2.5 M, 12.1 mmol, 1 
equiv) in hexane was added dropwise. The solution turned yellow and was stirred for an 
additional 2 h to give a white suspension. BF3·OEt2 (0.5 ml, 4.0 mmol, 0.33 equiv) was 
added dropwise and the mixture was allowed to warm to room temperature and stirred 
overnight. The resulting suspension was filtered and the filtrate is concentrated in vacuo. 
The yellow solid was dissolved in CHCl3 (5 ml) and kept at -40 °C over night. The cooled 
suspension was filtered and pentane (0.1 ml) was added. After storing it at -40 °C for an 
additional 4 h, a white solid crashed out and was filtered, washed with pentane (3 x 1ml) 
and dried under reduced pressure yielding 1n as a white solid. Yield: 244 mg, 0.54 mmol, 
22%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.60 (s, 1H), 7.60 (d, 3JHH = 9.1 Hz, 1H), 
7.37 (dd, 3,4JHH = 8.0, 1.6 Hz, 1H). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 65.8 (s). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 139.7, 137.4, 137.3, 133.0, 130.5. HRMS 
(ESI) m/z calculated for C18H10Cl6B [M+H]+: 445.9033, found: 445.9043. 
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9.2.2 Crystallographic data for 1h, 1i, 1l and 1n 
 
Compound 1h 1i 1l 1n 
Empirical 
Formula 
C18H6BF9 C18H6BF9 C18H12BF3 C18H9BCl6 
Space Group P 21/n P 21/n P 21/c P 21/n 
a/Å 9.6716(3) 10.3269(5) 8.2446(6) 10.9777(7) 
b/Å 12.3184(4) 19.3379(11) 17.9887(11) 15.5702(7) 
c/Å 13.4558(5) 15.9140(9) 9.8915(6) 11.5678(7) 
α/° 90 90 90 90 
β/° 100.288(3) 96.824(5) 101.431(6) 111.393(7) 
ϒ/° 90 90 90 90 
Volume/Å3 1577.34(9) 3155.5(3) 1437.91(16) 1841.0(2) 
Z 4 8 4 4 
T/K 150 150 150 150 
Dc/g·cm-3 1.701 1.701 1.368 1.619 
R (reflections) 0.0443(2480) 0.0428(5107) 0.0482(2296) 0.0370(3352) 
wR2 (reflections) 0.1305(3086) 0.1154(6877) 0.1382(3140) 0.0827(4190) 
Theta(max) 73.906 27.103 27.101 27.876 
     
 
9.2.3 Lewis acidities determined via the Gutmann Beckett method6 
 
Borane 31P NMR Shift [ppm] 𝐴𝑁 = (𝛿 − 41.0) 10086.14 − 41.0 
BPh3 64.94 53 
1c 75.98 76 
1h 76.92 79 
1i 71.90 69 
1l 66.73 57 
1n 76.24 78 
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9.2.4 General Procedure A1 for the Gutmann Beckett method 
The borane (1.0 equiv) was dissolved in CDCl3 (0.5 ml) and was added to 
triethylphosphine oxide (0.6 equiv). A capillary containing PPh3 in CDCl3 was added as 
a standard and the NMR tube was inverted several times. The 31P NMR chemical shift 
of the triphenylphosphine (PPh3) in CDCl3 was calibrated to δ = -5.21 ppm according to 
Demchuk et al.148 and the acceptor number was calculated according to Beckett et al.6 
9.2.4.1 Triphenylborane (BPh3) 
According to general procedure A1, triphenylborane (15 mg, 0.062 mmol, 1 equiv) and 
triethylphosphine oxide (5.0 mg, 0.037 mmol, 0.6 equiv). 31P NMR (162 MHz, CDCl3, 298 
k) δ/ppm: 64.94 (s). 
9.2.4.2 Tris(pentafluorophenyl)borane (1c) 
According to general procedure A1, tris(pentafluorophenyl)borane (20 mg, 0.04 mmol, 1 
equiv) and triethylphosphine oxide (3.14 mg, 0.023 mmol, 0.6 equiv). 31P NMR (162 MHz, 
CDCl3, 298 k) δ/ppm: 75.98 (s). 
9.2.4.3 Tris(3,4,5-trifluorophenyl)borane (1h) 
According to general procedure A1, tris(3,4,5-trifluorophenyl)borane (20 mg, 0.050 
mmol, 1 equiv) and triethylphosphine oxide (3.98 mg, 0.030 mmol, 0.6 equiv). 31P NMR 
(162, MHz, CDCl3, 298 k) δ/ppm: 76.92 (s). 
9.2.4.4 Tris(4-fluorophenyl)borane (1l) 
According to general procedure A1, tris(4-fluorophenyl)borane (20 mg, 0.068 mmol, 1 
equiv) and triethylphosphine oxide (5.5 mg, 0.041 mmol, 0.6 equiv). 31P NMR (162 MHz, 
CDCl3, 298 k) δ/ppm: 66.73 (s). 
9.2.4.5 Tris(3,4-dichlorophenyl)borane (1n) 
According to general procedure A1, tris(3,4-dichlorophenyl)borane (30 mg, 0.067 mmol, 
1 equiv) and triethylphosphine oxide (5.38 mg, 0.040 mmol, 0.6 equiv). 31P NMR (162, 
MHz, CDCl3, 298 k) δ/ppm: 76.24 (s). 
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9.3 Hydroboration of imines 
9.3.1 General procedure B1: 
In a glove box, a 2-ml GLC-vial equipped with a stirring bar is charged with BArF3 (1.0 
mol%), imine (1.0 equiv), and HBpin (1.2 equiv). Benzene (1 ml) is added to the reaction, 
and the resulting mixture is stirred for 18 h at room temperature. The resulting yellow 
orange solution is then diluted with CH2Cl2 (ca. 3 ml) and washed with water (3 × 5 ml). 
The combined organic layers are washed with brine (5.0 ml), dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The conversion is determined by GLC-MS 
analysis of the crude material. The crude mixture is further purified by flash-column 
chromatography on silica gel using the indicated eluent. 
9.3.2 Product characterisation 
9.3.2.1 Synthesis of 2.3a 
 
Prepared from (E)-N,1-diphenylethan-1-imine (0.2 mmol, 39.4 mg) and HBpin (30.7 mg, 
0.24 mmol, 1.2 equiv) according to the general procedure B1. The title compound was 
purified by flashcolumn chromatography using cyclohexane/TBME (25/1) as eluent to 
afford 2.3a as colourless oil. Spectroscopic data agrees with literature values.149 Yield: 
34.5 mg, 0.17 mmol, 87% 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.43–7.38 (m, 2H), 
7.35 (t, 3JHH = 7.5 Hz, 2H), 7.30–7.23 (m, 1H), 7.13 (t, 3JHH = 7.6 Hz, 2H), 6.69 (t, 3JHH = 
7.3 Hz, 1H), 6.55 (d, 3JHH = 8.6 Hz, 2H), 4.52 (q, 3JHH = 6.7 Hz, 1H), 4.16 (br. s, 1H), 1.55 
(d, 3JHH = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 147.3, 145.2, 129.2, 
128.7, 127.0, 125.9, 117.4, 113.4, 53.6, 25.1.  
9.3.2.2 Synthesis of 2.3b 
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Prepared from (E)-1-(3-bromophenyl)-N-phenylethan-1-imine (54.9 mg, 0.2 mmol) and 
HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3b as colourless oil. Spectroscopic data agrees with literature 
values.149 Yield: 42.3 mg, 0.15 mmol, 77% 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
7.44 (s, 1H), 7.30–7.24 (m, 1H), 7.22 (d, 3JHH = 7.7 Hz, 1H), 7.09 (t, 3JHH = 7.8 Hz, 1H), 
7.02 (t, 3JHH = 8.0 Hz, 2H), 6.59 (t, 3JHH = 7.3 Hz, 1H), 6.41 (d, 3JHH = 8.5 Hz, 2H), 4.35 
(q, 3JHH = 6.7 Hz, 1H), 4.15 (br. s, 1H), 1.42 (d, 3JHH = 6.8 Hz, 3H). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 148.0, 146.9, 130.4, 130.2, 129.3, 129.2, 124.7, 123.0, 117.9, 
113.6, 53.5, 25.2. 
9.3.2.3 Synthesis of 2.3c 
 
Prepared from (E)-1-(4-bromophenyl)-N-phenylethan-1-imine (55.4 mg, 0.2 mmol) and 
HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3c as colorless oil. Spectroscopic data agrees with literature 
values.149 Yield: 53.4 mg, 0.19 mmol, 96% 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
7.47 (d, 3JHH = 8.4 Hz, 2H), 7.28 (d, 3JHH = 8.2 Hz, 2H), 7.17–7.11 (m, 2H), 6.71 (t, 3JHH 
= 7.3 Hz, 1H), 6.53 (d, 3JHH = 7.6 Hz, 2H), 4.47 (q, 3JHH = 6.7 Hz, 1H), 4.29 (br. s, 1H), 
1.53 (d, 3JHH = 6.8 Hz, 3H). ). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 146.8, 144.3, 
131.9, 129.3, 127.8, 120.7, 117.9, 113.7, 53.4, 25.1. 
9.3.2.4 Synthesis of 2.3d 
 
Prepared from (E)-N-phenyl-1-(4-(trifluoromethyl)phenyl)ethan-1-imine (52.6 mg, 0.2 
mmol) and HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure 
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B1. The title compound was purified by flash-column chromatography using 
cyclohexane/TBME (25/1) as eluent to afford 2.3d as light-yellow oil. Spectroscopic data 
agrees with literature values.149 Yield: 47.5 mg, 0.18 mmol, 90%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.48 (d, 3JHH = 8.3 Hz, 2H), 7.40 (d, 3JHH = 8.2 Hz, 2H), 7.02 (t, 
3JHH = 8.0 Hz, 2H), 6.60 (t, 3JHH = 7.3 Hz, 1H), 6.40 (d, 3JHH = 7.7 Hz, 2H), 4.44 (q, 3JHH = 
6.8 Hz, 1H), 4.30 (br. s, 1H), 1.44 (d, 3JHH = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 149.4, 146.6, 129.3 (q, 2JCF = 32.3 Hz), 129.3, 126.3, 125.7 (q, 3JCF = 3.8 Hz), 
118.0, 113.6, 53.6, 25.2. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: −64.4 (s, CF3). 
9.3.2.5 Synthesis of 2.3e 
 
Prepared from (E)-1-(3,5-bis(trifluoromethyl)phenyl)-N-phenylethan-1-imine (0.2 mmol, 
66.5 mg) and HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure 
B1. The title compound was purified by flash-column chromatography using 
cyclohexane/TBME (18/1) as eluent to afford 2.3e as a colourless liquid. Spectroscopic 
data agrees with literature values.149 Yield: 56.0 mg, 0.17, 84%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.86 (s, 2H), 7.78 (s, 1H), 7.14 (t, 3JHH = 8.0 Hz, 2H), 6.74 (t, 3JHH 
= 7.3 Hz, 1H), 6.50 (d, 3JHH = 7.7 Hz, 2H), 4.59 (q, 3JHH = 6.7 Hz, 1H), 4.32 (br. s, 1H), 
1.57 (d, 3JHH = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 148.3, 146.4, 
132.2 (q, 2JCF = 33.3 Hz), 129.5, 126.4, 123.5 (q, 1JCF = 272.9 Hz), 121.4, 118.6, 113.8, 
53.8, 25.1.2 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: −62.9 (s, CF3). 
9.3.2.6 Synthesis of 2.3f 
 
Prepared from (E)-1-(3,5-dimethylphenyl)-N-phenylethan-1-imine (0.2 mmol, 45.2 mg) 
and HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The 
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title compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3f as a colourless liquid. Spectroscopic data agrees with 
literature values.149 Yield: 43.1 mg, 0.19 mmol, 95%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.17–7.11 (m, 2H), 7.02 (s, 2H), 6.91 (s, 1H), 6.73–6.67 (m, 1H), 6.61–6.56 (m, 
2H), 4.44 (q, 3JHH = 6.7 Hz, 1H), 4.28 (br. s, 1H), 2.34 (s, 6H), 1.54 (d, 3JHH = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 147.3, 145.2, 138.2, 129.2, 128.7, 123.8, 
117.4, 113.6, 53.8, 25.0, 21.5. 
9.3.2.7 Synthesis of 2.3g 
 
Prepared from (E)-1-(naphthalen-2-yl)-N-phenylethan-1-imine (0.2 mmol, 49.6 mg) and 
HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3g as a colourless liquid. Spectroscopic data agrees with 
literature values.150 Yield: 46.0 mg, 0.18 mmol, 92%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.88–7.82 (m, 4H), 7.55 (d, 3JHH = 8.6 Hz, 1H), 7.52–7.45 (m, 2H), 7.13 (t, 3JHH = 
8.0 Hz, 2H), 6.70 (t, 3JHH = 7.3 Hz, 1H), 6.62 (d, 3JHH = 8.5 Hz, 2H), 4.68 (q, 3JHH = 6.7 
Hz, 1H), 4.45 (br. s, 1H), 1.64 (d, 3JHH = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 147.2, 142.7, 133.7, 132.9, 129.3, 128.6, 128.0, 127.8, 126.1, 125.7, 124.6, 
124.5, 117.7, 113.7, 54.1, 25.0. 
9.3.2.8 Synthesis of 2.3h 
 
Prepared from (E)-1-(naphthalen-1-yl)-N-phenylethan-1-imine (0.2 mmol, 49.8 mg) and 
HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3h as a colourless liquid. Spectroscopic data agrees with 
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literature values.151 Yield: 49.9 mg, 0.2 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 8.20 (d, 3JHH = 8.3 Hz, 1H), 7.94 (d, 3JHH = 8.1 Hz, 1H), 7.79 (d, 3JHH = 8.2 Hz, 
1H), 7.70 (d, 3JHH = 7.2 Hz, 1H), 7.63–7.51 (m, 2H), 7.44 (t, 3JHH = 7.7 Hz, 1H), 7.14–
7.07 (m, 2H), 6.72– 6.66 (m, 1H), 6.54 (d, 3JHH = 7.6, 2H), 5.33 (q, 3JHH = 6.4 Hz, 1H), 
4.41 (s, 1H), 1.70 (d, 3JHH = 7.9 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
147.1, 140.0, 134.2, 130.9, 129.3, 127.6, 126.2, 126.0, 125.6, 122.7, 122.5, 117.5, 113.5, 
49.7, 23.7. 
9.3.2.9 Synthesis of 2.3i 
 
Prepared from (E)-1-phenyl-N-(4-(trifluoromethyl)phenyl)ethan-1-imine (0.2 mmol, 51.8 
mg) and HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. 
The title compound was purified by flash-column chromatography using 
cyclohexane/TBME (25/1) as eluent to afford 2.3i as a colourless liquid. Spectroscopic 
data agrees with literature values.149 Yield: 15.6 mg, 0.06 mmol, 30%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.34–7.31 (m, 6H), 7.28–7.24 (m, 1H), 6.53 (d, 3JHH = 7.8 
Hz, 2H), 4.52 (q, 3JHH = 6.7 Hz, 1H), 1.55 (d, 3JHH = 6.7 Hz, 3H). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 149.5, 144.2, 129.0, 127.4, 126.6 (q, 3JCF = 3.7 Hz), 125.9, 125.0 
(q, 1JCF = 269.8 Hz), 118.6 (q, 2JCF = 32.0 Hz), 112.8, 53.6, 24.9. 19F NMR (376 MHz, 
CDCl3, 298 K) δ/ppm: −65.1 (s, CF3). 
9.3.2.10 Synthesis of 2.3k 
 
Prepared from (E)-N-benzyl-1-phenylethan-1-imine (0.2 mmol, 42.9 mg) and HBpin 
(30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(10/1) as eluent to afford 2.3k as a colourless liquid. Spectroscopic data agrees with 
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literature values.152 Yield: 35.9 mg, 0.17 mmol, 83%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.33–7.18 (m, 10H), 3.78 (q, 3JHH = 6.6 Hz, 1H), 3.59 (q, 3JHH = 13.2 Hz, 2H), 2.61 
(br. s, 1H), 1.35 (d, 3JHH = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 144.9, 
139.9, 128.7, 128.6, 128.4, 127.3, 127.3, 126.9, 57.7, 51.6, 24.3. 
9.3.2.11 Synthesis of 2.3l 
 
Prepared from 4-methyl-N-(1-phenylethylidene)benzenesulfonamide (0.2 mmol, 55.1 
mg) and HBpin (30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. 
The title compound was purified by flash-column chromatography using 
cyclohexane/TBME (25/1) as eluent to afford 2.3l as a colourless liquid. Spectroscopic 
data agrees with literature values.153 Yield: 38.4 mg, 0.14 mmol, 70%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.62 (d, 3JHH = 8.3 Hz, 2H), 7.19–7.16 (m, 4H), 7.11–7.09 
(m, 2H), 5.12 (br. s, 1H), 4.49–4.42 (m, 1H), 2.38 (s, 3H), 1.41 (d, 3JHH = 6.9 Hz, 3H). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 143.2, 142.2, 137.7, 129.5, 128.6, 127.5, 127.2, 
126.2, 53.7, 23.7, 21.6. 
9.3.2.12 Synthesis of 2.3m 
 
Prepared from (E)-N,1-diphenylpropan-1-imine (0.2 mmol, 41.8 mg) and HBpin (30.7 
mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title compound 
was purified by flash-column chromatography using cyclohexane/TBME (25/1) as eluent 
to afford 2.3m as a colourless liquid. Spectroscopic data agrees with literature values.149 
Yield: 35.1 mg, 0.17 mmol, 83%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.38–7.30 
(m, 4H), 7.26–7.21 (m, 1H), 7.13 – 7.08 (m, 2H), 6.66 (t, 3JHH = 7.3 Hz, 1H), 6.55 (d, 3JHH 
= 7.8 Hz, 2H), 4.35 (br. s, 1H), 4.24 (t, 3JHH = 6.7 Hz, 1H), 1.95–1.78 (m, 2H), 0.97 (t, 
3JHH = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 147.3, 143.8, 129.2, 128.6, 
127.1, 126.7, 117.5, 113.6, 60.1, 31.7, 11.0. 
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9.3.2.13 Synthesis of 2.3n 
 
Prepared from N,1,1-triphenylmethanimine (0.2 mmol, 51.8 mg) and HBpin (30.7 mg, 
0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title compound was 
purified by flash-column chromatography using cyclohexane/TBME (25/1) as eluent to 
afford 2.3n as a colourless liquid. Spectroscopic data agrees with literature values.154 
Yield: 49.2 mg, 0.19 mmol, 94%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.61–7.45 
(m, 10H), 7.37–7.30 (m, 2H), 6.92 (t, 3JHH = 6.6 Hz, 1H), 6.78 (d, 3JHH = 7.5 Hz, 2H), 5.72 
(s, 1H), 4.46 (br. s, 1H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 147.3, 142.9, 129.2, 
128.9, 127.5, 127.4, 117.8, 113.6, 63.2 
9.3.2.14 Synthesis of 2.3o 
 
Prepared from (E)-N,1-diphenylmethanimine (0.2 mmol, 36.5 mg) and HBpin (30.7 mg, 
0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title compound was 
purified by flash-column chromatography using cyclohexane/TBME (25/1) as eluent to 
afford 2.3o as a colourless liquid. Spectroscopic data agrees with literature values.155 
Yield: 31.7 mg, 0.17 mmol, 86% 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.43–7.27 
(m, 5H), 7.21 (t, 3JHH = 7.6 Hz, 2H), 6.76 (t, 3JHH = 7.3 Hz, 1H), 6.68 (d, 3JHH = 7.7 Hz, 
2H), 4.36 (br. s, 1H), 4.36 (s, 2H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 148.0, 
139.4, 129.4, 128.8, 127.7, 127.4, 117.9, 113.2, 48.6. 
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9.3.2.15 Synthesis of 2.3p 
 
Prepared from (E)-N-benzhydryl-1-phenylmethanimine (0.2 mmol, 55.1 mg) and HBpin 
(30.7 mg, 0.24 mmol, 1.2 equiv) according to the General Procedure B1. The title 
compound was purified by flash-column chromatography using cyclohexane/TBME 
(25/1) as eluent to afford 2.3p as a colourless liquid. Spectroscopic data agrees with 
literature values.156 Yield: 47.9 mg, 0.17 mmol, 86% 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.44–7.42 (m, 4H), 7.33–7.18 (m, 11H), 4.86 (s, 1H), 3.75 (s, 2H), 2.04 (br. s, 
1H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 143.9, 140.3, 128.6, 128.5, 128.4, 127.5, 
127.2, 127.1, 66.5, 51.9. 
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9.4 Photophysical properties of imines 
9.4.1 General procedure C1 for the synthesis of aldehyde reagents 4.1 
In accordance with the literature71 CuI (1 mol%), Pd(PPh3)2Cl2 (2 mol%) and the 
corresponding aldehyde (1.0 equiv) were stirred in dry NEt3. The acetylene reagent (1.2 
equiv) was added slowly at room temperature. The reaction mixture was heated up to 60 
°C for 19 h. After cooling the solution to room temperature, the suspension was filtered 
using a silica plug and washed with Et2O (2 x 10 ml). The solvent was removed in vacuo 
and the crude product was purified by column chromatography. The resultant oil was 
distilled to give the desired product. 
9.4.1.1 Synthesis of 4.1a 
 
In accordance to General Procedure C1, CuI (20.6 mg, 0.11 mmol, 1 mol%), 
Pd(PPh3)2Cl2 (151 mg, 0.22 mmol, 2 mol%) and 2-bromobenzaldehyde (1.26 ml, 
11 mmol, 1.0 equiv) and phenylacetylene (1.42 ml, 13 mmol, 1.2 equiv) in dry NEt3 
(40 ml) were used to synthesise the compound 4.1a. The crude product was purified by 
column (SiO2, hexane/EtOAc, 50:1). The oil was distilled (180 °C, 15 mmHg) to give the 
desired product as an oil. Yield: 2.19 g, 9.70 mmol, 90%. Spectroscopic data agrees 
with literature known values.71 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 10.66 (d, 
4JHH = 0.8 Hz, 1H), 7.95 (ddd, 3JHH = 7.8 Hz, 4JHH = 1.5 Hz, 4JHH = 0.6 Hz, 1H), 7.63 (ddd, 
3JHH = 7.8 Hz, 4JHH = 1.5 Hz, 4JHH = 0.6 Hz, 1H), 7.59–7.53 (m, 3H), 7.49–7.44 (m, 1H), 
7.40–7.35 (m, 3H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 191.8, 135.9, 133.9, 
133.3, 131.8, 129.2, 128.7, 128.6, 127.3, 126.9, 122.4, 96.4, 85.0. 
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9.4.1.2 Synthesis of 4.1b 
 
In accordance to General Procedure C1, CuI (42 mg, 0.22 mmol, 4 mol%), Pd(PPh3)2Cl2 
(78 mg, 0.11 mmol, 2 mol%), 2-ethynylbenzaldehyde (0.94 g, 7.22 mmol, 1.3 equiv) and 
4-iodoanisol (1.30 g, 11 mmol, 1.0 equiv) in dry NEt3 (50 ml) were used to synthesise 
compound 4.1b. The crude product was purified by column (SiO2, hexane/EtOAc, 40:1, 
gradient to 35:1). The resulting orange oil was recrystallised with CH2Cl2/Hexane. The 
product was isolated as a colourless solid. Yield: 0.602 g, 2.5 mmol, 46%. Spectroscopic 
data agrees with literature known values.71 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
10.65 (d, 4JHH = 0.8 Hz, 1H), 7.94 (ddd, 3JHH = 7.9 Hz, 4JHH = 1.4 Hz, 4JHH = 0.6 Hz, 1H), 
7.65–7.55 (m, 2H), 7.54–7.48 (m, 2H), 7.43 (m, 1H), 6.94–6.88 (m, 2H), 3.85 (s, 3H). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 192.0, 160.4, 135.8, 133.9, 133.4, 133.2, 128.4, 
127.5, 127.3, 114.5, 114.3, 96.7, 83.9, 55.5. 
 
9.4.1.3 Synthesis of 4.1c 
 
In accordance with General Procedure C1, CuI (15 mg, 0.08 mmol, 1 mol%), 
Pd(PPh3)2Cl2 (114 mg, 0.17 mmol, 2 mol%), 4-ethynylanisole (1.05 ml, 8.1 mmol, 1.0 
equiv) and 4-bromobenzaldehyde (1.80 g, 9.7 mmol, 1.2 equiv) in dry NEt3 (60 ml) were 
used to synthesise compound 4.1c. The crude product was purified by column (SiO2, 
hexane/EtOAc, 40:1, gradient to 10:1). The product was isolated as a white solid. Yield: 
1.29 g, 5.5 mmol, 67%. Spectroscopic data agrees with literature known values.71 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 10.01 (s, 1H), 7.89–7.81 (m, 2H), 7.68–7.62 (m, 
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2H), 7.53–7.48 (m, 2H), 6.95–6.87 (m, 2H), 3.85 (s, 3H). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 191.6, 160.3, 135.2, 133.5, 132.0, 130.2, 129.7, 114.7, 114.3, 93.9, 87.6, 55.5. 
9.4.2 General procedure C2 & C3 for the synthesis of imine reagents 4.3 
General procedure C2:  
The aldehyde (1.0 equiv) was dissolved in dry CH2Cl2 with molecular sieves. The amine 
(4.0 equiv) was added dropwise over a period of 5 minutes. The reaction mixture was 
stirred for 18 h at room temperature. The solution was filtered and washed with CH2Cl2 
(2 x 10 ml). The solvent was removed in vacuo. The crude product was dried under 
vacuum to remove the excess amine.  
General procedure C3:  
The aldehyde (1.0 equiv) was dissolved in dry CH2Cl2 with MgSO4. The amine (4.0 equiv) 
was added added dropwise over a period of 5 minutes. The reaction mixture was stirred 
for 18 h at room temperature. The solution was filtered through a sinter funnel and 
washed with CH2Cl2. The solvent was removed in vacuo with the crude product being 
dried over MgSO4, and the volatiles removed in vacuo. 
9.4.2.1 Synthesis of 4.3a 
 
 
In accordance with General Procedure C2, 4.3a was synthesised using 4.1b (100 mg, 
0.42 mmol, 1.0 equiv) and aniline (0.15 ml, 1.7 mmol, 4.0 equiv) in CH2Cl2 (2.5 ml). The 
product was isolated as an orange oil. Yield: 83 mg, 0.27 mmol, 63 %. 1H NMR (500 
MHz, CDCl3) δ/ppm: 9.10 (s, 1H), 8.30 – 8.24 (m, 1H), 7.61 – 7.57 (m, 1H), 7.50 – 7.46 
(m, 2H), 7.44 – 7.40 (m, 2H), 7.18 – 7.13 (m, 2H), 6.91 – 6.87 (m, 2H), 6.76 (tt, 3,4JHH = 
7.4, 1.0 Hz, 1H), 6.71 – 6.68 (m, 2H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3) δ/ppm: 
160.1, 159.2, 152.4, 136.6, 133.2, 132.7, 131.0, 129.4, 129.4, 128.5, 126.7, 126.2, 121.2, 
118.7, 115.2, 114.3, 95.7, 85.2, 55.5. HRMS (ES+) m/z calculated for [C22H18NO]+ 
[M+H]+: 312.1388, found: 312.1388.  
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9.4.2.2 Synthesis of 4.3b 
 
In accordance with General Procedure C2, 4.3b was synthesised using 4.1b (150 mg, 
0.64 mmol, 1.0 equiv) and isopropylamine (0.22 ml, 2.6 mmol, 4.0 equiv) in CH2Cl2 
(2.5 ml). The product was isolated as a yellow oil. Yield: 58 mg, 0.21 mmol, 33%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.90 (d, 4JHH = 0.8 Hz, 1H), 8.09–8.03 (m, 1H), 
7.57–7.46 (m, 3H), 7.41–7.29 (m, 2H), 6.94–6.87 (m, 2H), 3.85 (s, 3H), 3.63 (pd, 
3JHH = 6.3 Hz, 4JHH = 0.8 Hz, 1H), 1.29 (d, 3JHH = 6.3 Hz, 6H). 13C NMR (126 MHz, CDCl3) 
δ/ppm: 160.0, 157.2, 137.0, 133.1, 132.4, 130.1, 128.4, 126.5, 124.3, 115.2, 114.2, 95.0, 
85.4, 62.0, 55.5, 24.4. HRMS (ES+) m/z calculated for [C19H20NO]+ [M+H]+: 278.1545, 
found: 278.1552. 
9.4.2.3 Synthesis of 4.3c 
 
In accordance with General Procedure C2, 4.3c was synthesised using 4.1b (270 mg, 
1.1 mmol, 1.0 equiv) and n-butylamine (0.45 ml, 4.4 mmol, 4.0 equiv) in CH2Cl2 (4 ml). 
The product was isolated as a yellow solid. Yield: 191 mg, 0.65 mmol, 57%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.87 (d, 4JHH = 1.4 Hz, 1H), 8.04 (dd, 3JHH = 7.4 Hz, 
4JHH = 1.9 Hz, 1H), 7.58–7.46 (m, 3H), 7.42–7.29 (m, 2H), 6.97–6.86 (m, 2H), 3.84 (s, 
3H), 3.68 (td, 3JHH = 7.0 Hz, 4JHH = 1.4 Hz, 2H), 1.79–1.66 (m, 2H), 1.49–1.34 (m, 2H), 
0.96 (t, 3JHH = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 207.2, 160.0, 
159.7, 136.8, 133.1, 132.5, 130.1, 128.4, 126.3, 124.4, 115.2, 114.2, 95.0, 85.4, 61.8, 
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55.5, 33.1, 20.6, 14.1. HRMS (ES+) m/z calculated for [C20H22NO]+ [M+H]+: 292.1701, 
found: 292.1700. 
9.4.2.4 Synthesis of 4.3d 
 
In accordance with General Procedure C2, 4.3d was synthesised using 4.1c (150 mg, 
0.63 mmol, 1.0 equiv) and aniline (0.23 ml, 2.5 mmol, 4.0 equiv) in CH2Cl2 (2 ml). The 
product was isolated as a light-yellow solid. Yield: 52.3 mg, 0.17 mmol, 26%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.46 (s, 1H), 7.92–7.85 (m, 2H), 7.64–7.58 (m, 2H), 
7.53–7.47 (m, 2H), 7.44–7.38 (m, 2H), 7.29–7.20 (m, 3H), 6.93–6.87 (m, 2H), 3.84 (d, 
4JHH = 0.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ/ppm: 207.2, 160.0, 159.6, 152.0, 135.6, 
133.3, 131.9, 129.4, 129.3, 128.8, 126.8, 126.3, 121.0, 115.2, 115.1, 114.2, 92.1, 88.1, 
55.5. HRMS (ES+) m/z calculated for [C22H18NO]+ [M+H]+: 312.1388, found: 312.1387. 
9.4.2.5 Synthesis of 4.3e 
 
In accordance with General Procedure C2, 4.3e was synthesised using 4.1c (250 mg, 
1.1 mmol, 1.0 equiv) and isopropylamine (0.36 ml, 4.2 mmol, 4.0 equiv) in CH2Cl2 (4 ml). 
The product was isolated as a yellow solid. Yield: 50 mg, 0.18 mmol, 17%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.29 (s, 1H), 7.72–7.68 (m, 2H), 7.56–7.52 (m, 2H), 7.50–
7.46 (m, 2H), 6.91–6.86 (m, 2H), 3.83 (s, 3H), 3.61–3.49 (m, 1H), 1.27 (d, 3JHH = 6.3 Hz, 
6H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 159.9, 157.8, 135.9, 133.3, 131.7, 128.1, 
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125.7, 115.3, 114.2, 91.3, 88.1, 61.9, 55.5, 24.3. HRMS (ES+) m/z calculated for 
[C19H20NO]+ [M+H]+: 277.1467, found: 277.1469. 
9.4.2.6 Synthesis of 4.3f 
 
In accordance with General Procedure C3, 4.3f was synthesised using 4.1c (500 mg, 
2.1 mmol, 1.0 equiv) and n-butylamine (0.84 ml, 8.5 mmol, 4.0 equiv) in CH2Cl2 (8 ml). 
The product was isolated as a yellow solid. Yield: 523 mg, 1.8 mmol, 85%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.26 (t, 4JHH = 1.3 Hz, 1H), 7.73–7.65 (m, 2H), 7.58–7.52 (m, 
2H), 7.50–7.43 (m, 2H), 6.94–6.84 (m, 2H), 3.83 (s, 3H), 3.62 (td, 3JHH = 7.0 Hz, 
4JHH = 1.3 Hz, 2H), 1.77–1.63 (m, 2H), 1.47–1.33 (m, 2H), 0.95 (t, 3JHH = 7.4 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ/ppm: 160.5, 160.2, 136.1, 133.6, 132.1, 128.3, 126.1, 115.6, 
114.5, 91.7, 88.4, 62.0, 55.8, 33.5, 21.0, 14.4. HRMS (ES+) m/z calculated for 
[C20H21NO]+ [M+H]+: 292.1701, found: 292.1700. 
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9.4.3 11B NMR shifts of the adducts of aldehydes 4.1a-c and 4.3a-f with various 
boranes 
9.4.3.1 Definition of adduct formation 
Observing the mixture of aldehydes (4.1) and imines (4.3) with the boranes in CDCl3 via 
11B NMR spectroscopy either showed no downfield shift resulting in the initial shift of the 
used borane or the signal (50 - 60 ppm depending on the borane) vanished and a new 
down-shifted signal (-10 - 25 ppm depending on the borane and aldehyde or imine) could 
be observed and adduct formation was assumed. 
 
 
Table 8: 11B-NMR-Shift of the adducts of aldehydes 1a-c and different boranes 
Compound\Lewis Acid B(C6F5)3 2,4,6-BArF9 BPh3 
4.1a 4.5 ppm 
  
4.1b 4.1 ppm 22.1 ppm 
 
4.1c 4.1 ppm 22.3 ppm 
 
 
Table 2: 11B-NMR-Shift of the adducts of imines 2a-e with different boranes 
Compound\Lewis Acid B(C6F5)3 2,4,6 BArF9 BPh3 
4.3a -5.3 ppm 
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4.3b -5.0 ppm -4.7 ppm 
 
4.3c -3.7 ppm -3.3 ppm -1.8 ppm 
4.3d -5.1 ppm 
  
4.3e -4.0 ppm -4.4 ppm 
 
4.3f -3.5 ppm -3.1 ppm 5.3 ppm 
 
9.4.4 General procedure C4 for the synthesis of the borane imine adducts 4.4  
The imine 4.3 (1.0 equiv) was dissolved in CDCl3 with subsequent addition to the borane 
(1.0 equiv). 
9.4.4.1 Synthesis of 4.3f-1c adduct 4.4a. 
 
In accordance with General Procedure C4, the adduct 4.4a was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and B(C6F5)3 (51.2 mg, 0.10 mmol, 1.0 equiv). 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.57 (s, 1H), 7.74–7.68 (m, 2H), 7.66–7.60 (m, 2H), 
7.54–7.49 (m, 2H), 6.97–6.88 (m, 2H), 4.25–3.96 (m, 2H), 3.85 (s, 3H), 1.07–0.91 (m, 
2H), 0.59 (t, 3JHH = 7.3 Hz, 3H), 0.09 (s, 2H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
169.8, 160.7, 148.2 (dm, 1JCF = 247.5 Hz), 140.4 (dm, 1JCF = 248.9 Hz), 137.4 (dm, 1JCF 
= 255.2 Hz), 133.7, 132.5, 130.1, 129.5, 128.9, 117.2, 114.4, 114.2, 95.4, 87.1, 55.5, 
52.9, 30.4, 20.4, 13.1.11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.5 (br. s). 19F NMR 
(471 MHz, CDCl3, 298 K) δ/ppm: -127.83 (br. s, 1F), -128.72 (br. s, 1F), -129.23 (br. d, 
1F), -130.55 (d, 2JFF = 21.8 Hz, 1F), -131.24 (br. s, 2F), -134.80 (s, 1F), -155.51 (br. d, 
1F), -157.18 (t, 2JFF = 20.1 Hz, 1F), -159.94 (br. s, 1F), -162.92 (br. s, 2F), -163.39 (t, 2JFF 
= 18.8 Hz, 1F), -163.96 (m, 3F) 
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9.4.4.2 Synthesis of 4.3f-1i adduct 4.4b. 
 
In accordance with General Procedure C4, the adduct 4.4b was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and 2,4,6-BarF9 (1i) (40.4 mg, 0.10 mmol, 1.0 equiv). 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.61 (s, 1H), 7.71–7.65 (m, 2H), 7.61–7.56 (m, 
2H), 7.55–7.49 (m, 2H), 6.96–6.88 (m, 2H), 6.51 (t, 3JHH = 9.1 Hz, 6H), 4.08 (t, 3JHH = 
11.6 Hz, 2H), 3.85 (s, 3H), 0.90 (pent., 3JHH = 7.2 Hz, 2H), 0.54 (t, 3JHH = 7.3 Hz, 3H), 
0.10 (s, 2H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 168.1, 166.1 (dt, 2JCF = 29.9 Hz, 
3JCF = 12.4 Hz), 162.3 (dt, 1JCF = 244.9 Hz, 3JCF = 15.8 Hz), 160.5, 133.6, 132.3, 130.2, 
128.9, 128.7, 117.4, 114.4, 114.4, 100.1–99.1 (m), 94.1, 87.2, 55.5, 52.7, 30.5, 20.6, 
13.2.11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.1 (br. s). 19F NMR (376 MHz, CDCl3) 
δ/ppm: -94.81 – -98.31 (m, 1F), -112.35 (s, 2F). 
9.4.4.3 Synthesis of 4.3f-BPh3 adduct 4.4c. 
 
In accordance with General Procedure C4, the adduct 4.4c was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and BPh3 (24.2 mg, 0.10 mmol, 1.0 equiv). 1H NMR 
(400 MHz, CDCl3) δ/ppm: 8.16 (s, 1H), 7.61–7.36 (m, 17H), 6.82–6.75 (m, 2H), 3.72 (s, 
3H), 1.64–1.55 (m, 2H), 1.36–1.25 (m, 2H), 1.17 (s, 2H), 0.86 (t, 3JHH = 7.4 Hz, 3H). 11B 
NMR (128 MHz, CDCl3) δ/ppm: 4.3 (br. s). 13C NMR (101 MHz, CDCl3) δ/ppm: 168.6, 
160.2, 159.9, 138.7, 135.8, 133.3, 132.2, 131.7, 130.1, 128.1, 127.5, 114.2, 91.4, 88.1, 
61.7, 55.4, 33.2, 20.6, 14.1. 
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9.4.4.4 Synthesis of 4.3f-1h adduct 4.4d. 
 
In accordance with General Procedure C4, the adduct 4.4d was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and 3,4,5-BArF9 (1h) (40.4 mg, 0.10 mmol, 1.0 equiv). 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.40 (s, 1H), 7.73 (d, 3JHH = 8.4 Hz, 2H), 7.58 
(d, 3JHH = 8.5 Hz, 2H), 7.54–7.48 (m, 2H), 6.96–6.89 (m, 2H), 6.81 (dd, 3JHH = 8.9 Hz, 
3JHH = 6.8 Hz, 6H), 3.85 (s, 3H), 3.82 (m, 2H), 1.29–1.18 (m, 3H), 1.14 (q, 3JHH = 7.1 Hz, 
2H), 0.72 (t, 3JHH = 7.2 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ/ppm: 170.4, 160.8, 151.0 
(ddd, 1JCF = 250.7 Hz, 3JCF = 9.2 Hz, 4JCF = 2.8 Hz), 145.6, 138.3 (dt, 1JCF = 250.5 Hz, 
3JCF = 15.5 Hz), 133.7, 132.60, 131.2, 130.8, 127.6, 117.6 (dd, 3JCF = 13.5 Hz, 4JCF = 4.4 
Hz), 114.4, 114.1, 96.1, 87.0, 55.5, 52.2, 30.7, 20.0, 13.3. 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 2.9 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.64 (d, 3JFF = 
20.3 Hz, 2F), -163.82 (d, 3JFF = 20.3 Hz, 1F).  
9.4.4.5 Synthesis of 4.3f-BF3 adduct 4.4e. 
 
In accordance with General Procedure C4, the adduct 4.4e was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and BF3·OEt2 (12.7 μl, 0.10 mmol, 1.0 equiv). 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.29 (br. s, 1H), 7.98–7.92 (m, 2H), 7.61–7.56 (m, 2H), 
7.51–7.45 (m, 2H), 6.92–6.83 (m, 2H), 3.82 (s, 3H), 1.84 (pent., 3JHH = 7.5 Hz, 2H), 1.45–
1.33 (m, 2H), 0.97 (t, 3JHH = 7.4 Hz, 3H), 0.91–0.81 (m, 2H). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 170.4, 160.5, 133.6, 131.5, 130.5, 128.2, 114.4, 114.3, 95.1, 87.6, 61.1, 
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55.5, 32.3, 32.3, 20.0, 13.7. 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -0.1 (s). 19F NMR 
(471 MHz, CDCl3, 298 K) δ/ppm: -144.19 (s, 3F). 
9.4.4.6 Synthesis of 4.3f-BCl3 adduct 4.4f. 
 
In accordance with General Procedure C4, the adduct 4.4f was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and BCl3 (100 μl, 1 M solution in CH2Cl2, 0.10 mmol, 1.0 
equiv). 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 9.33 (dd, 3JHH = 9.7 Hz, 4JHH = 4.1 Hz, 
1H), 8.15 (d, 3JHH = 8.6 Hz, 1H), 7.78 – 7.71 (m, 2H), 7.63–7.58 (m, 1H), 7.53–7.47 (m, 
2H), 6.94–6.87 (m, 2H), 4.32–4.18 (m, 2H), 3.84 (s, 3JHH = 5.1 Hz, 3H), 2.09–1.86 (m, 
2H), 1.51–1.39 (m, 2H), 1.04–0.93 (m, 3JHH = 10.6 Hz, 3JHH = 7.4 Hz, 3H). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 169.3, 160.8, 133.7, 132.6, 132.5, 131.6, 114.4, 113.9, 96.8, 
87.1, 55.5, 51.2, 30.9, 20.3, 13.6. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 8.1 (s). 
9.4.4.7 Synthesis of 4.3f-BCl3 adduct 4.4f. 
 
In accordance with General Procedure C4, the adduct 4.4f was synthesised using 4.3f 
(29.1 mg, 0.10 mmol, 1.0 equiv) and BBr3 (9.5 μl, 0.10 mmol, 1.0 equiv). 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 9.61 (s, 1H), 7.82–7.72 (m, 4H), 7.54–7.50 (m, 2H), 6.94–
6.90 (m, 2H), 3.85 (s, 3H), 1.54–1.40 (m, 2H), 1.25 (s, 3H), 1.02–0.94 (m, 4H). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 170.6, 160.8, 133.8, 132.8, 132.6, 131.6, 130.5, 114.4, 
113.9, 97.3, 87.3, 55.5, 52.4, 29.8, 20.3, 13.6. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
-7.1 (s).  
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9.4.5 Crystallographic data for 4.4a 
 
Compound 4.4a 
Empirical Formula C38H21BF15NO 
Space Group P-1 
a/Å 10.8591(5) 
b/Å 11.0549(4) 
c/Å 15.5476(7) 
α/° 75.088(4) 
β/° 69.996(4) 
ϒ/° 84.603(4) 
Volume/Å3 1694.73(14) 
Z 2 
T/K 150 
Dc/g·cm-3 1.574 
R (reflections) 0.0489(4994) 
wR2 (reflections) 0.1380 
Theta(max) 27.101 
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9.5 BCF promoted cyclisation: 
9.5.1 Synthesis of the starting materials: 
General procedure D1: 
According to literature procedure,157 magnesium turnings (1 equiv) were suspended in 
THF (15 ml) and activated with 1,2-dibromoethane (ca. 0.1 ml) being added at 0 °C. After 
stirring for 5 minutes halobenzene (0.9 equiv) was added drop wise as a solution in THF 
(20 ml). The mixture was allowed to warm to room temperature and stirred for an hour. 
The reaction mixture was cooled with an ice bath and benzaldehyde derivative (0.8 
equiv) in THF (20 ml) was added dropwise. After removing the ice bath, the mixture was 
allowed to stir overnight. The reaction was then quenched with saturated NH4Cl solution 
(50 ml). After separating the organic phase, the aqueous phase was extracted with Et2O. 
The combined organic layers were dried under vacuum to give desired benzhydrol 
derivative. The purity (tested via NMR spectroscopy) was satisfiying enough to use in 
further reaction steps. 
9.5.1.1 Synthesis of 4-fluorobenzhydrol: 
 
Synthesised according to General Procedure D1 using magnesium (0.8 g, 32.9 mmol), 
1-bromo-4-fluoro-benzene (5.3 g, 3.3 ml, 30.3 mmol) and benzaldehyde (2.69 g, 2.6 ml, 
25.3 mmol). The spectroscopic data agrees with literature established values.157 Yield: 
4.36 g, 21.6 mmol, 83% 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.39–7.32 (m, 4H, Ar-
H), 7.31–7.27 (m, 3H, Ar-H), 7.02 (t, 3JHH = 8.6 Hz, 2H, Ar-H), 5.83 (s, 1H, C(H)Ar2), 2.26 
(br. s, 1H, OH). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -115.05 – -115.11 (br. m, 1F, 
Ar-F). 
9.5.1.2 Synthesis of 4-Bromobenzhydrol: 
 
Synthesised according to General Procedure D1 using magnesium (0.5 g, 22.3 mmol), 
bromobenzene (3.49 g, 22.3 mmol, 3.3 ml) and 4-bromo-benzaldehyde (3.2 g, 17.1 
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mmol). The spectroscopic data agrees with literature established values.157 Yield: 3.52 
g, 13.4 mmol, 78%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.46 (d, 3JHH = 8.4 Hz, 2H, 
Ar-H), 7.37–7.28 (m, 5H, Ar-H), 7.26 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 5.80 (s, 1H, C(H)Ar2), 
2.23 (br. s, 1H, OH). 
9.5.1.3 Synthesis of 5.7b: 
 
A solution of diisopropylamine (20 ml, 0.14 mol) in THF (40 ml) was cooled to -78 °C and 
n-BuLi (1.6 M in hexanes, 79.2 ml, 0.13 mol) was added. The reaction was stirred for 1 
h. This mixture was transferred into a dropping funnel and slowly added to a solution of 
methyl isobutyrate (13.2 ml, 0.12 mol) in THF (30 ml) at 0 °C. The reaction was allowed 
to warm to room temperature and stirred for 1 h before cooling it down to 0 °C again. A 
solution of propargyl bromide (80 wt% in toluene, 12.2 ml, 0.12 mmol) in THF (10 ml) 
was then added dropwise. The reaction mixture was stirred overnight and allowed to 
warm to room temperature. Water was added and, using a separating funnel, the organic 
phase was removed, and the aqueous phase is extracted with Et2O (3 x 20 ml). The 
combined organic layers were washed with saturated NH4Cl solution and dried with 
MgSO4. After filtration all volatiles are removed under vacuum and the residue is distilled 
(50 °C, 1 x 10-3 bar) to give 5.7b as a colourless oil. The spectroscopic data agrees with 
literature values.105 Yield: 12.9 g, 42 mol, 84%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 
3.70 (s, 3H, OCH3), 2.44 (d, 4JHH = 2.6 Hz, 2H, CH2), 2.00 (t, 4JHH = 2.6 Hz, 1H, ≡CH), 
1.28 (s, 6H, C(CH3)2). 
9.5.1.4 Synthesis of 5.11b: 
 
2-Iodo-benzoicacid (15 g, 60.5 mmol, 1 equiv) was stirred in methanol (50 ml) for 10 min 
to dissolve the acid. The resulting clear solution was cooled with an ice bath and 
concentrated H2SO4 added. After warming the reaction mixture to room temperature, it 
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was set to reflux overnight. The mixture was allowed to cool down and was neutralised 
with saturated sodium bicarbonate solution (150 ml). The aqueous was extracted with 
hexane (3 x 50 ml) and the combined organic layers were filtered through silica and all 
volatiles were removed under vacuum to give 5.11b as a yellow oil. The spectroscopic 
data agrees with literature established values.158 Yield: 15.4 g, 58.7 mmol, 97%. 1H NMR 
(300 MHz, CDCl3, 298 K) δ/ppm: 7.99 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.80 (d, 3JHH = 7.8 
Hz, 1H, Ar-H), 7.40 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.15 (t, 3JHH = 7.7 Hz, 1H, Ar-H), 3.93 (s, 
3H, OCH3). 
General Procedure D2 to synthesise esters 5.8: 
5.7b (0.8 g, 5.7 mmol, 1 equiv) in THF (10 ml) was mixed with NEt3, iodobenzene 
derivative (1 equiv), Pd(PPh3)2Cl2 (58 mg, 1 mol%), CuI (23 mg, 2 mol%) and PPh3 (60 
mg, 4 mol%) were added according to literature procedure.105 The resulting mixture was 
refluxed for 10 h. After cooling to room temperature, the reaction was quenched with 
water and the organic layer was separated and the aqueous layer was extracted with 
Et2O (3 x 20 ml). The combined organic layers were dried with brine and layered over 
MgSO4. After filtration all volatiles are removed, and the residue is purified via column 
chromatography (SiO2) to give desired ester 5.8. 
9.5.1.5 Synthesis of 5.8a: 
 
Following General Procedure D2, 5.8a was synthesised using iodobenzene (0.63 ml, 5.7 
mmol, 1 equiv) The spectroscopic data agrees with values established in literature 
established.105 Rf value: 0.11 (2:1 hexane/CHCl3). Yield 1.16 g, 5.4 mmol, 95%. 1H NMR 
(300 MHz, CDCl3, 298 K) δ/ppm: 7.43–7.23 (m, 5H, Ar-H), 3.71 (s, 3H, OCH3), 2.66 (s, 
2H, CH2), 1.34 (s, 6H, C(CH3)2). 
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9.5.1.6 Synthesis of 5.8b: 
 
Following general procedure D2, 5.8b was synthesised using 4-(methoxy)iodobenzene 
(1.32 g, 5.7 mmol, 1 equiv). Rf value: 0.19 (2:1 hexane/CHCl3). Yield: 532 mg, 2.17 
mmol, 32%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 
6.81 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.80 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 2.64 (s, 2H, 
CH2), 1.33 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 177.5, 159.3, 
133.1, 116.0, 113.9, 85.1, 82.6, 55.4, 52.2, 42.7, 30.7, 24.8. HRMS (AP+) m/z calculated 
for [C15H19O3]+ [M+H]+: 247.1334, found: 247.1324. 
9.5.1.7 Synthesis of 5.8c: 
 
Following General Procedure D2, 5.8c was synthesised using 4-iodotoluene (1.24 g, 5.7 
mmol, 1 equiv). Rf value: 0.13 (2:1 hexane/CHCl3). Yield: 670 mg, 2.91 mmol, 49%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.27 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.08 (d, 3JHH = 
7.9 Hz, 2H, Ar-H), 3.71 (s, 3H, OCH3), 2.64 (s, 2H, CH2), 2.33 (s, 3H, Ar-Me), 1.33 (s, 
6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.5, 137.9, 131.6, 129.1, 
120.7, 85.9, 82.9, 52.2, 42.7, 30.7, 24.8, 21.6. HRMS (EI+) m/z calculated for [C15H18O2]+ 
[M]+: 230.1307, found: 230.1306. 
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9.5.1.8 Synthesis of 5.8d: 
 
Following General Procedure D2, 5.8d was synthesised using 4-
(trifluoromethyl)iodobenzene (1.55 g, 0.84 ml, 5.7 mmol, 1 equiv). Rf value: 0.15 (2:1 
hexane/CHCl3). Yield: 1.59 g, 5.6 mmol, 98%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 
7.50 (dd, 3JHH = 8.09 Hz, 3JHH = 8.07 Hz, 4H, Ar-H), 3.72 (s, 3H, OCH3), 2.67 (s, 2H, 
CH2), 1.34 (s, 6H, C(CH3)2). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -62.79 (s, 3F, 
CF3). HRMS (AP+) m/z calculated for [C15H15O2F3]+ [M+H]+: 284.1024, found: 284.1021. 
9.5.1.9 Synthesis of 5.8f: 
 
Following General Procedure D2, 5.8f was synthesised using 4-fluoroiodobenzene (1.27 
g, 5.7 mmol, 1 equiv). Rf value: 0.09 (3:1 hexane/CHCl3). Yield: 934 mg, 3.99 mmol, 
70%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.35 (dd, 3JHH = 8.8 Hz, 4JHF = 5.5 Hz, 
2H, Ar-H), 6.97 (t, 3JHH = 8.8 Hz, 2H, Ar-H), 3.71 (s, 3H, OCH3), 2.64 (s, 2H, CH2), 1.33 
(s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.3, 162.3 (d, 1JCF = 249 
Hz, 1C), 133.5 (d, 3JCF = 8.3 Hz, 2C), 119.8, 115.6 (d, 2JCF = 22.0 Hz, 2C), 86.4, 81.8, 
52.2, 42.7, 30.7, 24.8. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -111.97 (s, 1F, p-F). 
HRMS (AP+) m/z calculated for [C14H16O2F]+ [M+H]+: 235.1134, found: 235.1125. 
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9.5.1.10 Synthesis of 5.8g: 
 
Following General Procedure D2, 5.8g was synthesised using 1-bromo-2-iodobenzene 
(1.61 g, 5.7 mmol, 1 equiv). Rf value: 0.18 (2:1 hexane/CHCl3). Yield: 1.20 g, 4.07 mmol, 
71%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.55 (dd, 3JHH = 8.0 Hz, 4JHH = 1.1 Hz, 
1H, Ar-H), 7.42 (dd, 3JHH = 7.7 Hz, 4JHH = 1.6 Hz, 1H, Ar-H), 7.22 (td, 3JHH = 7.6 Hz, 4JHH 
= 1.1 Hz, 1H, Ar-H), 7.12 (td, 3JHH = 7.9 Hz, 4JHH = 1.7 Hz, 1H, Ar-H), 3.72 (s, 3H, OCH3), 
2.72 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
177.4, 133.6, 132.4, 129.0, 127.0, 125.9, 125.6, 91.9, 81.5, 52.3, 42.7, 30.8, 24.9. HRMS 
(EI+) m/z calculated for [C14H15BrO2]+ [M]+: 294.0255, found: 294.0258. 
9.5.1.11 Synthesis of 5.8h: 
 
Following General Procedure D2, 5.8g was synthesised using 2-(methoxy)iodobenzene 
(0.74 ml, 5.7 mmol, 1 equiv). Rf value: 0.18 (2:1 hexane/CHCl3). Yield: 746 mg, 3.03 
mmol, 53%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.35 (dd, 3JHH = 7.5 Hz, 4JHH = 1.6 
Hz, 1H, Ar-H), 7.25 (td, 3JHH = 7.8 Hz, 4JHH = 1.7 Hz, 1H, Ar-H), 6.89–6.84 (m, 2H, Ar-H), 
3.86 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 2.72 (s, 2H, CH2), 1.35 (s, 6H, C(CH3)2). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.5, 160.1, 133.7, 129.2, 120.5, 113.0, 110.7, 
91.0, 79.0, 55.9, 52.1, 42.7, 31.0, 24.7. HRMS (ES+) m/z calculated for [C15H18O3]+ [M]+: 
246.1256, found: 246.1250. 
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9.5.1.12 Synthesis of 5.8i: 
 
Following General Procedure D2, 5.8g was synthesised using 1-iodonaphthalene (0.83 
ml, 5.7 mmol, 1 equiv) Rf value: 0.14 (2:1 hexane/CHCl3). Yield: 505 mg, 1.89 mmol, 
33%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 8.30 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.83 
(d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.79 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.62 (d, 3JHH = 7.1 Hz, 1H, 
Ar-H), 7.58–7.48 (m, 2H, Ar-H), 7.40 (dd, 3JHH = 8.1 Hz, 3JHH = 7.3 Hz, 1H, Ar-H), 3.75 
(s, 3H, OCH3), 2.83 (s, 2H, CH2), 1.42 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 177.4, 133.6, 133.3, 130.4, 128.3, 128.3, 126.7, 126.4, 126.3, 125.3, 121.5, 
91.8, 80.9, 52.3, 42.9, 31.2, 25.0. HRMS (EI+) m/z calculated for [C18H18O2]+ [M]+: 
266.1307, found: 266.1312. 
General Procedure D3 to synthesise esters 5.12: 
Following literature procedure,109 methyl 2-iodobenzoate 5.11b (2.24 ml, 4.00 g, 15.3 
mmol, 1 equiv) was dissolved in THF (20 ml) and Pd(PPh3)2Cl2 (220 mg, 0.3 mmol, 2 
mol%), CuI (120 mg, 0.6 mmol, 4 mol%) and NEt3 (50 ml) were added. After stirring this 
mixture for a short time, the terminal alkyne was added (1.2 equiv). The reaction was set 
to reflux overnight and allowed to cool to room temperature after 16 h. The reaction was 
quenched with water (100 ml) and CH2Cl2 (60 ml) was added. The organic phase is 
separated and the aqueous phase is extracted with CH2Cl2 (2 x 60 ml). The organic 
layers are combined and all volatiles are removed under vacuum. The residue is purified 
via column chromatography (SiO2). 
9.5.1.13 Synthesis of 5.12a: 
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Compound 5.12a was synthesised according to General Procedure D3 with 
phenylacetylene (1.9 ml, 17.71 mmol, 1.16 equiv). The spectroscopic data agrees with 
literature established values.105 Rf value: 0.18 (hexane/EtOAc 95:5). Yield: 3.27 g, 13.84 
mmol, 91%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.98 (dd, 3JHH = 7.9 Hz, 4JHH = 0.9 
Hz, 1H, Ar-H), 7.65 (dd, 3JHH = 7.7 Hz, 4JHH = 0.8 Hz, 1H, Ar-H), 7.60–7.56 (m, 2H, Ar-
H), 7.50 (td, 3JHH = 7.6 Hz, 4JHH = 1.4 Hz, 1H, Ar-H), 7.41–7.34 (m, 4H, Ar-H), 3.97 (s, 
3H, OCH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 166.9, 134.1, 132.0, 131.9, 131.9, 
130.6, 128.7, 128.5, 128.0, 123.8, 123.4, 94.5, 88.3, 52.4. 
9.5.1.14 Synthesis of 5.12b: 
 
Compound 5.12b was synthesised according to General Procedure D3 with 4-
ethynyltoluene (2.25 ml, 17.71 mmol, 1.16 equiv). Rf value: 0.29 (90:10, hexane/EtOAc). 
Yield: 3.78 g, 15.1 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.97 (dd, 3JHH 
= 7.9, 4JHH = 0.9 Hz, 1H, Ar-H), 7.64 (dd, 3JHH = 7.7 Hz, 4JHH = 0.7 Hz, 1H, Ar-H), 7.51– 
7.45 (m, 3H, Ar-H), 7.37 (td, 3JHH = 7.8 Hz, 4JHH = 1.2 Hz, 1H, Ar-H), 7.17 (d, 3JHH = 7.9 
Hz, 2H, Ar-H), 3.97 (s, 3H, OCH3), 2.38 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 166.9, 138.8, 134.0, 131.8, 131.7, 131.7, 130.5, 129.2, 127.7, 123.9, 120.2, 94.6, 
87.6, 52.2, 21.6. HRMS (ES+) m/z calculated for [C17H14O2]+ [M+H]+: 250.0994, found: 
250.0987. 
9.5.1.15 Synthesis of 5.14b: 
 
Methyl 3-iodoacrylate 5.14a (2.24 ml, 4.00 g, 15.3 mmol, 1 equiv) was dissolved in THF 
(20 ml) and Pd(PPh3)2Cl2 (322 mg; 0.45 mmol; 2 mol%), CuI (175 mg, 0.92 mmol, 4 
mol%) and NEt3 (50 ml) were added. After stirring this mixture for a short time, 
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phenylacetylene (2.96 ml, 26.56 mmol, 1.16 equiv) was added. The reaction was set to 
stir overnight. The black suspension was quenched with saturated ammonium chloride 
solution (50 ml) and EtOAc (40 ml) was added. The organic phase was separated, and 
the aqueous phase is extracted with EtOAc (2 x 40 ml). The organic layers were 
combined, and all volatiles are removed under vacuum. The residue is purified via 
column chromatography (SiO2) to give 5.14b as a yellow-orange oil. The spectroscopic 
data agrees with literature established values.110 Rf value: 0.07 (50:1, hexane/EtOAc). 
Yield: 4.27 g, 22.93 mmol, 81%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.58–7.51 
(m, 2H, Ar-H), 7.36 (s, 3H, Ar-H), 6.37 (d, 3JHH = 11.4 Hz, 1H, =CH), 6.15 (d, 3JHH = 11.3 
Hz, 1H, =CH), 3.81 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.3, 
132.2, 129.3, 128.4, 127.8, 123.2, 122.6, 101.4, 86.3, 51.5. 
General procedure D4 to synthesise free acids 5.9, 5.13 and 5.15: 
Methyl esters are saponified according to literature procedures.105 A sodium hydroxide 
(5 equiv) solution in methanol (20 ml) was added to a solution of methyl esters in 
methanol (20 ml). The mixture was set to reflux overnight and allowed to cool to room 
temperature afterwards. Water (25 ml) was added and the aqueous mixture was 
extracted with Et2O and the organic phase is discarded. After neutralising the aqueous 
mixture to crash out the protonated acid, the white suspension is extracted with Et2O (3 
x 20 ml). The combined organic layers were dried under vacuum and the residue is 
purified via column chromatography. 
9.5.1.16 Synthesis of 5.9a: 
 
Compound 5.9a was synthesised according to General Procedure D4 with 5.8a (670 mg, 
2.91 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 92–98 
°C. Yield: 629 mg, 2.91 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.29 (d, 
3JHH = 8.0 Hz, 2H, Ar-H), 7.08 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 2.67 (s, 2H, CH2), 2.33 (s, 3H, 
PhMe), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 183.8, 137.9, 
131.6, 129.1, 120.7, 85.6, 83.1, 42.5, 30.4, 24.6, 21.6. HRMS (ES+) m/z calculated for 
[C14H16O2]+ [M]+: 216.1150, found: 216.1151. 
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9.5.1.17 Synthesis of 5.9b: 
 
Compound 5.9b was synthesised according to General Procedure D4 with 5.8b (532 
mg, 2.17 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 
104–108 °C. Yield: 501 mg, 2.17 mmol, 99%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 
7.32 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 6.80 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.79 (s, 3H, OCH3), 
2.66 (s, 2H, CH2), 1.36 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 
183.8, 159.3, 133.1, 115.9, 114.0, 84.8, 82.8, 55.4, 42.5, 30.4, 24.6. HRMS (ES–) m/z 
calculated for [C14H15O3]– [M-H]–: 231.1021, found: 231.1015. 
9.5.1.18 Synthesis of 5.9c: 
 
Compound 5.9c was synthesised according to General Procedure D4 with 5.8c (670 mg, 
2.91 mmol, 1 equiv) as the methyl ester to produce a white solid. to give an off-white 
solid. Melting point: 92–98 °C. Yield: 629 mg, 2.91 mmol, 99%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.29 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.08 (d, 3JHH = 7.9 Hz, 2H, Ar-
H), 2.67 (s, 2H, CH2), 2.33 (s, 3H, PhMe), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 183.8, 137.9, 131.6, 129.1, 120.7, 85.6, 83.1, 42.5, 30.4, 24.6, 
21.6. HRMS (ES+) m/z calculated for [C14H16O2]+ [M]+: 216.1150, found: 216.1151 
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9.5.1.19 Synthesis of 5.9d: 
 
Compound 5.9d was synthesised according to General Procedure D4 with 5.8d (1.59 g, 
5.6 mmol, 1 equiv) as the methyl ester to produce a white solid. to give an off-white solid. 
Melting point: 80–86 °C. Yield: 1.51 g, 5.6 mmol, 97%. 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 7.53–7.48 (m, 4H, Ar-H), 2.70 (s, 2H, CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR 
(126 MHz, CDCl3, 298 K) δ/ppm: 183.2, 132.0, 127.5, 125.3 (q, 3JCF = 3.8 Hz, 2C), 123.0, 
89.3, 81.9, 42.5, 30.4, 24.7. 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -62.80 (s, 3F, 
CF3). HRMS (AP+) m/z calculated for [C14H14O2F3]+ [M+H]+: 271.0946, found: 271.0933. 
9.5.1.20 Synthesis of 5.9f: 
 
Compound 5.9f was synthesised according to general procedure D4 with 5.8f (934 mg, 
3.99 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 77–82 
°C. Yield: 879 mg, 3.99 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.36 (dd, 
3JHH = 8.6 Hz, 4JHF = 5.5 Hz, 2H, Ar-H), 6.96 (t, 3JHH = 8.7 Hz, 2H, Ar-H), 2.67 (s, 2H, 
CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 182.7, 162.4 (d, 
1JCF = 250 Hz, 1C), 133.6 (d, 3JCF = 8.3 Hz, 2C), 119.7, 115.6 (d, 2JCF = 22.0 Hz, 2C), 
86.0, 82.0, 42.5, 30.4, 24.6. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -111.84 (s, 1F, 
p-F). HRMS (EI+) m/z calculated for [C13H13O2F]+ [M]+: 220.0900, found: 220.0898. 
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9.5.1.21 Synthesis of 5.9g: 
 
Compound 5.9g was synthesised according to General Procedure D4 with 5.8g (1.20 g, 
4.07 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 44–48 
°C. Yield: 1.13 g, 4.07 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.55 (dd, 
3JHH = 8.0 Hz, 4JHH = 0.9 Hz, 1H, Ar-H), 7.43 (dd, 3JHH = 7.7 Hz, 4JHH = 1.5 Hz, 1H, Ar-H), 
7.22 (td, 3JHH = 7.6 Hz, 4JHH = 1.1 Hz, 1H, Ar-H), 7.12 (td, 3JHH = 7.7 Hz, 4JHH = 1.6 Hz, 
1H, Ar-H), 2.75 (s, 2H, CH2), 1.42 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 182.6, 133.6, 132.4, 129.1, 127.0, 125.8, 125.6, 91.5, 81.7, 42.5, 30.6, 24.7. 
HRMS (EI+) m/z calculated for [C13H13O2Br]+ [M]+: 280.0099, found: 280.0090 
9.5.1.22 Synthesis of 5.9h: 
 
Compound 5.9g was synthesised according to General Procedure D4 with 5.8g (746 
mg, 3.03 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 90–
94 °C. Yield: 696 mg, 42.5 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.36 
(dd, 3JHH = 7.6 Hz, 4JHH = 1.5 Hz, 1H, Ar-H), 7.25 (td, 3JHH = 7.8 Hz, 4JHH = 1.6 Hz, 1H, 
Ar-H), 6.89–6.83 (m, 2H, Ar-H), 3.86 (s, 3H, OCH3), 2.75 (s, 2H, CH2), 1.40 (s, 6H, 
C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 183.8, 160.2, 133.6, 129.3, 120.5, 
112.9, 110.7, 90.7, 79.3, 55.9, 42.6, 30.6, 24.5. HRMS (EI+) m/z calculated for 
[C14H16O3]+ [M]+: 232.1099, found: 232.1095. 
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9.5.1.23 Synthesis of 5.9i: 
 
Compound 5.9i was synthesised according to General Procedure D4 with 5.8i (505 mg, 
1.89 mmol, 1 equiv) as the methyl ester to produce a white solid. Melting point: 118–
122 °C. Yield: 476 mg, 1.89 mmol, 99%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.31 
(d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.81 (d, 3JHH = 8.0 Hz, 1H, Ar-H), 7.77 (d, 3JHH = 8.2 Hz, 1H, 
Ar-H), 7.62 (d, 3JHH = 7.0 Hz, 1H, Ar-H), 7.54 (t, 3JHH = 7.1 Hz, 1H, Ar-H), 7.47 (d, 3JHH = 
7.1 Hz, 1H, Ar-H), 7.37 (d 3JHH = 7.7 Hz, 1H, Ar-H), 2.84 (s, 2H, CH2), 1.44 (s, 6H, 
C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 183.7, 133.6, 133.3, 130.4, 128.3, 
128.3, 126.8, 126.4, 126.4, 125.3, 121.4, 91.5, 81.1, 42.7, 30.8, 24.8. HRMS (EI+) m/z 
calculated for [C17H16O2]+ [M]+: 252.1150, found: 252.1149. 
9.5.1.24 Synthesis of 5.13a: 
 
Compound 5.13a was synthesised according to General Procedure D4 with 5.12a (3.27 
g, 13.84 mmol, 1 equiv) as the methyl ester to produce a white oil. The spectroscopic 
data agrees with literature established values.109 Rf value: 0.18 (chloroform). Yield: 2.84 
g, 12.78 mmol, 92%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.15 (dd, 3JHH = 7.9, 1H, 
Ar-H), 7.70 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.61–7.54 (m, 3H, Ar-H), 7.44 (td, 3JHH = 7.8, 
4JHH = 1.2 Hz, 1H, Ar-H), 7.36–7.28 (m, 3H, Ar-H). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 171.1, 134.2, 132.6, 131.8, 131.4, 130.5, 128.7, 128.4, 128.0, 124.4, 123.1, 95.5, 
88.0. 
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9.5.1.25 Synthesis of 5.13b: 
 
Compound 5.13b was synthesised according to General Procedure D4 with 5.12b (3.78 
g, 15.1 mmol, 1 equiv) as the methyl ester to produce a white oil. The spectroscopic data 
agrees with literature established values.109 Rf value: 0.23 (chloroform). Yield: 3.47 g, 
15.1 mmol, 93%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.14 (d, 3JHH = 7.8 Hz, 1H, 
Ar-H), 7.68 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.55 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.47 (d, 3JHH = 
7.7 Hz, 2H, Ar-H), 7.42 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.12 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 
2.35 (s, 3JHH = 13.8 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 171.8, 
138.9, 134.2, 132.7, 131.8, 131.5, 130.6, 129.3, 127.9, 124.8, 120.2, 95.9, 87.6, 21.7. 
9.5.1.26 Synthesis of 5.15a: 
 
Compound 5.15a was synthesised according to General Procedure D4 with 5.14b (3.78 
g, 15.1 mmol, 1 equiv) as the methyl ester to produce a bright yellow solid. The 
spectroscopic data agrees with literature established values.159 Yield: 3.55 g, 20.6 mmol, 
98%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.52 (d, 3JHH = 6.9 Hz, 2H, Ar-H), 7.40–
7.29 (m, 3H, Ar-H), 6.49 (d, 3JHH = 11.3 Hz, 1H, Ar-H), 6.19 (d, 3JHH = 11.3 Hz, 1H, Ar-
H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 169.2, 132.2, 129.5, 128.5, 127.3, 125.2, 
122.4, 103.2, 86.2. 
General Procedure D5 to synthesise esters 5.1, 5.2 and 5.3: 
According to literature procedure,108 DMAP (7 mol%) and an alcohol (1–3 equiv) were 
added to a solution of carboxylic acid in CH2Cl2. The solution was cooled to 0 °C and 
DCC (1.1 equiv) was added. The mixture was allowed to warm to room temperature and 
stirred overnight. The resulting urea was filtered off. The filtrate was washed twice with 
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a solution of HCl in water (0.5 M) and once with a saturated sodium bicarbonate solution. 
The organic phase was separated, dried over MgSO4 and filtered. All volatiles were 
removed from the filtrate and the residue was purified via column chromatography (SiO2) 
to give the desired esters 5.1-3 
9.5.1.27 Synthesis of 5.1a: 
 
In accordance with General Procedure D5, 5.1a was synthesised using 5.9a (750 mg, 
3.7 mmol, 1 equiv) and 2-propanol (11.1 mmol, 1.2 g, 3 equiv) yielding a yellow oil. Rf 
value: 0.64. Yield: 115 mg, 0.47 mmol, 13%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.43–7.21 (m, 5H, Ar-H), 5.01 (hept, 3JHH = 6.2 Hz, 1H, CH(CH3)2), 2.62 (s, 2H, CH2), 
1.30 (s, 6H, C(CH3)2), 1.23 (d, 3JHH = 6.3 Hz, 6H, OC(CH3)2). 13C NMR (126 MHz, CDCl3, 
298 K) δ/ppm: 176.4, 131.7, 128.3, 127.8, 123.9, 87.0, 82.7, 67.9, 42.5, 30.7, 24.7, 21.9. 
IR νmax (cm-1): 2981 (m), 1723 (s), 1601 (w), 1491 (m), 1471 (m), 1391 (w), 1385 (m), 
1375 (m), 1302 (w), 1249 (w), 1199 (m), 1143 (m), 1106 (s), 1023 (w), 927 (w), 877 (w), 
831 (w), 755 (s), 692 (s), 526 (m). HRMS (ES+) m/z calculated for [C16H21O2]+ [M+H]+: 
245.1542, found: 245.1536. 
9.5.1.28 Synthesis of 5.1b: 
 
In accordance with General Procedure D5, 5.1b was synthesised using 5.9a (500 mg, 
2.5 mmol, 1 equiv) and allylalcohol (0.80 g, 7.4 mmol, 3 equiv) yielding a yellow oil. Rf 
value: 0.67. Yield: 334 mg, 1.38 mmol, 56%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.42–7.24 (m, 5H, Ar-H), 5.97–5.88 (m, 1H, -CH=), 5.37 (d, 3JHH = 16.2 Hz 1H, =CH2, 
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trans), 5.19 (3JHH = 10.1 Hz 1H, =CH2 cis), 4.62 (d, 3JHH = 5.4 Hz 2H, OCH2–), 2.68 (s, 
2H, CH2), 1.36 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 176.5, 132.4, 
131.7, 128.3, 127.9, 123.8, 117.9, 86.8, 82.9, 65.4, 42.8, 30.7, 24.8. IR νmax (cm-1): 2977 
(w), 1730 (s), 1650 (w), 1597 (w), 1488 (m), 1471 (m), 1388 (w), 1365 (w), 1322 (m), 
1246 (m), 1196 (m), 1130 (s), 1070 (w), 984 (m), 924 (m), 848 (w), 755 (s), 692 (s), 526 
(w). HRMS (ES+) m/z calculated for [C16H19O2]+ [M+H]+: 243.1385, found: 243.1380. 
9.5.1.29 Synthesis of 5.1c: 
 
In accordance with General Procedure D5, 5.1c was synthesised using 5.9a (2.0 g, 9.89 
mmol, 1 equiv) and benzylalcohol (3.2 g, 30 mmol, 3 equiv) yielding a yellow oil. Rf value: 
0.85. Yield: 1.85 g, 6.34 mmol, 64%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37–
7.23 (m, 10H, Ar-H), 5.15 (s, 2H, OCH2–), 2.68 (s, 2H, CH2), 1.35 (s, 6H, C(CH3)2). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 176.6, 136.2, 131.6, 128.5, 128.2, 128.0, 127.8, 
127.7, 123.6, 86.6, 82.8, 66.5, 42.7, 30.6 , 24.7. IR νmax (cm-1): 2974 (w), 1730 (s), 1597 
(w), 1491 (m), 1458 (m), 1388 (w), 1319 (w), 1299 (w), 1246 (w), 1193 (m), 1126 (s), 984 
(w), 751 (s), 692 (s), 529 (m). HRMS (ES+) m/z calculated for [C20H21O2]+ [M+H]+: 
292.1463, found: 292.1452. 
9.5.1.30 Synthesis of 5.1d: 
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In accordance with General Procedure D5, 5.1d was synthesised using 5.9d (1.0 g, 3.7 
mmol, 1 equiv) and benzylalcohol (420 mg, 3.89 mmol, 1.05 equiv) yielding a yellow oil. 
Rf value: 0.76. Yield: 805 mg, 2.23 mmol, 61%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.55–7.38 (m, 4H, Ar-H), 7.38–7.28 (m, 5H, Ar-H), 5.16 (s, 2H, OCH2–), 2.70 (s, 2H, 
CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 176.4, 136.2, 
132.0, 129.6 (q, 2JCF = 32.6 Hz, 1C), 128.6, 128.3, 128.2, 128.0, 125.2 (q, 3JCF = 3.8 Hz, 
2C), 89.7, 81.8, 66.6 ,42.8, 42.8, 30.8, 24.9. 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: 
-62.77 (s, 3F, CF3). IR νmax (cm-1): 2977 (w), 1730 (s), 1617 (w), 1471 (w), 1458 (w), 1405 
(w), 1322 (s), 1242 (w), 1166 (m), 1123 (s), 1066 (s), 1017 (w), 841 (m), 741 (w), 695 
(m), 599 (w). HRMS (ES+) m/z calculated for [C21H20O2F3]+ [M+H]+: 361.1415, found: 
361.1418. 
9.5.1.31 Synthesis of 5.1e: 
 
In accordance with General Procedure D5, 5.1e was synthesised using 5.9a (800 mg, 
3.96 mmol, 1 equiv) and 4-fluorobenzhydrol (840 mg, 4.15 mmol, 1.05 equiv) yielding a 
white solid. Rf value: 0.72. Yield: 605 mg, 1.57 mmol, 40%. Melting point: 79–85 °C. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37–7.25 (m, 12, Ar-H), 6.98–6.90 (m, 2H, 
Ar-H), 6.85 (s, 1H, C(H)Ar2), 2.71 (s, 2H, CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 175.7, 162.4 (d, 1JCF = 246 Hz, 1C), 140.2, 136.3, 131.7, 
129.1 (d, 4JCF = 8.2 Hz, 2C), 128.5 (d, 2JCF = 50.2 Hz, 2C), 128.0 (d, 3JCF = 16.8 Hz, 2C), 
127.0, 123.6, 115.5, 115.3, 86.5, 83.0, 42.9, 31.1, 30.7, 24.9, 24.8. 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -114.33 (s, 1F, p-F). IR νmax (cm-1): 2977 (w), 1727 (s), 1607 (w), 
1511 (s), 1491 (m), 1468 (w), 1455 (w), 1388 (w), 1368 (w), 1322 (m), 1305 (m), 1226 
(m), 1199 (s), 1163 (s), 1133 (s), 1103 (w), 1073 (w), 1023 (w), 1000 (w), 917 (w), 861 
(w), 828 (m), 811 (w), 788 (m), 758 (s), 741 (m), 692 (s), 645 (w), 629 (w), 582 (m), 556 
(s), 506 (m). HRMS (ES+) m/z calculated for [C26H24FO2]+ [M+H]+: 387.1759, found: 
387.1760. 
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9.5.1.32 Synthesis of 5.1f: 
 
In accordance with General Procedure D5, 5.1f was synthesised using 5.9a (900 mg, 
4.5 mmol, 1 equiv) and 4-chlorobenzhydrol (1.07 g, 4.89 mmol, 1.1 equiv) yielding a 
white solid. Rf value: 0.83. Yield: 452 mg, 1.12 mmol, 26%. Melting point: 62– 67 °C. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37–7.27 (m, 14H, Ar-H), 6.85 (s, 1H, 
C(H)Ar2), 2.73 (s, 2H, CH2), 1.40 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 175.6, 139.9, 139.0, 133.9, 131.7, 128.8, 128.7, 128.6, 128.3, 128.2, 127.9, 
127.0, 123.6, 86.6, 83.1, 76.6, 43.0, 30.7, 24.9, 24.9. IR νmax (cm-1): 2977 (w), 1723 (s), 
1601 (w), 1494 (s), 1458 (w), 1388 (w), 1302 (m), 1193 (s), 1166 (m), 1133 (s), 1093 
(m), 1020 (m), 997 (m), 987 (m), 914 (q), 858 (q), 814 (m), 788 (m), 758 (s), 721 (m), 
698 (s), 642 (w), 622 (w), 582 (m), 549 (w), 516 (m), 489 (m), 413 (w). HRMS (ES+) m/z 
calculated for [C26H24O2Cl]+ [M+H]+: 403.1465, found: 403.1452. 
9.5.1.33 Synthesis of 5.1g: 
 
In accordance with General Procedure D5, 5.1g was synthesised using 5.9a (800 mg, 
3.96 mmol, 1 equiv) and 4-bromobenzhydrol (1.1 g, 4.15 mmol, 1.05 equiv) yielding a 
white solid. Rf value: 0.72. Yield: 795 mg, 1.78 mmol, 45%. Melting point: 70–76 °C 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.27-7.18 (m, 
10H, Ar-H), 7.15 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.74 (s, 1H, C(H)Ar2), 2.64 (s, 2H, CH2), 
1.30 (s, 6H, C(CH3)2) 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 175.6, 139.8, 139.5, 
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131.8, 131.7, 129.0, 128.7, 128.3, 128.2, 128.0, 127.0, 123.6, 122.0, 86.6, 83.2, 76.6, 
43.0, 30.8, 24.9, 24.9. IR νmax (cm-1): 2984 (w), 1727 (s), 1601 (w), 1487 (s), 1469 (w), 
1456 (w), 1444 (w), 1397 (w), 1388 (w), 1325 (w), 1316 (w), 1296 (w), 1195 (s), 1162 
(m), 1135 (s), 1071 (m), 1023 (w), 1001 (m), 916 13 (w), 859 (w), 814 (w), 785 (m), 753 
(s), 711 (w), 702 (s), 693 (s), 666 (w), 625 (w), 583 (m), 548 (w), 523 (w), 506 (w), 477 
(w). HRMS (ES+) m/z calculated for [C26H24O2Br]+ [M+H]+: 447.0960, found: 447.0962. 
9.5.1.34 Synthesis of 5.1h: 
 
In accordance with General Procedure D5, 5.1h was synthesised using 5.9d (1.0 g, 3.70 
mmol, 1 equiv) and 4-fluorobenzhydrol (790 mg, 3.89 mmol, 1.05 equiv) yielding a white 
solid. Rf value: 0.78. Yield: 405 mg, 1.68 mmol, 24%. Melting point: 68– 75 °C. 1H NMR 
(500 MHz, CDCl3, 298 K) δ/ppm: 7.54–7.47 (m, 2H, Ar-H), 7.37–7.27 (m, 9H, Ar-H), 
7.01–6.92 (m, 2H, Ar-H), 6.86 (s, 1H, C(H)Ar2), 2.72 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 
13C NMR partial (126 MHz, CDCl3, 298 K) δ/ppm: 175.4 (s), 162.3 (d, 1JCF = 246 Hz, 1C), 
140.1, 136.2 132.0, 129.1 (d, 3JCF = 8.1 Hz, 1C), 128.7, 128.1, 127.4, 127.0, 125.2 (q, 
3JCF = 3.9 Hz), 115.6 (d, 2JCF = 21.6 Hz, 2C), 89.5, 82.0, 76.6, 42.9, 31.1, 30.8, 24.9, 
24.9. 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -62.78 (s, 3F, CF3), -114.33 (s, 1F, p-
F). IR νmax (cm-1): 2974 (w), 1733 (m), 1717 (m), 1611 (w), 1511 (m), 1471 (w), 1451 (w), 
1405 (w), 1322 (s), 1229 (m), 1166 (s), 1126 (s), 1103 (s), 1066 (s), 1017 (m), 987 (m), 
911 (w), 841 (s), 828 (m), 788 (w), 765 (w), 738 (m), 698 (s), 649 (w), 625 (w), 599 (m), 
556 (m), 509 (m). HRMS (ES+) m/z calculated for [C27H22O2F4]+ [M+H]+: 454.1556, found: 
454.1552. 
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9.5.1.35 Synthesis of 5.1i: 
 
In accordance with General Procedure D5, 5.1i was synthesised using 5.9d (1.0 g, 3.7 
mmol, 1 equiv) and 4-chlorobenzhydrol (850 mg, 3.9 mmol, 1.05 equiv) yielding a white 
solid. Rf value: 0.74. Yield: 750 mg, 1.59 mmol, 43%. Melting point: 67–74 °C. 1H NMR 
(500 MHz, CDCl3, 298 K) δ/ppm: 7.53 (br. s, 2H, Ar-H), 7.33–7.29 (m, 11H, Ar-H), 6.87 
(s, 1H, C(H)Ar2), 2.74 (s, 2H, CH2), 1.40 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 
298 K) δ/ppm: 175.4, 139.8, 138.9, 134.0, 131.9, 128.9, 128.8, 128.7, 128.2, 127.0, 89.4, 
76.6, 42.9, 30.8, 25.0, 24.9. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -62.69 (s, 3F, 
CF3). IR νmax (cm-1): 2978 (w), 1731 (s), 1614 (w), 1494 (m), 1471 (w), 1451 (w), 1404 
(w), 1394 (w), 1324 (s), 1301 (m), 1194 (m), 1164 (s), 1120 (s), 1104 (s), 1067 (s), 1020 
(m), 1000 (m), 960 (w), 910 (w), 844 (s), 817 (s), 787 (m), 760 (m), 717 (m), 697 (s), 620 
(w), 597 (w), 570 (m), 517 (m), 490 (m). HRMS (ES+) m/z calculated for [C27H22O2F4Cl]+ 
[M+H]+: 470.1260, found: 470.1263. 
9.5.1.36 Synthesis of 5.1j: 
 
In accordance with General Procedure D5, 5.1j was synthesised using 5.9d (1.0 g, 3.7 
mmol, 1 equiv) and 4-bromobenzhydrol (3.89 mmol, 1.0 g, 1.05 equiv) Rf value: 0.61. 
Yield: 577 mg, 1.12 mmol, 31%. Melting point: 74–80 °C. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.51 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.39 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.33–
7.27 (m, 7H, Ar-H), 7.39 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.82 (s, 1H, C(H)Ar2), 2.72 (s, 2H, 
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CH2), 1.38 (s, 6H, C(CH3)2). 13C NMR partial (126 MHz, CDCl3, 298 K) δ/ppm: 175.4, 
139.8, 139.4, 131.9, 131.8, 129.0, 128.8, 128.2, 127.0, 125.2 (q, 3JCF = 3.8 Hz, 1C), 
122.1, 89.4, 82.0, 76.7, 43.0, 30.8, 25.0, 24.9. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: 
-62.77 (s, 3F, CF3). IR νmax (cm-1): 2987 (w), 1730 (w), 1617 (w), 1491 (w), 1475 (w), 
1455 (w), 1405 (w), 1388 (w), 1322 (s), 1302 (m), 1196 (m), 1163 (s), 1116 (s), 1106 (s), 
1066 (s), 1017 (m), 997 (m), 957 (w), 914 (w), 841 (s), 818 (m), 788 (w), 751 (s), 715 
(m), 698 (m), 672 (w), 622 (w), 599 (m), 572 (m), 519 (w), 506 (m), 493 (m). HRMS (ES+) 
m/z calculated for [C26H23O2]+ [M+H]+: 515.0834, found: 515.0834. 
9.5.1.37 Synthesis of 5.2a: 
 
In accordance with General Procedure D5, 5.2a was synthesised using 5.15a (0.500 g, 
2.9 mmol) and 4-fluorobenzhydrol (0.646 g, 3.19 mmol, 1.1 equiv) yielding a yellow oil. 
Rf value: 0.44 (chloroform). Yield: 0.946 g, 2.65 mmol, 91%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.46–7.27 (m, 12H, Ar-H), 7.01 (s, 1H, C(H)Ar2), 6.97 (t, 3JHH = 8.2 Hz, 
2H, Ar-H), 6.44 (d, 3JHH = 11.7 Hz, 1H, =CH), 6.21 (d, 3JHH = 11.5 Hz, 1H, =CH). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 163.9, 162.5 (d, 1JCF = 247 Hz), 140.1, 136.2 (d, 4JCF = 
3.1 Hz), 132.1, 129.4, 129.3 (d, 3JCF = 8.2 Hz, 2C), 128.7, 128.5, 128.1, 127.9, 127.3, 
123.7, 122.6, 115.5 (d, 2JCF = 21.6 Hz, 2C), 102.1, 86.6, 76.6. 19F NMR (376 MHz, CDCl3, 
298 K) δ/ppm: -114.30 (s, 1F, p-F). HRMS (ES+) m/z calculated for [C24H17FO2]+ [M]+: 
356.1213, found: 356.1210 
9.5.1.38 Synthesis of 5.2b: 
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In accordance with General Procedure D5, 5.2b was synthesised using 5.15a (0.500 g, 
2.9 mmol) and 4-chlorobenzhydrol (0.699 g, 3.19 mmol, 1.1 equiv) yielding a yellow oil. 
Rf value: 0.49 (chloroform). Yield: 0.797 g, 2.14 mmol, 74%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.41–7.26 (m, 14H, Ar-H), 6.99 (s, 1H, C(H)Ar2), 6.45 (d, 3JHH = 11.5 Hz, 
1H, =CH), 6.21 (d, 3JHH = 11.6 Hz, 1H, =CH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
163.9, 139.8, 138.9, 133.9, 132.1, 129.4, 128.8, 128.8, 128.8, 128.5, 128.2, 127.8, 127.3, 
123.8, 122.6, 102.1, 86.6, 76.6. HRMS (ES+) m/z calculated for [C24H17ClO2]+ [M]+: 
372.0917, found: 372.0919. 
9.5.1.39 Synthesis of 5.2c: 
 
In accordance with General Procedure D5, 5.2c was synthesised using 5.15a (0.500 g, 
2.9 mmol) and 4-bromobenzhydrol (0.841 g, 3.19 mmol, 1.1 equiv) yielding a yellow oil. 
Rf value: 0.53 (chloroform). Yield: 0.641 g, 1.54 mmol, 53%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.44–7.27 (m, 14H, Ar-H), 6.97 (s, 1H, C(H)Ar2), 6.45 (d, 3JHH = 11.5 Hz, 
1H, =CH), 6.21 (d, 3JHH = 11.5 Hz, 1H, =CH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
163.7, 139.6, 139.2, 132.0, 131.7, 129.3, 129.0, 128.6, 128.4, 128.1, 127.6, 127.2, 123.7, 
122.4, 121.9, 102.0, 86.4, 76.5. HRMS (ES+) m/z calculated for [C28H17FO2]+ [M]+: 
416.0412, found: 416.0415. 
9.5.1.40 Synthesis of 5.3a: 
 
In accordance with General Procedure D5, 5.3a was synthesised using 5.13a (0.60 g, 
2.7 mmol) and 4-fluorobenzhydrol (0.610 g, 2.97 mmol, 1.1 equiv) giving a colourless oil. 
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Rf value: 0.63 (chloroform). Yield: 0.876 g, 2.16 mmol, 80%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 8.06 (d, 3JHH = 8.0 Hz, 1H, Ar-H), 7.67 (d, 3JHH = 7.0 Hz, 1H, Ar-H), 7.52 
(t, 3JHH = 7.4 Hz, 1H, Ar-H), 7.48–7.27 (m, 13H, Ar-H), 7.16 (s, 1H, C(H)Ar2), 6.95 (t, 3JHH 
= 8.1 Hz, 2H, Ar-H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.5, 162.5 (d, 1JCF = 
247 Hz), 140.1, 136.2 (d, 4JCF = 3.2 Hz), 134.6, 132.1 (s, 15 1C), 131.8, 131.6, 131.0, 
129.36 (d, 3JCF = 8.2 Hz, 2C), 128.7, 128.6, 128.4, 128.1, 128.1, 127.3, 124.0, 123.3, 
115.5 (d, 2JCF = 21.6 Hz, 2C), 94.8, 88.5, 77.4. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: 
-114.31 (s, 1F, p-F). HRMS (ES+) m/z calculated for [C28H20FO2]+ [M+H]+: 407.1447, 
found: 407.1441. 
9.5.1.41 Synthesis of 5.3b: 
 
In accordance with General Procedure D5, 5.3b was synthesised using 5.13a (0.60 g, 
2.7 mmol) and 4-chlorobenzhydrol (0.650 g, 2.97 mmol, 1.1 equiv) yielding a colourless 
oil. Rf value: 0.64 (chloroform). Yield: 1.06 g, 2.51 mmol, 93%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.06 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.67 (d, 3JHH = 7.6 Hz, 1H, Ar-
H), 7.52 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.47–7.21 (m, 16H, Ar-H), 7.13 (s, 1H, C(H)Ar2). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.4, 139.8, 138.9, 134.6, 134.0, 132.1, 131.8, 
131.6, 131.0, 128.9, 128.8, 128.8, 128.7, 128.4, 128.2, 128.2, 127.3, 124.0, 123.2, 94.8, 
88.5, 77.5. HRMS (ES+) m/z calculated for [C28H20ClO2]+ [M+H]+: 423.1152, found: 
423.1164. 
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9.5.1.42 Synthesis of 5.3c: 
 
In accordance with General Procedure D5, 5.3c was synthesised using 5.13a (0.790 g, 
2.97 mmol, 1.1 equiv) yielding a colourless oil. Rf value: 0.65 (chloroform). Yield: 1.04 
g, 2.23 mmol, 83%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.05 (d, 3JHH = 7.8 Hz, 1H, 
Ar-H), 7.67 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.52 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.36 (dd, 3JHH 
= 13.8, 3JHH = 7.0 Hz, 16H, Ar-H), 7.11 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 165.5, 139.7, 139.4, 134.6, 132.1, 131.8, 131.8, 131.5, 131.0, 129.2, 129.2, 
128.8, 128.7, 128.4, 128.2, 128.2, 127.3, 124.0, 123.2, 122.1, 94.8, 88.5, 77.5. HRMS 
(ES+) m/z calculated for [C28H20BrO2]+ [M+H]+: 467.0647, found: 467.0668. 
9.5.1.43 Synthesis of 5.3d: 
 
In accordance with General Procedure D5, 5.3d was synthesised using 5.13b (0.60 g, 
2.54 mmol) and 4-fluorobenzhydrol (0.570 g, 2.79 mmol, 1.1 equiv) yielding a colourless 
oil. Rf value: 0.65 (chloroform). Yield: 0.725 g, 1.72 mmol, 68%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.98 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.59 (d, 3JHH = 7.7 Hz, 1H, Ar-
H), 7.43 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 7.41–7.15 (m, 10H, Ar-H), 7.08 (s, 1H, C(H)Ar2), 
7.03 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 6.88 (t, 3JHH = 8.3 Hz, 2H, ArH), 2.29 (s, 3H, CH3). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.5, 162.5 (d, 1JCF = 247 Hz), 140.1, 138.8, 
136.2 (d, 4JCF = 3.2 Hz), 134.5, 132.0, 131.7, 131.5, 131.0, 129.4 (d, 3JCF = 8.2 Hz, 2C), 
129.2, 128.7, 128.1, 127.9, 127.3, 124.2, 120.2, 115.5 (d, 2JCF = 21.6 Hz, 2C), 95.1, 88.0, 
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77.4, 21.7. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -114.36 (s). HRMS (ES+) m/z 
calculated for [C29H22FO2]+ [M+H]+: 421.1604, found: 421.1604. 
9.5.1.44 Synthesis of 5.3e: 
 
In accordance with General Procedure D5, 5.3e was synthesised using 5.13b (0.60 g, 
2.54 mmol) and 4-chlorobenzhydrol (0.61 g, 2.79 mmol, 1.1 equiv) yielding a colourless 
oil. Rf value: 0.67 (chloroform). Yield: 1.07 g, 2.45 mmol, 96%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.07 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.68 (d, 3JHH = 7.6 Hz, 1H, Ar-
H), 7.53 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.49–7.22 (m, 12H, Ar-H), 7.14 (d, 3JHH = 8.3 Hz, 
2H, Ar-H), 7.11 (s, 1H, C(H)Ar2), 2.39 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 165.5, 139.9, 138.9, 138.9, 134.5, 133.9, 132.1, 131.7, 131.5, 131.0, 129.2, 
129.0, 128.8, 128.8, 128.2, 128.0, 127.3, 124.2, 120.2, 95.1, 87.9, 77.5, 21.7. HRMS 
(ES+) m/z calculated for [C29H22ClO2]+ [M+H]+: 437.1309, found: 437.1308. 
9.5.1.45 Synthesis of 5.3f: 
 
In accordance with General Procedure D5, 5.3f was synthesised using 5.13b (0.600 g, 
2.54 mmol) and 4-bromobenzhydrol (0.740 g, 2.79 mmol, 1.1 equiv) giving a colourless 
oil. Rf value: 0.70 (chloroform). Yield: 1.18 g, 15.1 mmol, 97%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.07 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.68 (d, 3JHH = 7.9 Hz, 1H, Ar-
H), 7.53 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.49–7.23 (m, 15H, Ar-H), 7.14 (s, 2H, Ar-H), 7.12 
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(s, 1H, C(H)Ar2), 2.39 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.5, 
139.8, 139.4, 138.9, 134.5, 132.1, 131.8, 131.7, 131.5, 131.0, 129.2, 128.8, 128.2, 128.0, 
127.3, 124.2, 122.1, 120.2, 95.1, 87.9, 77.5, 21.7. HRMS (ES+) m/z calculated for 
[C29H22BrO2]+ [M+H]+: 481.0803, found: 481.0825. 
9.5.1.46 Synthesis of 5.3g: 
 
In accordance with General Procedure D5, 5.3g was synthesised using 5.13b (0.216 g, 
1.07 mmol) and 1-phenylethanol (0.14 ml, 0.143 g, 1.17 mmol, 1.1 equiv) yielding a 
colourless oil. Rf value: 0.26 (1:1, hexane/CHCl3). Yield: 82 mg, 0.26 mmol, 24%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.42–7.24 (m, 7H, Ar-H), 7.10 (d, 3JHH = 5.8 Hz, 
2H, Ar-H), 5.98–5.89 (m, 1H, C(H)CH3), 2.70 (s, 2H, CH2), 2.36 (s, 3H, CH3), 1.61–1.58 
(m, 3H, CH3), 1.38 (s, 6H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 176.1, 142.0, 
137.8, 131.6, 129.1, 128.6, 127.8, 126.0, 120.7, 86.0, 82.9, 72.6, 42.7, 30.7, 24.8, 24.8, 
22.5, 21.6. HRMS (ES+) m/z calculated for [C22H24O2]+ [M+H]+: 321.1855, found 
321.1842. 
9.5.2 Products of the stoichiometric cyclisation reactions 
General procedure D6 to give pyranone borane adducts: 
B(C6F5)3 (51 mg, 0.1 mmol, 1 equiv) was added to a solution of free acids and esters 
(0.1 mmol, 1 equiv) in CDCl3 (0.5 ml). The mixture was stirred and when full conversion 
was observed in 1H NMR spectra the solvent was removed under vacuum and the 
residue was washed with hexane (2 x 1 ml) to give the desired cyclised heterocyclic 
borane adduct. 
  141 
9.5.2.1 Synthesis of 5.10a: 
 
In accordance with General Procedure D6, 5.10a was synthesised using 5.9a (20 mg, 
0.1 mmol) yielding a white solid, that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 68 mg, 0.09 mmol, 96%. Melting point: 70–
76 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.38–7.30 (m, 3H, Ar-H), 7.07 (d, 3JHH 
= 7.2 Hz, 2H, Ar-H), 5.95 (t, 3JHH = 4.0 Hz, 1H, =CH), 2.54 (d, 3JHH = 3.8 Hz, CH2), 1.46 
(s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 150.5, 147.9 (dm, 1JCF ≈ 240 
Hz, 6C), 140.3 (dm, 1JCF ≈ 240 Hz, 3C), 137.3 (dm, 1JCF ≈ 250 Hz, 6C), 130.5, 129.3, 
129.0, 124.4, 103.2, 37.6, 32.8, 24.0. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 2.0 (br. 
s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.04 (d, 3JFF = 15.9 Hz, 6F, o-F 
B(C6F5)3), -156.64 (br. s, 3F, p-F B(C6F5)3), -163.63 (br. s, 6F, m-F B(C6F5)3). IR νmax (cm-
1): 2982 (w), 2936 (w), 1716 (m), 1678 (m), 1647 (m), 1557 (m), 1518 (s), 1465 (s), 1389 
(m), 1342 (w), 1287 (m), 1275 (m), 1209 (w), 1099 (s), 1055 (w), 970 (s), 893 (w), 791 
(m), 760 (m), 746 (m), 689 (m), 613 (w), 576 (w). HRMS (AP+) m/z calculated for 
[C14H16O2]+ [M+H - (B(C6F5)3)]+: 203.1072, found: 203.1079 
9.5.2.2 Synthesis of 5.10b: 
 
In accordance with General Procedure D6, 5.10b was synthesised using 5.9b (23 mg, 
0.1 mmol) yielding a white solid. Yield: 69 mg, 0.09 mmol, 93%. Melting point: 80–87 
°C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 6.99 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.79 (d, 
3JHH = 8.3 Hz, 2H, Ar-H), 5.77 (t, 3JHH = 4.3 Hz, 1H, =CH), 3.79 (s, 3H, OCH3), 2.48 (d, 
3JHH = 4.2 Hz, 2H, CH2), 1.43 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 
161.3, 150.4, 148.0 (dm, 1JCF ≈ 240 Hz, 6C), 140.3 (dm, 1JCF ≈ 250 Hz, 3C), 137.2 (dm, 
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1JCF ≈ 250 Hz, 6C), 126.0, 121.8, 114.3, 101.1, 55.5, 37.6, 32.7, 24.0. 11B NMR (128 
MHz, CDCl3, 298 K) δ/ppm: 1.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.03 
(d, 3JFF = 19.4 Hz, 6F, o-F B(C6F5)3), - 156.84 (t, 3JFF = 20.3 Hz, 3F, p-F B(C6F5)3), -
163.72 (t, 3JFF = 18.2 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2982 (w), 2845 (w), 1705 (w), 
1647 (m), 1611 (m), 1516 (s), 1460 (s), 1381 (m), 1287 (m), 1271 (m), 1251 (m), 1238 
(m), 1178 (m), 1099 (s), 1033 (w), 972 (s), 891 (m), 864 (m), 835 (w), 793 (w), 775 (w), 
764 (w), 746 (w), 685 (w), 673 (w), 608 (w). HRMS (AP+) m/z calculated for [C14H17O3]+ 
[M+H - (B(C6F5)3)]+: 233.1178, found: 233.1183. 
9.5.2.3 Synthesis of 5.10c: 
 
In accordance with General Procedure D6, 5.10c was synthesised using 5.9c (22 mg, 
0.1 mmol) and yielding a white solid. Yield: 68 mg, 0.09 mmol, 93%. Melting point: 75–
81 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.10 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 7.01 
(d, 3JHH = 7.3 Hz, 2H, Ar-H), 5.87 (t, 3JHH = 4.5 Hz, 1H, =CH), 2.49 (s, 2H, CH2), 2.35 (s, 
3H, p-Me), 1.44 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 150.5, 148.0 
(dm, 1JCF ≈ 240 Hz, 6C), 140.8, 140.2 (dm, 1JCF ≈ 250 Hz, 3C), 137.3 (dm, 1JCF ≈ 250 Hz, 
6C), 129.6, 126.8, 124.3, 101.9, 37.5, 32.8, 24.1, 21.4. 11B NMR (128 MHz, CDCl3, 298 
K) δ/ppm: 1.5 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.05 (d, 3JFF = 18.5 
Hz, 6F, o-F B(C6F5)3), -156.86 (t, 3JFF = 19.2 Hz, 3F, p-F B(C6F5)3), -163.74 (br. s, 6F, m-
F B(C6F5)3). IR νmax (cm-1): 2955 (w), 2910 (w), 2876 (w), 1726 (w), 1678 (m), 1599 (s), 
1576 (m), 1510 (m), 1483 (w), 1418 (w), 1368 (w), 1317 (m), 1261 (m), 1171 (s), 1072 
(w), 1032 (w), 1004 (m), 976 (w), 907 (m), 841 (m), 841 (m). HRMS (ES+) m/z calculated 
for [C14H16O2]+ [M-B(C6F5)3]+: 216.1150, found 216.1149. 
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9.5.2.4 Synthesis of 5.4a: 
 
In accordance with General Procedure D6, 5.4a was synthesised using 5.1c (57 mg, 0.2 
mmol). However, the adduct could not be isolated by the same work up procedure and 
was purified via column chromatography (SiO2, chloroform) yielding dihydropyrone 5.4a 
as a yellow oil. Rf value: 0.49. Yield: 48 mg, 0.17 mmol, 84%. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.54–7.49 (m, 2H, Ar-H), 7.42– 7.29 (m, 5H, Ar-H), 7.21–7.15 (m, 3H, Ar-
H), 3.55 (s, 2H, CH2), 2.18 (s, 2H, CH2), 1.26 (s, 6H, C(CH3)2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 174.2, 146.8, 138.7, 133.0, 129.1, 128.8, 128.8 128.7, 128.5, 
112.3, 38.7, 37.8, 36.5, 24.9. IR νmax (cm-1): 2980 (w), 2361 (w), 1717 (m), 1647 (m), 
1517 (s), 1460 (s), 1379 (m), 1344 (m), 1287 (m), 1211 (w), 1101 (s), 1053 (w), 965 (s), 
868 (w), 789 (w), 764 (m), 746 (w), 700 (m), 678 (m), 625 (w), 577 (w), 517 (w), 444 (w). 
HRMS (ES+) m/z calculated for [C20H20O2]+ [M+H]+: 292.1463, found: 292.1462. 
9.5.2.5 Synthesis of 5.4b: 
 
In accordance with General Procedure D6, 5.4b was synthesised using 5.1d (45 mg, 0.1 
mmol) yielding a white solid. Yield: 89 mg, 0.09 mmol, 92%. Melting point: 80–86 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.68 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.38–7.34 
(m, 2H, Ar-H), 7.25–7.18 (m, 3H, Ar-H), 7.10 (d, 3JHH = 7.2 Hz, 2H, Ar-H), 3.52 (s, 2H, 
CH2Ph), 2.38 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 1.7 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -63.30 (s, 3F, CF3), -134.94 
(br. s, 6F, o-F-B(C6F5)3), -156.30 (br. s, 3F, p-F B(C6F5)3), -163.44 (br. s, 6F, m-F 
B(C6F5)3). IR νmax (cm-1): 2936 (w), 2361 (w), 2332 (w), 1717 (w), 1647 (w), 1618 (w), 
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1541 (w), 1518 (s), 1461 (s), 1406 (w), 1381 (w), 1323 (s), 1288 (m), 1169 (m), 1103 (s), 
1067 (s), 1018 (w), 972 (s), 845 (w), 793 (w), 775 (w), 745 (w), 700 (w), 673 (w), 609 (w), 
577 (w). HRMS (ES+) m/z calculated for [C23H23F3NO2]+ [M+MeCN+H-(B(C6F5)3)]+: 
402.1681, found: 402.1674. 
9.5.2.6 Synthesis of 5.4c: 
 
In accordance with General Procedure D6, 5.4c was synthesised using 5.1e (39 mg, 0.1 
mmol) yielding a white solid. Yield: 81 mg, 0.09 mmol 90%. Melting point: 168–175 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.45 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.34 (pent., 
3JHH = 6.5 Hz, 5H, Ar-H), 7.06–7.03 (m, 6H, Ar-H), 6.99 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 5.14 
(s, 1H, CH(Ar)2), 2.42–2.32 (m, 2H, CH2) 1.25 (d, 4JHH = 4.0 Hz, 6H, C(CH3)2). 13C NMR 
(126 MHz, CDCl3, 298 K) δ/ppm: 162.0 (d, 1JCF = 245 Hz, 1C), 148.0 (dm, 1JCF = 250 Hz, 
6C), 140.4, 140.1 (dm, 1JCF = 245 Hz, 3C), 137.1 (dm, 1JCF = 245 Hz, 6C), 136.6, 130.5, 
129.01 (s), 129.0 (d, 3JCF = 7.4 Hz, 2C), 128.9, 128.3, 127.6, 50.7, 37.0, 34.6, 23.9, 23.8. 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 1.6 (br. s). 19F NMR (376 MHz, CDCl3, 298 
K) δ/ppm: -114.56 (s, 1F, p-F), -135.31 – -135.36 (m, 6F, o-F B(C6F5)3), -157.08 (t, 3JFF 
= 20.5 Hz, 3F, p-F B(C6F5)3), -163.85 (td, 6F, 3JFF = 23.9 Hz, 4JFF = 8.3 Hz, m-F B(C6F5)3). 
IR νmax (cm-1): 2982 (w), 1763 (w), 1647 (w), 1611 (m), 1518 (m), 1506 (m), 1467 (s), 
1408 (m), 1383 (w), 1366 (w), 1331 (w), 21283 (w), 1227 (m), 1227 (m), 1105 (m)1049 
(w), 976 (s), 937 (w), 885 (w), 856 (w), 841 (w), 831 (w), 808 (w), 789 (m), 775 (w), 765 
(m), 745 (w), 727 (w), 696 (m), 681 (m), 667 (m), 624 (w), 610 (w). HRMS (ES+) m/z 
calculated for [C26H24O2F]+ [M-B(C6F5)3+H]+: 387.1760, found: 387.1752. 
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9.5.2.7 Synthesis of 5.4d: 
 
In accordance with General Procedure D6, 5.4d was synthesised using 5.1f (40 mg, 0.1 
mmol) and yielding a white solid. Yield: 88 mg, 0.09 mmol, 97%. Melting point: 149–
155 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.38 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.30 
– 7.22 (m, 7H, Ar-H), 6.99 – 6.90 (m, 4H, Ar-H), 6.86 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 5.05 
(s, 1H, C(H)Ar2), 2.32 (s, 2H, CH2), 1.22 (s, 3H, CH3), 1.19 (s, 3H, CH3). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 186.2, 147.8 (dm, 1JCF ≈ 250 Hz, 6C), 147.5, 140.0 (dm, 1JCF 
≈ 250 Hz, 3C), 139.6, 138.6, 137.1 (dm, 1JCF ≈ 250 Hz, 6C), 133.6, 131.0, 130.2, 129.3, 
129.2, 129.1, 128.8, 128.2, 127.9, 119.4, 50.7, 37.4, 34.1, 23.6, 23.4. 11B NMR (128 
MHz, CDCl3, 298 K) δ/ppm: 1.4 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -135.31 
(d, 3JFF = 18.5 Hz, 6F, o-F B(C6F5)3), -157.03 (t, 3JFF = 20.3 Hz, 3F, p-F B(C6F5)3), -163.66 
– -163.94 (m, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2982 (w), 2361 (w), 1647 (w), 1611 (s), 
1518 (s), 1491 (m), 1462 (s), 1406 (m), 1381 (m), 1364 (m), 1331 (w), 1283 (m), 1229 
(m), 1091 (s), 1048 (m), 1015 (w), 976 (s), 935 (w), 885 (w), 856 (w), 839 (w), 824 (w), 
789 (m), 766 (m), 698 (s), 681 (m), 665 (m), 625 (m), 610 (m). HRMS (ES+) m/z 
calculated for [C26H24O2Cl]+ [(M-B(C6F5)3)+H]+: 403.1465, found: 403.1455. 
9.5.2.8 Synthesis of 5.4e: 
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In accordance with General Procedure D6, 5.4e was synthesised using 5.1g (45 mg, 0.1 
mmol) yielding a white solid. Yield: 92 mg, 0.09 mmol, 96%. Melting point: 154–159 
°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.43–7.35 (m, 3H, Ar-H), 7.31–7.19 (m, 
5H, Ar-H), 6.96 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 6.87 (d, 3JHH = 8.4 Hz, 4H, Ar-H), 5.04 (s, 
1H, C(H)Ar2), 2.32 (s, 2H, CH2), 1.22 (s, 3H, CH3), 1.19 (s, 3H, CH3). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 147.8 (dm, 1JCF ≈ 240 Hz, 6C), 147.6, 140.2 (dm, 1JCF ≈ 250 Hz, 
3C), 140.2 (d, 3JCF = 47.6 Hz, 1C), 137.1 (dm, 1JCF ≈ 250 Hz, 6C), 132.0, 130.7, 130.26, 
129.0, 128.9, 128.9, 128.3, 127.5, 121.3, 51.1, 36.7, 34.9, 24.1, 24.0. 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 1.5 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -135.32 
(d, 3JFF = 16.9 Hz, 6F, o-F B(C6F5)3), -157.02 (t, 3JFF = 20.5 Hz, 3F, p-F B(C6F5)3), -163.79 
(td, 3JFF = 23.9, 4JFF =8.2 Hz, m-F B(C6F5)3). IR νmax (cm-1): 2982 (w), 2361 (w), 1647 (w), 
1611 (s), 1518 (s), 1487 (m), 1462 (s), 1406 (m), 1381 (m), 1364 (m), 1331 (w), 1283 
(m), 1229 (m), 1101 (s), 1047 (m), 1011 (m), 976 (s), 885 (w), 856 (w), 837 (w), 789 (m), 
775 (m), 766 (m), 721 (m), 696 (s), 680 (m), 671 (m), 624 (w), 610 (w). HRMS (ES+) m/z 
calculated for [C26H24O2Br]+ [(M-B(C6F5)3)+H]+: 447.0960, found: 447.0947. 
9.5.2.9 Synthesis of 5.4f: 
 
In accordance with General Procedure D6, 5.4f was synthesised using 5.1h (45 mg, 0.1 
mmol) yielding a white solid. Yield: 89 mg, 0.09 mmol, 92%. Melting point: 165–171 
°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.55 (d, 3JHH = 8.3 Hz, 2H), 7.33–7.27 (m, 
3H, Ar-H), 7.19 (d, 3JHH = 6.5 Hz, 2H, Ar-H), 7.03–6.97 (m, 5H, Ar-H), 5.03 (s, 1H, 
C(H)Ar2), 2.41–2.39 (m, 2H, CH2), 1.29 (s, 23 3H, CH3), 1.28 (s, 3H, CH3). 13C NMR 
partial (126 MHz, CDCl3, 298 K) δ/ppm: 148.1 (dm, 1JCF = 245 Hz, 6C), 147.9, 140.1, 
139.1, 137.3 (dm, 1JCF = 250 Hz, 6C), 134.0, 131.3, 130.1, 129.6, 129.6, 129.5, 129.2, 
128.6, 128.3, 51.1, 37.7, 34.5, 24.0, 23.92. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
0.0 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -63.04 (s, 3F, -CF3), -114.76 (m, 
1F, p-F-Ph), -138.45 (dd, 3JFF = 21.7 Hz, 4JFF = 8.5 Hz, 6F, o-F B(C6F5)3), -153.49 (br. s, 
3JFF = 20.1 Hz, 4JFF = 6.9 Hz, 3F, p-F B(C6F5)3), -161.81 – -161.94 (m, 6F, m-F B(C6F5)3). 
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9.5.2.10 Synthesis of 5.4g: 
 
In accordance with General Procedure D6, 5.4g was synthesised using 5.1i (47 mg, 0.1 
mmol) yielding a white solid. Yield: 92 mg, 0.09 mmol, 94%. Melting point: 160–168 
°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.54 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.26–
7.24 (m, 4H, Ar-H), 7.00–6.90 (m, 8H, Ar-H), 4.99 (s, 1H, C(H)Ar2), 2.35 (s, 2H, CH2), 
1.26 (s, 3H, CH3), 1.23 (s, 3H, CH3). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 2.6 (br. 
s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 188.0, 146.6 (dm, 1JCF = 240 Hz, 6C), 
144.8, 140.6, 138.9 (dm, 1JCF = 245 Hz, 3C), 138.5, 137.4, 136.0 (dm, 1JCF = 245 Hz, 
6C), 132.6, 129.0, 128.4, 128.2, 128.1, 128.2, 127.6, 127.6, 126.8, 124.9 (q, 3JCF = 3.5 
Hz, 2C), 49.7, 36.0, 33.6, 22.6, 22.6. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -63.39 
(s, 3F, CF3), -135.12 (d, 3JFF = 18.3 Hz, 6F, o-F B(C6F5)3), -156.46 (s, 3F, p-F B(C6F5)3), 
-163.58 (t, 3JFF = 17.7 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2982 (w), 2359 (w), 2332 
(w), 1716 (m), 1647 (m), 1616 (w), 1518 (s), 1462 (s), 1406 (m), 1381 (m), 1323 (s), 1288 
(m), 1225 (w), 1169 (m), 1101 (s), 1067 (s), 1016 (m), 972s, 847 (m), 791 (w), 775 (w), 
744 (w), 704w, 679 (m), 608 (w), 579 (w), 561 (w). HRMS (ES+) m/z calculated for 
[C27H23O2F3Cl]+ [(M-B(C6F5)3)+H]+: 471.1339, found: 471.1330. 
9.5.2.11 Synthesis of 5.4h: 
 
In accordance with General Procedure D6, 5.4h was synthesised using 5.1j (51 mg, 0.1 
mmol) yielding a white solid. Yield: 93 mg, 0.09 mmol, 92%. Melting point: 105–110 
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°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.48 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.35 (d, 
3JHH = 8.5 Hz, 2H, Ar-H), 7.23–7.21 (m, 3H, Ar-H), 6.94–6.88 (m, 4H, Ar-H), 6.79 (d, 3JHH 
= 8.3 Hz, 2H, Ar-H), 4.91 (s, 1H, C(H)Ar2), 2.30 (s, 1H), 1.21 (s, 3H, CH3), 1.18 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 189.2, 147.9 (dm, 1JCF = 245 Hz, 6C), 
146.3, 141.3, 140.1 (dm, 1JCF = 245 Hz, 3C), 140.0, 136.9 (dm, 1JCF = 245 Hz, 6C), 132.1, 
130.1, 129.1, 128.9, 128.8, 127.7, 125.8 (q, 3JCF = 3.8 Hz, 2C), 121.4, 51.2, 36.7, 35.5, 
24.3, 24.2. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 2.6 (br. s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -63.26 (s, 3F, -CF3), -134.97 (br. s, 6F, o-F B(C6F5)3), -156.09 (br. 
s, 3F, p-F B(C6F5)3), -163.44 (br. s, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2934 (w), 22361 
(w), 1717 (w), 1647 (w), 1618 (w), 24 1518 (s), 1462 (s), 1381 (m), 1323 (s), 1288 (m), 
1227 (w), 1169 (m), 1126 (s), 1103 (s), 1067 (s), 972 (s), 847 (m), 791 (w), 775 (w), 745 
(w), 704 (w), 673 (m), 608 (w), 577 (w), 561 (w). HRMS (ES+) m/z calculated for 
[C27H23O2F3Br]+ [(M-B(C6F5)3)+H]+: 515.0834, found: 515.0831. 
9.5.2.12 Synthesis of 5.16a: 
 
In accordance with General Procedure D6, 5.16a was synthesised using 5.13a (22 mg, 
0.1 mmol) yielding a pale green solid, that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 33 mg, 0.05 mmol, 45%. Melting point: 205–
211 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.57 (d, 3JHH = 8.1 Hz, 1H, Ar-H), 8.09 
(t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.89–7.70 (m, 2H, Ar-H), 7.57–7.48 (m, 1H, Ar-H), 7.47–7.32 
(m, 5H, Ar-H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.7, 148.1 (dm, 1JCF = 244 
Hz, 6C), 140.0 (dm, 1JCF = 247 Hz, 3C) 139.3, 139.2, 137.2 (dm, 1JCF = 253 Hz, 6C), 
131.8, 130.9, 130.6, 129.4, 127.0, 125.6, 117.4, 106.5. 11B NMR (128 MHz, CDCl3, 298 
K) δ/ppm: 0.8 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.77 (d, 3JFF = 19.6 
Hz, 6F, o-F B(C6F5)3), -157.14 (t, 3JFF = 19.9 Hz, 3F, p-F B(C6F5)3), -163.79 (t, 3JFF = 17.7 
Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2160 (w), 1681 (m), 1645 (m), 1606 (m), 1564 (m), 
1517 (s), 1426 (s), 1379 (m), 1344 (w), 1286 (m), 1242 (m), 1159 (w), 1089 (s), 1029 
(w), 968 (s), 879 (w), 798 (w), 765 (m), 688 (s), 673 (s), 621 (w), 574 (w), 538 (w), 524 
(w). HRMS (ES+) m/z calculated for [C15H11O2]+ [M+H - (B(C6F5)3)]+: 223.0759, found: 
223.0760. 
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9.5.2.13 Synthesis of 5.16b: 
 
In accordance with General Procedure D6, 5.16a was synthesised using 5.13b (24 mg, 
0.1 mmol) yielding a pale green solid, that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 39 mg, 0.05 mmol, 52%. Melting point: 187–
192 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.55 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 8.07 
(t, 3JHH = 7.8 Hz, 1H, Ar-H), 7.85– 7.64 (m, 2H, Ar-H), 7.38 (s, 1H, =CH), 7.25 (q, 3JHH = 
8.3 Hz, 4H), 2.41 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.9, 147.9 
(dm, 1JCF = 241 Hz, 6C), 142.5, 140.0 (dm, 1JCF = 246 Hz, 3C), 139.3, 139.2, 137.0 (dm, 
3JCF = 253 Hz, 6C), 130.5, 130.4, 130.0, 126.7, 125.3, 117.0, 105.6, 21.5. 11B NMR (128 
MHz, CDCl3, 298 K) δ/ppm: 0.7 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.76 
(d, 3JFF = 18.0 Hz, 6F, o-F B(C6F5)3), - 157.27 (t, 3JFF = 20.3 Hz, 3F, p-F B(C6F5)3), -
163.86 (t, 3JFF = 18.3 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2362 (w), 2160 (w), 1647 (m), 
1606 (m), 1579 (m), 1558 (m), 1517 (s), 1458 (s), 1381 (m), 1340 (m), 1286 (m), 1244 
(w), 1192 (w), 1163 (w), 1101 (s), 984 (s), 881 (w), 854 (w), 831 (w), 817 (m), 796 (m), 
773 (s), 752 (s), 696 (s), 677 (s), 630 (w), 582 (m), 524 (s). HRMS (ES+) m/z calculated 
for [C16H13O2]+ [M+H - (B(C6F5)3)]+: 237.0916, found: 237.0920. 
9.5.2.14 Synthesis of 5.5a: 
 
In accordance with General Procedure D6, 5.5a was synthesised using 5.2a (36 mg, 0.1 
mmol) yielding a pale green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 80 mg, 0.09 mmol, 92%. Melting point: 117–
123 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.92 (br. s, 1H, =CH), 7.57 (t, 3JHH = 
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7.5 Hz, 1H, Ar-H), 7.45–7.31 (m, 5H, Ar-H), 7.11–7.03 (m, 4H, Ar-H), 7.00–6.94 (m, 4H, 
Ar-H), 6.91 (br. s, 1H, =CH), 5.49 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 162.2 (d, 1JCF = 248 Hz, 1C), 148.0 (dm, 1JCF = 241 Hz, 6C), 140.4, 140.0 (dm, 
1JCF = 249 Hz, 3C), 137.1 (dm, 1JCF = 245 Hz, 6C), 136.5, 132.4, 130.5 (d, 3JCF = 8.1 Hz, 
2C), 129.6, 129.2, 128.8, 128.5, 128.2, 117.7, 116.5 (d, 2JCF = 21.6 Hz, 2C), 113.6, 49.4. 
11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.1 (br. s). 19F NMR (471 MHz, CDCl3, 298 
K) δ/ppm: -113.7 (s, 1F, p-F), -134.7 (d, 3JFF = 17.9 Hz, 6F, o-F B(C6F5)3), -157.6 (t, 3JFF 
= 20.3 Hz, 3F, p-F B(C6F5)3), -164.2 (t, 3JFF = 18.3 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 
3030 (w), 2158 (w), 1973 (w), 1639 (m), 1606 (m), 1564 (s), 1517 (s), 1506 (m), 1435 
(s), 137 (m), 1282 (m), 1224 (m), 1161 (w), 1099 (s), 985 (m), 974 (s), 858 (m), 788 (m), 
771 (s), 746 (m), 738 (m), 715 (m), 690 (s), 613 (m). HRMS (ES+) m/z calculated for 
[C24H18O2F]+ [M+H - (B(C6F5)3)]+: 357.1291, found: 357.1293. 
9.5.2.15 Synthesis of 5.5b: 
 
In accordance with General Procedure D6, 5.5b was synthesised using 5.2b (37 mg, 0.1 
mmol) yielding a pale green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 76 mg, 0.09 mmol, 86%. Melting point: 120–
126 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.95 (d, 3JHH = 9.4 Hz, 1H, =CH), 7.58 
(t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.44–7.32 (m, 8H, Ar-H), 7.06 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 
6.99–6.86 (m, 6H, Ar-H), 5.49 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 168.6, 162.0, 153.9, 148.0 (dm, 1JCF = 238 Hz, 6C), 140.1, 140.0 (dm, 1JCF = 250 
Hz, 3C), 139.1, 137.1 (dm, 1JCF = 248 Hz, 6C), 134.2, 132.6, 130.2, 129.7, 129.7, 129.3, 
128.8, 128.5, 128.3, 128.1, 124.7, 113.5, 49.6. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
0.1 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.7 (d, 3JFF = 18.6 Hz, 6F, o-F 
B(C6F5)3), -157.6 (t, 3JFF = 20.1 Hz, 3F, p-F B(C6F5)3), -164.2 (t, 3JFF = 18.3 Hz, 6F, m-F 
B(C6F5)3). IR νmax (cm-1): 3028 (w), 2158 (w), 1637 (m), 1606 (w), 1564 (m), 1517 (m), 
1458 (s), 1375 (m), 1280 (m), 1174 (w), 1097 (m), 1014 (w), 987 (m), 974 (m), 933 (w), 
906 (w), 858 (m), 839 (m), 821 (m), 794 (m), 773 (m), 746 (m), 738 (m), 721 (m), 690 
(m), 673 (m). HRMS (ES+) m/z calculated for [C24H18O2Cl]+ [M+H - (B(C6F5)3)]+: 
373.0995, found: 373.1005. 
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9.5.2.16 Synthesis of 5.5c: 
 
In accordance with General Procedure D6, 5.5c was synthesised using 5.2c (42 mg, 0.1 
mmol) yielding a pale green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 78 mg, 0.08 mmol, 84%. Melting point: 92–
95 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.95 (d, 3JHH = 9.2 Hz, 1H), 7.58 (t, 3JHH 
= 7.6 Hz, 1H), 7.50 (d, 3JHH = 8.5 Hz, 2H), 7.45–7.33 (m, 7H), 7.06 (d, 3JHH = 7.5 Hz, 2H), 
6.97 (d, 3JHH = 6.7 Hz, 3H), 6.86 (d, 3JHH = 8.5 Hz, 2H), 5.47 (s, 1H, C(H)Ar2). 13C NMR 
(126 MHz, CDCl3, 298 K) δ/ppm: 161.9, 147.9 (dm, 1JCF = 238 Hz, 6C), 140.1, 140.0 (dm, 
1JCF = 254 Hz, 3C), 139.7, 137.0 (dm, 1JCF = 253 Hz, 6C), 132.6, 130.5, 129.6, 129.3, 
128.8, 128.5, 128.2, 122.2, 113.5, 49.6. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.0 
(br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: - 134.72 (d, 3JFF = 17.8 Hz, 6F, o-F 
B(C6F5)3), -157.58 (t, 3JFF = 20.2 Hz, 3F, p-F B(C6F5)3), -164.14 (t, 3JFF = 18.1 Hz, 6F, m-
F B(C6F5)3). IR νmax (cm-1): 3032 (w), 2160 (w), 1637 (m), 1606 (w), 1564 (m), 1516 (m), 
1425 (s), 1377 (m), 1321 (w), 1282 (m), 1172 (w), 1097 (s), 1008 (m), 985 (s), 974 (s), 
935 (w), 906 (w), 856 (m), 821 (m), 790 (m), 746 (m), 740 (m), 717 (m), 690 (s), 675 (s), 
625 611 (m), 576 (m). HRMS (ES+) m/z calculated for [C24H18O2Br]+ [M+H - (B(C6F5)3)]+: 
417.0490, found: 417.0503. 
9.5.2.17 Synthesis of 5.6a: 
 
In accordance with General Procedure D6, 5.6a was synthesised using 5.3a (41 mg, 0.1 
mmol) yielding a white solid that was recrystallised by slow evaporation of a saturated 
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CH2Cl2/hexane solution. Yield: 79 mg, 0.09 mmol, 86%. Melting point: 190–195 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.62 (d, 3JHH = 7.4 Hz, 1H, Ar-H), 7.79 (t, 3JHH = 
7.2 Hz, 1H, Ar-H), 7.73 (t, 3JHH = 7.4 Hz, 1H, Ar-H), 7.67 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 
7.48 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.34–7.24 (m, 6H, Ar-H), 7.08–7.00 (m, 4H, Ar-H), 6.97 
(t, 3JHH = 8.4 Hz, 4H, Ar-H), 5.81 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 169.3, 161.9 (d, 1JCF = 247 Hz, 1C), 154.2 (s, 148.2 (dm, 1JCF = 245 Hz, 6C), 
139.8 (dm, 1JCF = 250 Hz, 3C), 139.0, 139.0, 136.9 (dm, 1JCF = 250 Hz, 6C), 135.6 (d, 
3JCF = 3.3 Hz, 2C), 131.5, 131.1, 130.6, 129.6, 129.2, 129.1, 128.8, 128.6, 127.8, 127.7, 
120.9, 118.3, 116.0 (d, 2JCF = 12.1 Hz, 2C), 49.4. 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 0.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: - 114.54 (s, 1F, CF), -
134.98 (d, 3JFF = 19.2 Hz, 6F, o-F B(C6F5)3), -157.48 (t, 3JFF = 18.0 Hz, 3F, p-F B(C6F5)3), 
- 164.03 (br. t, 3JFF = 18.2 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 3032 (w), 2957 (w), 1645 
(m), 1603 (m), 1556 (m), 1452 (s), 1377 (m), 1284 (m), 1228 (m), 1161 (w), 1099 (s), 
1016 (w), 974 (s), 860 (w), 835 (w), 790 (m), 745 (m), 739 (m), 696 (s), 665 (m), 611 (w), 
574 (w). HRMS (ES+) m/z calculated for [C28H20O2F]+ [M+H - (B(C6F5)3)]+: 407.1447, 
found: 407.1440. 
9.5.2.18 Synthesis of 5.6b: 
 
In accordance with General Procedure D6, 5.6b was synthesised using 5.3b (42 mg, 0.1 
mmol) yielding a white solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 85 mg, 0.09 mmol, 91%. Melting point: 194–200 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.61 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.78 (t, 3JHH = 
7.2 Hz, 1H, Ar-H), 7.72 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.64 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 
7.47 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.32 (t, 3JHH = 7.8 Hz, 2H, Ar-H), 7.29– 7.17 (m, 4H, Ar-
H), 7.05 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 6.99 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.95 (d, 3JHH = 7.5 
Hz, 2H, Ar-H), 5.79 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 169.3, 
154.3, 148.0 (dm, 1JCF = 238 Hz, 6C), 140.0 (dm, 1JCF = 250 Hz, 3C), 139.4, 138.9, 138.4, 
137.07 (dm, 1JCF = 241 Hz, 6C). 133.5, 131.5, 131.1, 130.5, 130.3, 129.5, 129.3, 129.2, 
129.1, 128.8, 128.6, 127.8, 127.7, 120.6, 118.3, 49.5. 11B NMR (128 MHz, CDCl3, 298 
K) δ/ppm: 0.6 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.98 (d, 3JFF = 18.5 
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Hz, o-F B(C6F5)3), -157.47 (t, 3JFF = 20.0 Hz, p-F B(C6F5)3), -164.02 (t, 3JFF = 18.3 Hz, m-
F B(C6F5)3). IR νmax (cm-1): 3059 (w), 2158 (w), 2027 (w), 1635 (m), 25 1602 (w), 1564 
(m), 1517 (m), 1465 (s), 1408 (m), 1377 (m), 1284 (m), 1168 (w), 1097 (m), 970 (m), 908 
(m), 858 (w), 829 (w), 800 (m), 790 (m), 767 (m), 696 (s), 611 (w), 513 (w). HRMS (ES+) 
m/z calculated for [C28H20ClO2]+ [M+H - (B(C6F5)3)]+: 423.1152, found: 423.1151. 
9.5.2.19 Synthesis of 5.6c: 
 
In accordance with General Procedure D6, 5.6c was synthesised using 5.3c (47 mg, 0.1 
mmol) yielding white solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 83 mg, 0.08 mmol, 85%. Melting point: 185–189 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.61 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.83–7.69 (m, 
2H, Ar-H), 7.64 (d, 3JHH = 8.1 Hz, 1H, Ar-H), 7.48 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.40 (d, 
3JHH = 8.5 Hz, 2H, Ar-H), 7.37–7.21 (m, 6H, Ar-H), 7.06 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 
7.00–6.88 (m, 3H, Ar-H), 5.78 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 154.3, 148.0 (dm, 1JCF = 245 Hz, 6C), 140.0 (dm, 1JCF = 250 Hz, 3C), 139.4, 
139.0, 138.8, 137.1 (dm, 1JCF = 247 Hz, 6C), 132.2, 131.5, 131.1, 130.6, 130.5, 129.2, 
129.1, 128.8, 128.6, 127.7, 127.7, 121.5, 49.5. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
0.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.98 (br. s, 6F, o-F B(C6F5)3), -
157.40 (br. s, 3F, p-F B(C6F5)3), -163.95 (br. s, 6F, m-F B(C6F5)3). IR νmax (cm-1): 3064 
(w), 3030 (w), 1645 (m), 1602 (m), 1568 (m), 1518 (m), 1436 (s), 1379 (m), 1286 (m), 
1166 (w), 1099 (s), 1010 (w), 974 (s), 906 (m), 792 (m), 765 (m), 729 (m), 694 (s), 617 
(w), 609 (w), 576 (w). HRMS (ES+) m/z calculated for [C28H20BrO2]+ [M+H - (B(C6F5)3)]+: 
467.0647, found: 467.0652. 
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9.5.2.20 Synthesis of 5.6d: 
 
In accordance with General Procedure D6, 5.6d was synthesised using 5.3d (42 mg, 0.1 
mmol) and yielding a white solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 75 mg, 0.08 mmol, 81%. Melting point: >230 
°C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.59 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.79–
7.50 (m, 3H, Ar-H), 7.27 (q, 3JHH = 8.2 Hz, 3H, Ar-H), 7.12 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 
7.03–7.01 (m, 4H, Ar-H), 6.95 (t, 3JHH = 8.1 Hz, 2H, Ar-H), 6.85 (d, 3JHH = 7.2 Hz, 1H, Ar-
H), 5.83 (s, 1H, CH(Ar)2), 2.36 (s, 3H, CH3). 13C NMR (126 MHz, DMSO-d6, 298 K) 
δ/ppm: 161.7, 160.8 (d, 1JCF = 243 Hz, 1C), 153.9, 147.2 (dm, 1JCF = 239 Hz, 6C), 140.7, 
140.1, 139.1 (dm, 1JCF = 251.1 Hz, 3C), 137.2, 136.8, 136.8, 136.2 (dm, 1JCF = 246 Hz), 
134.0, 130.6, 130.6, 130.2, 129.2, 129.1, 128.6, 128.0, 126.7 (d, 3JCF = 7.0 Hz, 2C), 
121.3, 115.3 (d, 2JCF = 21.3 Hz, 2C), 114.2, 48.5, 20.9. 11B NMR (128 MHz, CDCl3, 298 
K) δ/ppm: 0.5 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -114.70 (s, 1F, p-F), -
134.97 (d, 3JFF = 19.6 Hz, 6F, o-F B(C6F5)3), -157.69 (t, 3JFF = 19.0 Hz, 3F, p-F B(C6F5)3), 
-164.16 (t, 3JFF = 18.0 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 3030 (w), 2158 (w), 1973 
(w), 1639 (m), 1606 (w), 1564 (s), 1518 (m), 1506 (m), 1425 (s), 1371 (m), 1282 (m), 
1224 (m), 1161 (w), 1099 (m), 985 (m), 974 (s), 858 (w), 788 (m), 771 (m), 746 (m), 715 
(m), 690 (s), 675 (m), 613 (m). HRMS (ES+) m/z calculated for [C29H22FO2]+ [M+H - 
(B(C6F5)3)]+: 421.1604, found: 421.1609. 
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9.5.2.21 Synthesis of 5.6e: 
 
In accordance with General Procedure D6, 5.6e was synthesised using 5.3e (44 mg, 0.1 
mmol) yielding a white solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 79 mg, 0.08 mmol, 84%. Melting point: 207–213 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.58 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.78–7.66 (m, 
2H, Ar-H), 7.62 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.29 (q, 3JHH = 6.3, 5.7 Hz, 3H, Ar-H), 7.25 
(d, 3JHH = 8.6 Hz, 3H, Ar-H), 7.13 (d, 3JHH = 7.9 Hz, 2H, ArH), 7.07 (d, 3JHH = 7.4 Hz, 2H, 
Ar-H), 7.01 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.87 (br. s, 2H, Ar-H), 5.82 (s, 1H, C(H)Ar2), 2.38 
(s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.59, 148.03 (dm, 1JCF = 239 
Hz, 6C), 142.2, 140.3 (dm, 1JCF = 246 Hz, 3C) 139.6, 139.0, 138.6, 137.1 (dm, 1JCF = 247 
Hz, 6C), 133.4, 131.0, 130.3, 129.7, 129.2, 128.8, 128.6, 127.7, 49.5, 21.6. 11B NMR 
(128 MHz, CDCl3, 298 K) δ/ppm: 0.5 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -
134.98 (d, 3JFF = 17.6 Hz, 6F, o-F B(C6F5)3), -157.60 (t, 3JFF = 20.3 Hz, p-F B(C6F5)3), -
164.11 (t, 3JFF = 24.2 Hz, m-F B(C6F5)3). IR νmax (cm-1): 3028 (w), 2158 (w), 1637 (m), 
1606 (w), 1564 (s), 1517 (s), 1432 (s), 1375 (w), 1280 (m), 1174 (w), 1097 (s), 1014 )m), 
987 (m), 974 (s), 906 (w), 858 (m), 839 (m), 821 (m), 794 (m), 738 (s), 707 (m), 690 (s), 
673 (m), 626 (m), 613 (m). HRMS (ES+) m/z calculated for [C29H22ClO2]+ [M+H - 
(B(C6F5)3)]+: 437.1308, found: 437.1307. 
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9.5.2.22 Synthesis of 5.6f: 
 
In accordance with General Procedure D6, 5.6f was synthesised using 5.3f (48 mg, 0.1 
mmol) yielding a white solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 87 mg, 0.09 mmol, 88%. Melting point: 220–224 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.63 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.80 (t, 3JHH = 
7.3 Hz, 1H, Ar-H), 7.74 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.66 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 
7.42 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 7.31 (dt, 3JHH = 6.9 Hz, 3H, Ar-H), 7.16 (d, 3JHH = 7.9 
Hz, 2H, Ar-H), 7.09 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 6.97 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.87 
(d, 3JHH = 7.9 Hz, 2H, Ar-H), 5.83 (s, 1H, C(H)Ar2), 2.41 (s, 3H, CH3). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 169.3, 154.6, 148.0 (dm, 1JCF = 241 Hz, 6C), 142.3, 140.0 (d, 1JCF 
= 262 Hz, 3C), 139.4, 139.1, 137.1 (d, 1JCF = 249 Hz, 6C), 132.2, 131.1, 130.7, 130.4, 
129.7, 129.2, 128.8, 128.5, 127.7, 127.7, 126.6, 121.5, 120.2, 118.2, 49.6, 21.6. 11B 
NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.5 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) 
δ/ppm: -134.98 (d, 3JFF = 18.2 Hz, 6F, o-F B(C6F5)3), - 157.60 (t, 3JFF = 19.9 Hz, 3F, p-F 
B(C6F5)3), -164.10 (t, 3JFF = 18.2 Hz, 6F, m-F B(C6F5)3). IR νmax (cm-1): 3032 (w), 2160 
(w), 1638 (m), 1606 (w), 1564 (m), 1518 (m), 1589 (s), 1377 (m), 1321 (w), 1282 (m), 
1172 (w), 1097 (s), 1009 (m), 985 (s), 974 (s), 935 (w), 906 (w), 856 (m), 821 (m), 790 
(s), 773 (s), 740 (m), 717 (m), 690 (s), 675 (s), 624 (m), 611 (w). HRMS (ES+) m/z 
calculated for [C29H22O2Br]+ [M+H - B(C6F5)3)]+: 481.0803, found: 481.0810. 
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9.5.2.23 Synthesis of 5.6g: 
 
In accordance with General Procedure D6, 5.6g was synthesised using 5.3g (68 mg, 0.2 
mmol) yielding a yellow solid. Yield: 148 mg, 0.17 mmol, 87%. Melting point: 72–78 °C. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.51 (s, 1H, Ar-H), 7.70 (s, 1H, Ar-H), 7.61 (s, 
1H, Ar-H), 7.45 (s, 1H, Ar-H), 7.24 (t, 3JHH = 7.6 Hz, 2H, Ar-H), 7.14 (d, 3JHH = 8.0 Hz, 5H, 
Ar-H), 6.99 (s, 2H, Ar-H), 4.48 (q, 3JHH = 7.3 Hz, 1H, C(H)(Me)Ar), 2.33 (s, 3H, CH3), 1.72 
(d, 3JHH = 7.3 Hz, 3H, C(H)(Me)Ar). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:153.1, 
148.1 (d, 1JCF = 238.1 Hz), 141.9, 141.7, 140.0 (d, 1JCF = 248.4 Hz), 138.4, 138.3, 137.1 
(d, 1JCF = 217.8 Hz), 131.1, 130.2, 130.1, 129.8, 129.2, 128.5, 128.4, 127.0, 126.9, 126.6, 
125.5, 37.3, 21.5, 18.6. 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 0.9 (br. s). 19F NMR 
(376 MHz, CDCl3, 298 K) δ/ppm: -134.96 (br. s, 6F, o-F B(C6F5)3), -157.81 (br. s, 3F, p-
F B(C6F5)3, -164.22 (br. s, 6F, m-F B(C6F5)3). IR νmax (cm-1): 2943 (w), 1645 (m), 1608 
(w), 1566 (w), 1516 (s), 1495 (s), 1377 (m), 1286 (m), 1184 (w), 1099 (s), 1022 (w), 974 
(s), 864 (w), 815 (m), 788 (m), 771 (m), 748 (m), 698 (m), 973 (m). HRMS (EI+) m/z 
calculated for [C24H20O2]+ [M-B(C6F5)3]+: 340.1463, found: 340.1462. 
9.5.3 Products of the catalytic cyclisation reactions 
General procedure D7 for the catalytic cyclisation of alkynyl acids and esters. 
B(C6F5)3 (3 mg, 5 μmol, 5 mol%) was added to a solution of carboxylic acid or ester (0.1 
mmol, 1 equiv) in CD2Cl2 (0.5 ml) in a sealed tube and the mixture was heated at 70 °C 
until complete conversion could be observed in the 1H NMR spectrum. The resulting 
solution was allowed to cool to room temperature and all volatiles were removed under 
vacuum. The residue was either purified via column chromatography (SiO2) or 
recrystallisation in a saturated CH2Cl2 solution to give the desired free cyclised 
heterocyclic product. 
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9.5.3.1 Synthesis of 5.17b: 
 
In accordance with General Procedure D7, 5.17b was synthesised using 5.9b (23 mg, 
0.1 mmol) yielding a white solid after recrystallisation. Yield: 21 mg, 0.09 mmol 91%. 
Melting point: 68–74 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.53 (d, 3JHH = 8.2 
Hz, 2H, Ar-H), 6.88 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 5.60 (t, 3JHH = 4.4 Hz, 1H, =CH), 3.82 
(s, 3H, OCH3), 2.35 (d, 3JHH = 4.4Hz, 2H, CH2), 1.32 (s, 6H, C(CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 160.3, 149.8, 126.0, 114.0, 97.4, 55.5, 36.6, 34.5, 25.1. IR 
νmax (cm-1 ): 3067 (w), 2959 (w), 1724 (s), 1676 (s), 1599 (s), 1576 (m), 1508 (m), 1483 
(w), 1467 (w), 1427 (s), 1366 (w), 1306 (w), 1253 (m), 1170 (m), 1120 (s), 1093 (s), 1028 
(s), 995 (m), 974 (m), 916 (w), 874 (w), 835 (w), 773 (w), 736 (m), 719 (s), 695 (s), 542 
(w), 501 (s), 482 (m). HRMS (ES+) m/z calculated for [C14H17O3]+ [M+H]+: 233.1178, 
found: 233.1179. 
9.5.3.2 Synthesis of 5.17c: 
 
In accordance with General Procedure D7, 5.17c was synthesised using 5.9b (58 mg, 
0.2 mmol, 1 equiv). yielding a pale-yellow oil after column chromatography (SiO2, 
chloroform). Rf value: 0.50. Yield: 19 mg, 0.7 mmol, 33%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.52–7.30 (br. m, 7H, Ar-H), 7.18–7.17 (br. s, 3H, Ar-H), 3.55 (s, 2H, 
CH2Ph), 2.18 (s, 2H, CH2), 1.26 (s, 6H, C(CH3)2). Agreeing with values obtained for 5.4a. 
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9.5.3.3 Synthesis of 5.17d: 
 
In accordance with General Procedure D7, 5.17d was synthesised using 5.1j (500 mg, 
0.9 mmol) yielding a white solid after column chromatography (SiO2, chloroform). Rf 
value: 0.64. Yield: 138 mg, 0.3 mmol, 27%. Melting point: 125–131 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.64 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.51 (d, 3JHH = 8.2 Hz, 2H, 
Ar-H), 7.46 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 7.35–7.29 (m, 3H, Ar-H), 7.07 (d, 3JHH = 7.2 Hz, 
2H, Ar-H), 6.98 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 5.17 (s, 1H), 2.29 (d, 2JHH = 17.1 Hz, 1H, 
diastereotopic CH2), 2.16 (d, 2JHH = 17.1 Hz, 1H, diastereotopic CH2), 1.19 (s, 3H, CH3), 
1.17 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 173.1, 146.7, 140.8 (d, 2JCF 
= 45.7 Hz, 1C), 136.3, 131.9, 130.8, 129.0, 129.0, 128.9, 127.4, 125.7 (q, 4JCF = 3.8 Hz, 
2C) 121.1, 115.5, 51.3, 36.4, 36.2, 29.9, 24.9, 24.8. 19F NMR (471 MHz, CDCl3, 298 K) 
δ/ppm: -62.82 (s). IR νmax (cm-1): 2981 (w), 2925 (w), 1761 (s), 1668 (w), 1615 (w), 1487 
(m), 1465 (w), 1454 (m), 1424 (w), 1410 (w), 1392 (w), 1323 (s), 1228 (m), 1225 (w), 
1211 (w), 1194 (w), 1178 (w), 1153 (m), 1129 (s), 1100 (s), 1075 (s), 1065 (s), 1016 (m), 
1009 (m), 910 (w), 877 (m), 857 (s), 827 (m), 788 (m), 761 (w), 752 (w), 717 (w), 701 (s), 
681 (w), 667 (w), 623 (w), 600 (w), 559 (m), 536 (w), 518 (m), 497 (w), 474 (m), 438 (w). 
HRMS (ES+) m/z calculated for [C27H23O2BrF3]+ [M+H]+: 514.0755, found: 514.0761. 
9.5.3.4 Synthesis of 5.17e: 
 
In accordance with General Procedure D7, 5.17e was synthesised using 5.3g (32 mg, 
0.1 mmol) yielding a white oil after column chromatography (1:2 hexane/chloroform). Rf 
value: 0.23 Yield: 17 mg, 0.055 mmol, 55%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.38 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.31–7.20 (m, 5H, Ar-H), 7.15 (d, 3JHH = 7.5 Hz, 2H, 
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Ar-H), 4.05 (q, 3JHH = 7.0 Hz, 1H, C(H)(Me)Ar), 2.39 (s, 3H, CH3), 2.15 (d, 2JHH = 16.8 
Hz, 1H, CH2), 1.89 (d, 2JHH = 16.8 Hz, 1H, CH2), 1.45 (d, 3JHH = 7.1 Hz, 3H, C(H)(Me)Ar), 
1.26 (s, 3H, CH3), 1.07 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 174.2, 
145.9, 142.9, 139.0, 130.4, 129.3, 128.8, 128.4, 127.4, 126.6, 117.5, 38.2, 36.1, 34.3, 
24.7, 24.7, 21.5, 17.3. IR νmax (cm-1): 1753 (w), 1448 (s), 1386 (s), 1170 (s), 1072 (w), 
1024 (m), 910 (s), 827 (s), 777 (s), 732 (m), 700 (w), 410 (s), 401 (m). HRMS (ES+) m/z 
calculated for [C29H21O2F]+ [M+H]+: 320.1855, found: 320.1856. 
9.5.3.5 Synthesis of 5.17a: 
 
In accordance with General Procedure D7, 5.17a was synthesised using 5.1e (39 mg, 
0.1 mmol) gave a white solid after column chromatography (SiO2, chloroform). Rf value: 
0.51. Yield: 37 mg, 0.95 mmol, 95%. Melting point: 139–144 °C. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.30–7.17 (m, 8H, Ph–H), 7.03–6.97 (m, 4H, Ph–H), 6.92 (t, 3JHH 
= 8.5 Hz, 2H, Ph–H), 5.18 (s, 1H, C(H)Ar2), 2.20–2.10 (m, 2H, CH2), 1.07 (s, 6H, 
C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 173.8, 161.7 (d, 1JCF = 245.8 Hz, 
1C), 147.9, 141.7, 137.6 (d, 3JCF = 3.3 Hz, 1C), 132.9, 130.6 (d, 3JCF = 7.9 Hz, 2C), 129.4, 
129.0, 128.6, 128.6, 128.5, 127.0, 115.4 (d, 2JCF = 21.2 Hz, 2C), 114.3, 50.9, 36.4, 35.9, 
24.8, 24.7. 19F NMR (376 Hz, CDCl3, 298 K) δ/ppm: –115.82 (s, 1F, p-F). IR νmax (cm-1): 
30 2988 (w), 1760 (s), 1671 (w), 1603 (m), 1504 (s), 1493 (m), 1466 (w), 1445 (m), 1388 
(w), 1367 (w), 1344 (w), 1282 (w), 1219 (s), 1189 (w), 1155 (w), 1132 (w), 1099 (s), 1082 
(s), 1070 (s), 1029 (w), 1015 (w), 1003 (w), 926 (w), 876 (w), 835 (m), 807 (w), 773 (m), 
731 (w), 700 (s), 635 (w), 624 (w), 618 (w), 598 (w), 570 (w), 549 (m), 533 (m), 506 (m). 
HRMS (EI+) m/z calculated for [C26H24O2F]+ [M+H]+: 387.1760, found: 387.1751. 
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9.5.3.6 Synthesis of 5.17f: 
 
In accordance with General Procedure D7, 5.17f was synthesised using 5.1f (40 mg, 0.1 
mmol) yielding a white solid after column chromatography (SiO2, chloroform). Rf value: 
0.49. Yield: 36 mg, 0.90 mmol, 90%. Melting point: 104–110 °C. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.39–7.26 (m, 10H, Ar-H), 7.07 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 7.04 
(d, 3JHH = 8.3 Hz, 2H, Ar-H), 5.23 (s, 1H, C(H)Ar2), 2.23 (s, 2H, CH2), 1.16 (s, 3H, CH3), 
1.15 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 174.1, 148.0, 141.3, 140.4, 
132.8, 132.7, 130.5, 129.5, 129.0, 128.8, 128.7, 128.6, 128.5, 127.2, 114.2, 51.1, 36.4, 
35.8, 24.8, 24.7. IR νmax (cm-1): 2982 (w), 1759 (s), 1668 (w), 1601 (w), 1515 (w), 1489 
(s), 1464 (s), 1389 (w), 1352 (w), 1277 (w), 1225 (w), 1194 (w), 1179 (w), 1157 (w), 1134 
(w), 1099 (s), 1069 (s), 1013 (s), 976 (w), 921 (w), 870 (w), 833 (w), 773 (s), 756 (w), 
727 (w), 705 (s), 648 (w), 611 (w), 598 (w), 550 (w), 519 (w). HRMS (EI+) m/z calculated 
for [C26H23O2Cl]+ [M]+: 402.1387, found: 402.1399. 
9.5.3.7 Synthesis of 5.17g: 
 
In accordance with General Procedure D7, 5.17g was synthesised using 5.1g (45 mg, 
0.1 mmol) yielding a white solid after column chromatography (SiO2, chloroform). Rf 
value: 0.44. Yield: 42 mg, 0.93 mmol, 93%. Melting point: 116–121 °C. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.37 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.30 (s, 5H, Ar-H), 7.25–
7.18 (m, 3H, Ar-H), 7.01 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 6.92 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 
5.16 (s, 1H, C(H)Ar2), 2.15 (s, 2H, CH2), 1.09 (s, 3H, CH3), 1.07 (s, 3H, CH3). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 174.0, 148.1, 141.3, 140.9, 132.7, 131.7, 130.9, 129.5 
  162 
(s), 129.1, 128.7, 128.6, 128.5, 127.2, 120.9, 114.0, 51.2, 36.4, 35.8, 24.8, 24.7. IR νmax 
(cm-1): 3058 (w), 2981 (s), 1767 (m), 1751 (w), 1684 (w), 1667 (w), 1601 (w), 1487 (m), 
1446 (m), 1386 (m), 1344 (w), 1285 (w), 1217 (w), 1155 (w), 1107 (s), 1091 (m), 1068 
(s), 1029 (w), 1008 (m), 993 (s), 921 (w), 854 (w), 829 (m), 798 (w), 767 (m), 746 (m), 
725 (w), 715 (w), 700 (s), 694 (s), 680 (w), 669 (w), 602 (m), 547 (m), 501 (w), 487 (m), 
474 (m), 424 (w). HRMS (EI+) m/z calculated for [C26H24O2Br]+ [M+H]+: 447.0960, found: 
447.0964 
9.5.3.8 Synthesis of 5.17h: 
 
In accordance with General Procedure D7, 5.17h was synthesised using B(C6F5)3 (5 mg, 
10 µmol, 10 mol%) and 5.3a (41 mg, 0.1 mmol) yielding a white oil after filtration. Yield: 
29 mg, 0.071 mmol, 71%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.39–8.35 (m, 1H, 
Ar-H), 7.45–7.37 (m, 7H, Ar-H), 7.32–7.26 (m, 3H, Ar-H), 7.20–7.14 (m, 5H, Ar-H), 6.99–
6.94 (m, 2H, Ar-H), 5.82 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
162.2, 161.6 (d, 1JCF = 246 Hz, 1C), 154.4, 141.2, 137.2, 137.1, 137.1, 133.9, 133.3, 
130.7 32 (d, 3JCF = 7.9 Hz, 2C), 130.1, 130.1, 129.2, 129.0, 128.8, 128.6, 127.9, 127.2, 
127.0, 122.0, 115.5 (d, 2JCF = 21.3 Hz, 2C), 49.3. 19F NMR (376 MHz, CDCl3, 298 K) 
δ/ppm: -115.92 (s, 1F, p-F). IR νmax (cm-1): 3059 (w), 1774 (w), 1730 (s), 1624 (w), 1602 
(m), 1560 (w), 1504 (m), 1483 (m), 1448 (m), 1305 (w), 1222 (m), 1159 (m), 1136 (w), 
1093 (s), 1051 (m), 1029 (m), 1002 (m), 905 (w), 873 (w), 831 (m), 792 (w), 765 (s), 729 
(s), 685 (s), 611 (w). HRMS (ES+) m/z calculated for [C28H19O2F]+ [M+H]+: 406.1369, 
found: 406.1366. 
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9.5.3.9 Synthesis of 5.17i: 
 
In accordance with General Procedure D7, 5.17i was synthesised using B(C6F5)3 (5 
mg, 10 µmol, 10 mol%) and 5.3b (43 mg, 0.1 mmol) yielding a white oil after filtration. 
Yield: 33 mg, 0.078 mmol, 78%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.39–8.34 
(m, 1H, Ar-H), 7.46–7.35 (m, 8H, Ar-H), 7.32–7.26 (m, 3H, Ar-H), 7.24 (s, 1H, Ar-H), 
7.20–7.11 (m, 5H, Ar-H), 5.81 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 162.2., 154.5, 140.9, 139.9, 137.1, 133.9, 133.3, 132.7, 130.5, 130.1, 130.1, 
129.2, 129.0, 128.8, 128.8, 128.7, 128.0, 127.1, 127.0, 122.0, 114.9, 49.4. IR νmax (cm-
1): 3026 (w), 2962 (w), 1778 (w), 1730 (s), 1602 (m), 1560 (w), 1483 (s), 1404 (w), 
1305 (m), 1284 (m), 1261 (m), 1224 (m), 1136 (w), 1089 (s), 1051 (m), 1029 (s), 1012 
(s), 906 (m), 825 (m), 796 (m), 765 (m), 746 (m), 727 (s), 705 (s), 646 (m), 619 (w), 609 
(w). HRMS (ES+) m/z calculated for [C29H21O2Br]+ [M+H]+: 422.1082, found: 480.1074. 
9.5.3.10 Synthesis of 5.17j: 
 
In accordance with General Procedure D7, 5.17j was synthesised using B(C6F5)3 (5 mg, 
10 µmol, 10 mol%) and 5.3c (47 mg, 0.1 mmol) yielding a white solid after filtration. 
Yield: 35 mg, 0.075 mmol, 75%. Melting point: 85–91 °C. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 8.31–8.27 (m, 1H, Ar-H), 7.37–7.27 (m, 10H, Ar-H), 7.24–7.18 (m, 3H, Ar-
H), 7.12–7.08 (m, 2H, Ar-H), 7.02–6.98 (m, 2H, Ar-H), 5.71 (s, 1H, C(H)Ar2). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 162.2, 154.5, 140.8, 140.4, 137.1, 133.9, 133.3, 131.7, 
130.9, 130.1, 130.1, 129.2, 129.0, 128.8, 128.7, 128.0, 127.1, 127.04, 121.9, 120.8, 
114.8, 49.5. IR νmax (cm-1): 2945 (w), 1778 (w), 1732 (s), 1604 (m), 1560 (w), 1483 (s), 
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1446 (m), 1398 (w), 1305 (m), 1284 (m), 1226 (m), 1182 (m), 1136 (w), 1093 (s), 1074 
(s), 1051 (m), 1029 (s), 1008 (s), 908 (w), 825 (m), 792 (w), 765 (m), 744 (m), 695 (s). 
HRMS (ES+) m/z calculated for [C29H21O2Br]+ [M+H]+: 466.0568, found: 466.0570. 
9.5.3.11 Synthesis of 5.17k: 
 
In accordance with General Procedure D7, 5.17k was synthesised using 5.3d (42 mg, 
0.1 mmol) yielding a white solid after filtration. Yield: 41 mg, 0.097 mmol, 97%. Melting 
point: 142–148 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.26–8.23 (m, 1H, Ar-H), 
7.31–7.22 (m, 5H, Ar-H), 7.20–7.11 (m, 4H, Ar-H), 7.10–7.03 (m, 7H, Ar-H), 6.88–6.83 
(m, 2H, Ar-H), 5.74 (s, 1H, C(H)Ar2), 2.27 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 162.4, 161.6 (d, 1JCF = 246 Hz), 154.6, 141.3, 140.3, 137.3, 137.2, 133.8, 
130.7 (d, 3JCF = 7.8 Hz, 2C), 130.4, 130.0, 129.3, 129.0, 129.0, 128.7, 127.8, 127.1, 
126.9, 121.9, 115.4 (d, 2JCF = 21.3 Hz, 2C), 114.8, 49.3, 21.5. 19F NMR (471 MHz, CDCl3, 
298 K) δ/ppm: -115.94 – -116.02 (m, 1F, p-F). IR νmax (cm-1): 1737 (w), 1625 (s), 1600 
(s), 1504 (w), 1483 (m), 1446 (s), 1224 (w), 1161 (s), 1089 (w), 1051 (s), 1024 (m), 837 
(m), 825 (s), 808 (s), 765 (w), 752 (m), 727 (m), 698 (w), 677 (m), 609 (s), 526 (w), 509 
(s), 497 (s). HRMS (ES+) m/z calculated for [C29H21O2F]+ [M+H]+: 420.1526, found: 
420.1515. 
9.5.3.12 Synthesis of 5.17l: 
 
In accordance with General Procedure D7, 5.17l was synthesised using 5.3e (44 mg, 
0.1 mmol) yielding a white solid after filtration. Yield: 42 mg, 0.096 mmol, 96%. Melting 
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point: 72–76 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.31–8.27 (m, 1H, Ar-H), 
7.36–7.32 (m, 2H, Ar-H), 7.30–7.25 (m, 3H, Ar-H), 7.25–7.14 (m, 6H, Ar-H), 7.12 (d, 3JHH 
= 8.0 Hz, 4H, Ar-H), 7.07 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 5.77 (s, 1H, C(H)Ar2), 2.31 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.2, 154.6, 140.8, 140.2, 139.9, 
137.1, 133.7, 132.5, 130.4, 130.3, 129.9, 129.2, 128.9, 128.9, 128.6, 128.6, 127.7, 127.0, 
126.9, 121.8, 114.5, 49.3, 21.5. IR νmax (cm-1): 1730 (w), 1606 (s), 1508 (s), 1487 (m), 34 
1448 (s), 1284 (s), 1089 (m), 1051 (s), 1026 (s), 1014 (s), 831 (s), 769 (m), 748 (m), 729 
(s), 698 (m), 547 (s), 518 (s), 499 (s). HRMS (ES+) m/z calculated for [C29H21O2Cl]+ 
[M+H]+: 436.1230, found: 233.1227. 
9.5.3.13 Synthesis of 5.17m: 
 
In accordance with General Procedure D7, 5.17m was synthesised using 5.3f (48 mg, 
0.1 mmol) yielding a white solid after filtration. Yield: 43 mg, 0.089 mmol, 89%. Melting 
point: 56–59 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.27–8.23 (m, 1H, Ar-H), 
7.32–7.27 (m, 4H, Ar-H), 7.27–7.22 (m, 3H, Ar-H), 7.20–7.11 (m, 4H, Ar-H), 7.08 (d, 3JHH 
= 7.9 Hz, 4H, ArH), 6.98 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 5.72 (s, 1H, C(H)Ar2), 2.28 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.3, 154.7, 140.8, 140.5, 140.3, 
137.2, 133.8, 131.7, 130.9, 130.4, 130.0, 129.3, 129.0 129.0, 128.7, 127.8, 127.0, 127.0, 
121.9, 120.7, 114.5, 49.5, 21.5. IR νmax (cm-1): 2980 (w), 1728 (m), 1483 (m), 1091 (m), 
1074 (s), 1026 (s), 1008 (s), 769 (s), 744 (m), 727 (m), 698 (w), 682 (s), 545 (s), 516 (s), 
497 (s), 468 (s). HRMS (ES+) m/z calculated for [C29H21O2Br]+ [M+H]+: 480.0725, found: 
480.0725. 
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9.5.3.14 Synthesis of 5.17n: 
 
In accordance with General Procedure D7, 5.17n was synthesised using 5.2a (36 mg, 
0.1 mmol) yielding a yellow oil after filtration. Yield: 29 mg, 0.080 mmol, 80%. 1H NMR 
(500 MHz, CDCl3, 298 K) δ/ppm: 7.41–7.32 (m, 5H, Ar-H), 7.30–7.27 (m, 1H, Ar-H), 
7.25– 7.16 (m, 3H, Ar-H), 6.99–6.93 (m, 6H, Ar-H), 6.22 (d, 3JHH = 9.6 Hz, 1H, Ar-H), 
5.37 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.8 (d, 1JCF = 247 
Hz, 1C), 161.7, 159.3, 146.2, 142.1, 138.1 (d, 3JCF = 3.3 Hz, 2C), 132.0, 130.6, 130.6, 
130.5, 129.1, 129.0, 128.8, 128.7, 127.4, 117.4, 115.85 (d, 2JCF = 21.4 Hz, 2C), 114.98, 
49.21. 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -115.24 – -115.32 (m, 1F, p-F). IR νmax 
(cm-1): 2980 (s), 1707 (m), 1548 (s), 1504 (w), 1490 (m), 1446 (s), 1226 (m), 1157 (m), 
1116 (s), 1097 (m), 1076 (s), 991 (s), 852 (s), 825 (w), 806 (s), 771 (m), 759 (m), 732 
(w), 698 (w), 663 (m), 644 (m), 615 (m), 594 (w), 565 (w), 526 (s), 509 (w). HRMS (ES+) 
m/z calculated for [C24H17O2F]+ [M+H]+: 356.1213, found: 356.1209. 
9.5.3.15 Synthesis of 5.17o: 
 
In accordance with General Procedure D7, 5.17o was synthesised using 5.2b (38 mg, 
0.1 mmol) yielding a yellow solid after filtration and removal of solvent. Yield: 29 mg, 
0.078 mmol, 78%. Melting point: 45 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.41–
7.35 (m, 4H, Ar-H), 7.31– 7.27 (m, 3H, Ar-H), 7.25–7.20 (m, 3H, Ar-H), 7.19–7.16 (m, 
1H, Ar-H), 6.98 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 6.95–6.92 (m, 2H, Ar-H), 6.23 (d, 3JHH = 9.6 
Hz, 1H, Ar-H), 5.37 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.6, 
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159.5, 146.1, 35 141.8, 140.9, 133.2, 132.1, 131.9, 130.6, 130.4, 129.1, 129.1, 129.0, 
128.8, 128.7, 117.1, 115.0, 49.4. IR νmax (cm-1): 2980 (s), 1720 (w), 1543 (s), 1489 (w), 
1446 (m), 1155 (m), 1089 (m), 1014 (s), 1002 (s), 991 (s), 819 (m), 752 (m), 734 (m), 
696 (w), 663 (s), 615 (s), 594 (m), 514 (s), 491 (m). HRMS (ES+) m/z calculated for 
[C24H17O2Cl]+ [M+H]+: 372.0917, found: 372.0914. 
9.5.3.16 Synthesis of 5.17p: 
 
In accordance with General Procedure D7, 5.17p was synthesised using 5.2c (42 mg, 
0.1 mmol) and yielding a yellow oil after filtration. Yield: 30 mg, 0.072 mmol, 72%. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.39–7.32 (m, 6H, Ar-H), 7.25–7.17 (m, 4H, Ar-
H), 7.16– 7.12 (m, 1H, Ar-H), 6.94 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 6.86–6.82 (m, 2H, Ar-H), 
6.20 (d, 3JHH = 9.6 Hz, 1H, Ar-H), 5.32 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 160.5, 158.3, 144.9, 140.6, 140.3, 130.9, 129.6, 129.4 (s), 128.0, 127.8, 127.6, 
127.6, 126.3, 126.1, 120.1, 115.9, 113.9, 48.3. IR νmax (cm-1): 2980 (s), 1720 (m), 1487 
(m), 1155 (s), 1097 (s), 1072 (m), 1010 (m), 993 (s), 821 (s), 750 (w), 732 (w), 696 (w), 
665 (s), 594 (m), 505 (s), 486 (s). HRMS (ES+) m/z calculated for [C24H17O2Br]+ [M+H]+: 
416.0412, found: 416.0418. 
9.5.4 Crystallographic data for 5.16a and 5.4c 
Compound 5.16a 5.4c 
Empirical Formula C34H12BCl2F15O2 C44H23BClF15O2 
Space Group P-1 P 21/n 
a/Å 10.8906(6) 16.4273(3) 
b/Å 11.6131(10) 12.13337(18) 
c/Å 12.4826(7) 21.5533(3) 
α/° 90.902(6) 90 
β/° 95.194(5) 103.2592(15) 
ϒ/° 98. 525(6) 90 
Volume/Å3 1554.20(19) 4181.44(11) 
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Z 2 4 
T/K 150 100 
Dc/g·cm-3 1.750 1.426 
R (reflections) 0.0413 0.0144 
wR2 (reflections) 0.1214 0.1026 
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9.6 FLP mediated Heck-type reaction 
9.6.1 General procedure E1 to synthesise ester 6.1 
Acyl chloride and alcohol were dissolved in pyridine at 0 °C. The mixture was allowed to 
stir at room temperature overnight. The reaction was quenched with water and extracted 
with ethyl acetate (3 x 25 ml). The combined organic fractions were washed with 
saturated NaCl solution (1 x 50 ml) and dried over MgSO4. All volatiles were removed in 
vacuo and the residue was purified via column chromatography. 
9.6.1.1 Synthesis of 6.1a: 
 
In accordance to General Procedure E1, 1,4-(trifluoromethyl)benzoyl chloride (3.90 ml, 
26.25 mmol, 1.16 equiv), bis(4-fluorophenyl)methanol (5.00 g, 5.01 mmol, 1.00 equiv) 
and pyridine (18 ml). All volatiles were removed in vacuo and the residue was purified 
via column chromatography as a colourless oil (SiO2, hexane/EtOAc 20:1). Rf value: 
0.54). Yield: 7.25 g, 19.37 mmol, 85%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.25 
(d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.74 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.46 – 7.36 (m, 4H, Ar-H), 
7.13 (s, 1H), 7.11 – 7.05 (m, 4H, Ar-H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 164.4, 
162.7 (d, 1JCF = 247.5 Hz), 135.6 (d, 5JCF = 3.2 Hz), 134.9 (q, 2JCF = 32.7 Hz), 133.3 – 
133.2 (m), 130.3, 129.1 (d, 4JCF = 8.3 Hz), 125.7 (q, 3JCF = 3.7 Hz), 123.7 (q, 1JCF = 272.8 
Hz), 115.8 (d, 3JCF = 21.7 Hz), 76.9. 19F{1H} NMR (376 MHz, CDCl3, 298 K) δ/ppm: -
63.12 (s, 3F), -113.38 (s, 2F). IR (ATR) νmax (cm-1): 2980, 2970, 1724, 1605, 1508, 1412, 
1323, 1261, 1227, 1157, 1128, 1094, 1065, 1017, 966, 860, 829, 758, 772, 762, 702, 
565, 540, 500, 482, 419. HRMS (EI+) m/z calculated for C21H13O2F5: 392.0836, found: 
392.0828.  
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9.6.1.2 Synthesis of 6.1b: 
 
In accordance to General Procedure E1, 1,4-(trifluoromethyl)benzoyl chloride (0.5 ml, 
4.00 mmol, 1.00 equiv), bis(4-fluorophenyl)methanol (5.00 g, 5.01 mmol, 0.88 equiv) and 
pyridine (3 ml). All volatiles were removed in vacuo and the residue was purified via 
column chromatography as a white solid (SiO2, Chloroform). Rf value: 0.75. Yield: 0.865 
g, 2.44 mmol, 61% (white solid) 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.24 – 8.18 
(m, 2H), 7.71 (dd, 3,3JHH = 8.6, 8.0 Hz, 4H), 7.62 (dd, 3,4JHH = 7.5, 1.0 Hz, 2H), 7.50 – 7.42 
(m, 2H), 7.32 (td, 3,4JHH = 7.5, 1.1 Hz, 2H), 7.05 (s, 1H). 19F NMR (376 MHz, CDCl3, 298 
K) δ/ppm: -63.11 (s). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 166.3, 141.9, 141.3, 
134.8 (q, 2JCF = 32.7 Hz), 133.3, 130.5, 129.9, 128.1, 126.2, 125.6 (q, 3JCF = 3.7 Hz), 
123.7 (q, 1JCF = 272.8 Hz), 120.3, 76.3. IR νmax (cm-1): 420, 493, 586, 621, 653, 700, 727, 
738, 759, 773, 860, 916, 933, 954, 1014, 1064, 1097, 1116, 1168, 1257, 1313, 1409, 
1454, 1720. HRMS (ESI) m/z calculated for C21H13F3O2 [M+H]+: 354.0868, found: 
354.0875.  
9.6.2 Synthesis of phosphonium compounds 
9.6.2.1 Synthesis of 6.2a 
 
Tris(pentafluorophenyl)borane (205 mg, 0.40 mmol, 1 equiv) and trimesitylphosphine 
(155 mg, 0.40 mmol, 1 equiv) were mixed in CHCl3 (1 ml) to form a bright pink solution. 
This was then added to a solution of ester 6.1a (157 mg, 0.40 mmol, 1 equiv) in CHCl3 
(1 ml) which gave an intense and deep violet colour. The reaction vessel was sealed and 
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heated for 4 h at 61 oC which resulted in a gradual change of colour to dark brown initially 
and ultimately to an amber colour. Recrystallisation was achieved by slow evaporation 
of the solvent and washing the residue with pentane. Removing the solvent in vacuo 
gave the title compound as a white crystalline solid. Yield: 288 mg, 0.26 mmol, 66%. 
Melting Point: 198 oC. 1H NMR (500 MHz, CD3CN, 298 K) δ/ppm: 8.46 (d, 1JPH = 492.1 
Hz, 1H), 8.12 (d, 3JHH = 8.0 Hz, 2H), 7.72 (d, 3JHH = 8.1 Hz, 2H), 7.29 – 7.04 (m, 6H), 2.36 
(s, 9H), 2.33-1.96 (m, 18H.) 13C NMR (126 MHz, CD3CN, 298 K) (partial, without B(C6F5)3 
signals) δ/ppm: 167.0, 147.7 (d, 4JCF = 2.9 Hz), 139.4, 133.2 (q, 2JCF = 32.1 Hz), 131.3, 
129.9, 129.2, 126.1 (q, 3JCF = 3.9 Hz), 125.3 (q, 1JCF = 271.6 Hz), 112.8 (d, 2JCF = 82.8 
Hz), 22.4, 21.6, 21.4 (d, 5JCF = 1.2 Hz). 19F NMR (471 MHz, CD3CN, 298 K) δ/ppm: -
63.32, -135.50 (d, 3JFF = 21.4 Hz), -163.00 (t, 3JFF = 19.6 Hz), -167.95 (t, 3JFF = 17.9 Hz). 
11B NMR (160 MHz, CD3CN, 298 K) δ/ppm: -4.53 (s). 31P NMR (202 MHz, CD3CN, 298 
K) δ/ppm: -27.47 (d, 1JPH = 492.2 Hz). IR (ATR) νmax (cm-1): 1672, 1512, 1464, 1449, 
1317, 1306, 1279, 1136, 1084, 1069, 978, 914, 785, 652, 428. HRMS (ES+) m/z 
calculated for [C27H34P]+: 389.2398, found: 389.2400. HRMS (ES–) m/z calculated for 
[C26H4O2F18B]–: 701.0017, found: 701.0020.  
9.6.2.2 Synthesis of 6.3c 
Bis(4-fluorophenyl)methyl 4-(trifluoromethyl)benzoate (39.2 mg, 0.1 mmol, 1 equiv) and 
tris(pentafluorophenyl)borane (51 mg, 0.1 mmol, 1 equiv) where mixed in in CDCl3 (0.3 
ml). To the resulting red solution triphenylphosphine (26.2 mg, 0.1 mmol, 1 equiv) in 
CDCl3 (0.3 ml) was added. The resulting mixture was heated to 80 °C in an oil bath for 8 
h to give a clear light-yellow solution. In situ 1H NMR indicates >95% conversion based 
on the ester starting material. Removing the solvent quantitatively yields a white solid. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.11 (d, 3JHH = 8.0 Hz, 2H), 7.83 – 7.77 (m, 
3H), 7.61 – 7.55 (m, 6H), 7.50 (d, 3JHH = 8.1 Hz, 2H), 7.31 (ddd, 3,3,4JHH = 12.2, 8.4, 1.1 
Hz, 6H), 7.02 – 6.95 (m, 8H), 5.88 (d, 2JPH = 17.2 Hz, 1H). 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: -4.23 (s). 13C NMR (101 MHz, CDCl3, 298 K) (partial, without B(C6F5)3 
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signals) δ/ppm: 167.2, 164.5 (d, 4JCF = 2.7 Hz), 162.0 (d, 4JCF = 2.7 Hz), 138.5, 136.0 (d, 
4JCF = 3.0 Hz), 134.5 (d, 3JCF = 9.1 Hz), 132.7 (q, 2JCF = 32.0 Hz), 130.7 (d, 3JCF = 12.3 
Hz), 130.1, 127.5 (t, 4JCF = 3.7 Hz), 124.9 (q, 3JCF = 3.7 Hz), 122.9, 117.0 (d, 2JCF = 82.6 
Hz), 117.0 (dd, 2,4JCF = 21.9, 1.4 Hz), 49.0 (d, 1JPH = 44.8 Hz). 19F{1H} NMR (376 MHz, 
CDCl3, 298 K) δ/ppm: -62.74 (s, 3F), -109.59 (d, 6JPF = 4.0 Hz, 2F), -134.35 (d, 3JFF = 
21.3 Hz, 6F), -161.96 (t, 3JFF = 20.6 Hz, 3F), -166.18 (t, 3JFF = 19.3 Hz, 6F). 19F NMR (376 
MHz, CDCl3, 298 K) δ/ppm: -62.74 (s), -109.59 (d, 3JHF = 4.0 Hz), -134.35 (d, 3JFF = 21.3 
Hz), -161.96 (t, 3JFF = 20.6 Hz), -166.18 (t, 3JFF = 19.3 Hz). 31P{1H} NMR (162 MHz, 
CDCl3, 298 K) δ/ppm: 21.69 (t, 6JPF = 4.5 Hz). 
9.6.3 Reaction of other homoleptic phosphines PR3 
 
R H in1H NMR δ [ppm] 2JPH [Hz] 
Ph 5.88 17.20 
o-tol 6.10 16.85 
m-F-Ph 5.93 17.21 
Cy 4.90 16.55 
p-MeO-Ph 5.48 17.26 
Bn 4.91 16.48 
9.6.4 Synthesis of homo-coupled product 6.2b 
 
Trismesitylphosphine (0.333 mmol, 130 mg, 1 equiv) and tris(pentafluorophenyl)borane 
(0.333 mmol, 171 mg, 1 equiv) were dissolved in chloroform (1.0 ml) and ester 1a (0.333 
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mmol, 131 mg, 1 equiv) dissolved in chloroform (0.7 ml) was added. The deep purple 
solution was heated in a sealed vial in an oil bath at 61 °C for 3h. All volatiles were 
removed in vacuo and the residue was purified via column chromatography (SiO2, 
hexane/EtOAc 20:1) to isolate compound 6.2b as a white solid. Rf value: 0.16. Yield: 
0.024 g, 0.059 mmol, 35%. Spectroscopic analyses agree with literature established 
values.160 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.09 – 7.00 (m, 8H, Ar-H), 6.88 – 
6.77 (m, 8H, Ar-H), 4.63 (s, 2H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.3 (d, 
1JCF = 245.2 Hz), 138.7 (d, 4JCF = 3.3 Hz), 129.9 (d, 3JCF = 7.9 Hz), 115.4 (d, 2JCF = 21.3 
Hz), 55.3. 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -116.48 (tt, 3JHF = 8.6, 4JHF = 5.3 
Hz, 4F). 19F{1H} NMR (376 MHz, CDCl3, 296 K) δ/ppm: -116.48 (s, 4F). HRMS (TOF MS 
E-) calculated for [M-HCl] [C26H19F4Cl]: 441.1033, found: 441.1024. 
9.6.5 General procedure E2 to synthesise heterocoupled-coupled products 6.4 
Trismesitylphosphine (0.2 mmol, 78 mg, 1 equiv) and tris(pentafluorophenyl)borane (0.2 
mmol, 102 mg, 1 equiv) were dissolved in THF (0.5 ml) and alkene (5 equiv) was added. 
To this faint pink solution, a solution of ester 1 (1 equiv) in THF (0.5 ml) was added. The 
solution was heated to 66 °C in an oil bath in a sealed NMR-tube. All volatiles were 
removed in vacuo and the residue was purified via column chromatography.  
9.6.5.1 Synthesis of 6.4a 
 
In accordance to General Procedure E2, styrene (104 mg, 1.00 mmol, 5 equiv), ester 
6.1a (79 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4a. The crude 
product was purified by column chromatography (SiO2, hexane) to isolate compound 
6.4a as a colourless oil. Rf value: 0.14. Yield: 0.022 g, 0.072 mmol, 36%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.40 – 7.36 (m, 1H), 7.32 (dd, 3JHF,HH = 10.2, 4.8 Hz, 1H), 
7.23 (ddd, 3,4JHH,HF = 6.2, 3.8, 1.3 Hz, 1H), 7.21 – 7.15 (m, 2H), 7.05 – 6.98 (m, 2H), 6.60 
(dd, 3,3JHH = 15.8, 7.4 Hz, 1H), 6.31 (d, 3JHH = 15.9 Hz, 1H), 4.87 (d, 3JHH = 7.4 Hz, 1H). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 161.7 (d, 1JCF = 245.1 Hz), 139.1 (d, 4JCF = 
3.1 Hz), 137.1, 132.2, 131.9, 130.2 (d, 3JCF = 7.9 Hz), 128.7, 127.7, 126.5, 115.5 (d, 2JCF 
= 21.2 Hz), 52.7. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -116.40 (s). IR νmax (cm-1): 
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487, 501, 542, 551, 588, 692, 723, 740, 767, 829, 968, 1014, 1097, 1157, 1220, 1448, 
1504, 1600, 3026. HRMS (ASAP+) calculated for [M]+ [C21H16F2]+: 366.1220, found: 
366.1221.  
9.6.5.2 Synthesis of 6.4c 
 
In accordance to General Procedure E2, 4-methylstyrene (118 mg, 1.00 mmol, 5 equiv), 
ester 6.1a (78 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4c. The 
crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4c as a colourless oil. Rf value: 0.15. Yield: 0.016 g, 0.050 mmol, 25%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.27 (d, 3JHH = 7.4 Hz, 2H), 7.20 – 7.14 (m, 4H), 
7.12 (d, 3JHH = 7.9 Hz, 2H), 7.04 – 6.97 (m, 4H), 6.54 (dd, 3,3JHH = 15.8, 7.4 Hz, 1H), 6.28 
(d, 3JHH = 15.8 Hz, 1H), 4.85 (d, 3JHH = 7.4 Hz, 1H), 2.34 (s, 3H). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 161.7 (d, 1JCF = 245.0 Hz), 139.3 (d, 4JCF = 3.1 Hz), 137.5, 134.3, 
131.7, 131.2, 130.2 (d, 3JCF = 7.9 Hz), 129.4, 126.4, 115.5 (d, 2JCF = 21.2 Hz), 52.7, 21.3. 
19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -116.53 (s). IR νmax (cm-1): 408, 414, 420, 426, 
441, 459, 472, 489, 501, 526, 543, 570, 767, 806, 821, 831, 970, 1014, 1037, 1074, 
1095, 1157, 1220, 1504, 1600, 2922. HRMS (AP-) calculated for [M-H]- [C22H17F2]: 
319.1298, found: 329.1292.  
9.6.5.3 Synthesis of 6.4d 
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In accordance to General Procedure E2, 4-tert-butylstyrene (160 mg, 1.00 mmol, 5 
equiv), ester 6.1a (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4d. 
The crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4d as a colourless oil. Rf value: 0.18. Yield: 0.016 g, 0.044 mmol, 22%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.36 – 7.30 (m, 4H), 7.20 – 7.14 (m, 4H), 7.04 – 
6.97 (m, 4H), 6.56 (dd, 3,3JHH = 15.8, 7.4 Hz, 1H), 6.29 (dd, 3,4JHH = 15.8, 1.2 Hz, 1H), 
4.86 (d, 3JHH = 7.3 Hz, 1H), 1.32 (s, 9H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 161.7 
(d, 1JCF = 245.0 Hz), 150.9, 139.3 (d, 4JCF = 3.1 Hz), 134.3, 131.6, 131.5, 130.2 (d, 3JCF 
= 7.9 Hz), 126.2, 125.7, 115.5 (d, 2JCF = 21.2 Hz), 52.7, 34.7, 31.4. 19F NMR (376 MHz, 
CDCl3, 298 K) δ/ppm: -116.53 (s). IR νmax (cm-1): 536, 569, 775, 829, 970, 1014, 1097, 
1157, 1222, 1363, 1504, 1600, 2958. HRMS (AP-) calculated for [M-H]- [C25H23F2]-: 
361.1768, found: 361.1765 
9.6.5.4 Synthesis of 6.4e 
 
In accordance to General Procedure E2, 4-fluorostyrene (122 mg, 1.00 mmol, 5 equiv), 
ester 6.1a (78 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4e. The 
crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4e as a colourless oil. Rf Value: 0.33. Yield: 0.024 g, 0.074 mmol, 37%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.50 – 7.42 (m, 2H), 7.34 – 7.25 (m, 4H), 7.18 – 
7.08 (m, 6H), 6.64 (dd, 3,3JHH = 15.8, 7.3 Hz, 1H), 6.39 (d, 3JHH = 16.4 Hz, 1H), 4.98 (d, 
3JHH = 7.3 Hz, 1H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 162.4 (d, 1JCF = 246.8 Hz), 
161.8 (d, 1JCF = 245.3 Hz), 139.0 (d, 4JCF = 3.2 Hz), 133.2 (d, 4JCF = 3.3 Hz), 132.0, 132.0, 
130.1 (d, 3JCF = 7.9 Hz), 128.0 (d, 3JCF = 8.0 Hz), 115.6 (d, 2JCF = 21.6 Hz), 115.5 (d, 2JCF 
= 21.3 Hz), 52.7. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -114.39 (s, 1F), -116.18 (s, 
2F). IR νmax (cm-1): 433, 459, 507, 524, 543, 570, 771, 798, 819, 846, 968, 1014, 1095, 
1155, 1219, 1504, 1600, 3039 HRMS (AP-) calculated for [M-H]- [C21H14F3]-: 323.1048, 
found: 323.1048. 
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9.6.5.5 Synthesis of 6.4f 
 
In accordance to General Procedure E2, 4-chlorostyrene (139 mg, 1.00 mmol, 5 equiv), 
ester 6.1a (78 mg, 0.2 mmol, 1 equiv) were used to synthesise the compound 6.4f. The 
crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4f as a colourless oil. Rf Value: 0.18. Yield: 0.022 g, 0.065 mmol, 32%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.31 – 7.26 (m, 1H), 7.20 – 7.14 (m, 1H), 7.05 – 
6.99 (m, 1H), 6.58 (dd, 3JHH = 15.8, 7.3 Hz, 1H), 6.26 (dd, 3,4JHH = 15.8, 1.3 Hz, 1H), 4.86 
(d, 3JHH = 7.3 Hz, 1H). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -116.19 (s). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 161.8 (d, 1JCF = 245.3 Hz), 138.9 (d, 4JCF = 3.2 Hz), 
135.6, 133.3, 133.0, 130.7, 130.1 (d, 3JCF = 7.9 Hz), 128.9, 127.7, 115.6 (d, 2JCF = 21.3 
Hz), 52.7. IR νmax (cm-1): 487, 501, 543, 561, 731, 769, 783, 829, 970, 1012, 1091, 1157, 
1220, 1404, 1458, 1465, 1490, 1504, 1600, 3032 HRMS (EI+) calculated for [M+] 
[C21H15F2Cl]+: 340.0830, found: 340.0834. 
9.6.5.6 Synthesis of 6.4g 
 
In accordance to General Procedure E2, styrene (104 mg, 1.00 mmol, 5 equiv), ester 
6.1b (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4g. The crude 
product was purified by column chromatography (SiO2, hexane) to isolate compound 
6.4g as a white solid. Rf value: 0.15. Yield: 0.021 g, 0.078 mmol, 39%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.80 (d, 3JHH = 7.6 Hz, 2H), 7.52 (d, 3JHH = 7.4 Hz, 2H), 7.44 
– 7.38 (m, 4H), 7.36 – 7.29 (m, 4H), 7.26 – 7.21 (m, 1H), 6.89 (d, 3JHH = 15.6 Hz, 1H), 
6.05 (dd, 3JHH = 15.6, 9.1 Hz, 1H), 4.65 (d, 3JHH = 9.1 Hz, 1H). 13C NMR (101 MHz, CDCl3, 
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298 K) δ/ppm: 146.2, 141.1, 137.3, 132.7, 129.1, 128.7, 127.7, 127.5, 127.3, 126.4, 
125.6, 120.1, 52.5. IR νmax (cm-1): 410, 416, 441, 491, 542, 609, 621, 655, 690, 729, 738, 
761, 806, 941, 958, 1029, 1101, 1296, 1444, 3016. HRMS (ES-) calculated for [M-H]- 
[C21H15]: 267.1774, found: 267.1774. 
9.6.5.7 Synthesis of 6.4h 
 
In accordance to General Procedure E2, 4-methylstyrene (118 mg, 1.00 mmol, 5 equiv), 
ester 6.1b (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4h. The 
crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4h as a white solid. Rf value: 0.26. Yield: 0.016 g, 0.057 mmol, 28%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.79 (d, 3JHH = 7.5 Hz, 2H), 7.55 – 7.49 (m, 2H), 
7.43 – 7.38 (m, 2H), 7.33 (dd, 3,4JHH = 7.4, 1.2 Hz, 2H), 7.31 – 7.28 (m, 2H), 7.12 (d, 3JHH 
= 8.0 Hz, 2H), 6.86 (d, 3JHH = 15.6 Hz, 1H), 5.99 (dd, 3,3JHH = 15.6, 9.1 Hz, 1H), 2.34 (s, 
3H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 146.4, 141.1, 137.3, 134.5, 132.5, 129.4, 
128.1, 127.6, 127.3, 126.3, 125.6, 120.0, 52.5, 21.3. IR νmax (cm-1): 418, 499, 588, 621, 
725, 738, 758, 788, 827, 941, 966, 1292, 1298, 1444, 1473, 1510, 2918, 1296. HRMS 
(AP-) calculated for [M-H]- [C22H17]-: 281.1330, found: 281.1330. 
9.6.5.8 Synthesis of 6.4i 
 
In accordance to General Procedure E2, 4-tert-butylstyrene (160 mg, 1.00 mmol, 5 
equiv), ester 6.1b (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4i. 
The crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4i as a white solid. Rf value: 0.21. Yield: 0.016 g, 0.049 mmol, 25%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.80 (d, 3JHH = 7.5 Hz, 2H), 7.52 – 7.48 (m, 2H), 
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7.43 – 7.39 (m, 2H), 7.35 (s, 4H), 7.32 (td, 3,4JHH = 7.4, 1.2 Hz, 2H), 6.88 (dd, 3,4JHH = 
15.6, 0.8 Hz, 1H), 6.01 (dd, 3,3JHH = 15.6, 9.2 Hz, 1H), 4.64 (d, 3JHH = 9.1 Hz, 1H), 1.32 
(s, 9H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 150.7, 146.4, 141.1, 134.5, 132.5, 
128.3, 127.6, 127.3, 126.2, 125.7, 125.6, 120.0, 52.6, 34.7, 31.4. IR νmax (cm-1): 420, 
516, 547, 584, 597, 621, 644, 727, 740, 761, 794, 831, 837, 893, 960, 968, 1018, 1112, 
1265, 1361, 1411, 1444, 1473, 1512, 2962. HRMS (AP-) calculated for [M-H]- [C25H23]-: 
323.1800, found: 323.1804. 
9.6.5.9 Synthesis of 6.4b 
 
In accordance to General Procedure E2, 4-fluorostyrene (122 mg, 1.00 mmol, 5 equiv), 
ester 6.1b (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4b. The 
crude product was purified by column chromatography (SiO2, hexane) to isolate 
compound 6.4b as a white solid. Rf Value: 0.15. Yield: 0.037 g, 0.073 mmol, 37%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.80 (d, 3JHH = 7.5 Hz, 2H), 7.51 (d, 3JHH = 7.4 Hz, 
2H), 7.44 – 7.39 (m, 2H), 7.37 – 7.30 (m, 4H), 7.03 – 6.96 (m, 2H), 6.84 (d, 3JHH = 15.6 
Hz, 1H), 5.97 (dd, 3,3JHH = 15.6, 9.1 Hz, 1H), 4.63 (d, 3JHH = 9.1 Hz, 1H). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 162.2 (d, 1JCF = 246.5 Hz), 146.0, 141.0, 133.3, 131.3, 128.8 
(d, 4JCF = 2.3 Hz), 127.8 (d, 3JCF = 7.9 Hz), 127.6, 127.2, 125.4, 120.0, 115.5 (d, 2JCF = 
21.6 Hz), 52.3. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -114.77. IR νmax (cm-1): 417, 
418, 446, 503, 552, 594, 624, 664, 695, 731, 744, 765, 913, 955, 965, 1037, 1104, 1297, 
1449, 3023. HRMS (EI+) calculated for [M]+ [C21H15F]+: calculated 286.1158, found: 
286.1158.  
9.6.5.10 Synthesis of 6.4j 
 
  179 
In accordance to General Procedure E2, 4-chlorostyrene (139 mg, 1.00 mmol, 5 equiv), 
ester 6.1b (71 mg, 0.2 mmol, 1 equiv) were used to synthesise compound 6.4j. The 
crude product was purified by column chromatography (SiO2, hexane) as a white solid 
Rf value: 0.18. Yield: 0.024 g, 0.079 mmol, 40%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.75 (d, 3JHH = 7.5 Hz, 2H), 7.45 (ddd, 3,4,4JHH = 7.3, 1.8, 0.9 Hz, 2H), 7.39 – 7.34 
(m, 2H), 7.30 – 7.26 (m, 2H), 7.26 – 7.20 (m, 4H), 6.77 (d, 3JHH = 15.6 Hz, 1H), 5.98 (dd, 
3,3JHH = 15.6, 9.1 Hz, 1H), 4.59 (d, 3JHH = 9.1 Hz, 1H). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 146.0, 141.1, 135.8, 133.1, 131.3, 129.9, 128.8, 127.8, 127.6, 127.4, 125.5, 
120.1, 52.4. IR νmax (cm-1): 401, 408, 414, 422, 459, 497, 514, 576, 621, 642, 682, 727, 
740, 756, 792, 821, 833, 889, 937, 943, 958, 1012, 1080, 1093, 1292, 1404, 1444, 1473, 
1489, 3018. HRMS (AP-) calculated for [M-H]- [C21H14Cl]-: 301.0790, found: 301.0788. 
9.6.6 Reaction of 6.1a with α-methylstyrene 
In accordance to General Procedure E2, alpha-methylstyrene (118 mg, 1.00 mmol, 5 
equiv), ester 6.1a (79 mg, 0.2 mmol, 1 equiv) were used to synthesise the structural 
isomers 6.5a and 6.5b. The crude product was purified by column chomatography (SiO2, 
hexane). Rf value: 0.11. Yield: 0.057 g, 0.178 mmol, 89%.  
9.6.6.1 Major product 5a 
 
Yield (calculated by 19F NMR): 0.118 mmol, 0.038 g, 59% 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.49 – 7.28 (m, 5H), 7.16 – 7.09 (m, 4H), 7.00 – 6.95 (m, 4H), 5.18 (d, 
4JHH = 1.0 Hz, 1H), 4.89 – 4.85 (m, 1H), 4.07 (t, 3JHH = 7.7 Hz, 1H), 3.23 (d, 3JHH = 7.8 
Hz, 2H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 161.5 (d, 1JCF = 244.5 Hz), 146.1, 
141.0, 140.1 (d, 4JCF = 3.1 Hz), 129.5 (d, 3JCF = 7.8 Hz), 128.6, 127.7, 126.5, 115.4, 115.3 
(d, 2JCF = 21.3 Hz), 47.8, 42.2. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -116.85 (s). 
HRMS (EI+) calculated for [M+] [C22H18F2]+: 320.1377, found: 320.1381. Retention Time 
(TOF MS EI+): 25.269. 
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9.6.6.2 Major product 5a 
 
Yield (calculated by 19F NMR): 0.059 mmol, 0.019 g, 30% 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.48 – 7.28 (m, 5H), 7.24 – 7.18 (m, 4H), 7.06 – 7.00 (m, 4H), 6.22 – 6.13 
(m, 1H), 5.07 (d, 3JHH = 9.3 Hz, 1H), 2.16 – 2.14 (m, 3H). 19F NMR (376 MHz, CDCl3, 298 
K) δ/ppm: -116.68 (s). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 161.6 (d, 1JCF = 244.8 
Hz), 143.4, 140.3 (d, 4JCF = 3.2 Hz), 136.2, 130.4, 129.8 (d, 3JCF = 7.9 Hz), 128.4, 127.3, 
126.0, 115.5 (d, 2JCF = 19.8 Hz), 48.6, 16.4. HRMS (EI+) calculated for [M+] [C22H18F2]+: 
320.1377, found: 320.1381. Retention Time (TOF MS EI+): 26.103. 
9.6.7 Crystallographic data for 6.2a and 6.2b 
 
Compound 5.16a 5.4c 
Empirical Formula C34H12BCl2F15O2 C44H23BClF15O2 
Space Group P-1 P 21/n 
a/Å 10.8906(6) 16.4273(3) 
b/Å 11.6131(10) 12.13337(18) 
c/Å 12.4826(7) 21.5533(3) 
α/° 90.902(6) 90 
β/° 95.194(5) 103.2592(15) 
ϒ/° 98. 525(6) 90 
Volume/Å3 1554.20(19) 4181.44(11) 
Z 2 4 
T/K 150 100 
Dc/g·cm-3 1.750 1.426 
R (reflections) 0.0413 0.0144 
wR2 (reflections) 0.1214 0.1026 
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9.7 Sterics directed halo- and Carbo-boration 
9.7.1 General procedure F1 to synthesise propargyl esters 7.1 
Propargyl esters 7.1 were synthesised according to literature procedure.30 NEt3 (3.5 ml, 
25 mmol, 2 equiv) was added to a solution of acyl chloride (15 mmol, 1.2 equiv) in CH2Cl2 
(50 ml) and cooled to 0 °C. After adding alkynyl alcohol (1 equiv) dropwise to this solution, 
the reaction mixture was allowed to warm room temperature and stirred overnight. To 
quench the reaction water (100 ml) was added and the phases were separated. The 
aqueous phase was extracted with CH2Cl2 (3 x 50 ml) and the combined organic layers 
were dried with brine and layered over MgSO4. After filtration all volatiles were removed 
under vacuum and the residue was purified via recrystallisation or column 
chromatography. 
9.7.1.1 Synthesis of 7.1a 
 
According to General Procedure F1, ester 7.1a was synthesised using propargyl alcohol 
(0.73 ml, 12.5 mmol, 1 equiv.) and benzoyl chloride (1.74 ml, 15 mmol, 1.2 equiv). Yield: 
1.68 g, 10.5 mmol, 84%. Spectroscopic data agrees with literature values.141 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.08 (ddd, 3JHH = 6.8, 4JHH = 2.8, 4JHH = 1.5 Hz, 2H, Ar-
H), 7.61 – 7.55 (m, 1H, Ar-H), 7.49 – 7.42 (m, 2H, Ar-H), 4.93 (d, 4JHH = 2.5 Hz, 2H, CH2), 
2.52 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.9, 133.5, 
129.9, 129.5, 128.6, 77.9, 75.1, 52.6. 
9.7.1.2 Synthesis of 7.1b 
 
According to General Procedure F1, ester 7.1b was synthesised using propargyl alcohol 
(0.73 ml, 12.5 mmol, 1 equiv) and 4-fluorobenzoyl chloride (1.77 ml, 15 mmol, 1.2 equiv). 
Yield: 1.87 g, 10.5 mmol, 84%. Spectroscopic data agrees with literature values.161 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.12 – 8.06 (m, 2H, Ar-H), 7.15 – 7.10 (m, 2H, 
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Ar-H), 4.92 (d, 4JHH = 2.5 Hz, 2H, CH2), 2.52 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 166.1 (d, 1JCF = 255.2 Hz), 165.0, 132.6 (d, 3JCF = 9.4 Hz), 
125.8 (d, 4JCF = 3.0 Hz), 115.8 (d, 2JCF = 22.1 Hz), 77.7, 75.3, 52.7. 19F NMR (376 MHz, 
CDCl3, 298 K) δ/ppm: -104.9 (s). 
9.7.1.3 Synthesis of 7.1c 
 
According to General Procedure F1, ester 7.1c was synthesised using propargyl alcohol 
(0.73 ml, 12.5 mmol, 1 equiv) and p-nitrobenzoylchloride (2.77 g, 15 mmol, 1.2 equiv). 
7.1c was purified via recrystallisation from a saturated of CH2Cl2 to give a yellow 
crystalline solid. Yield: 2.36 g, 11.5 mmol, 96%. Spectroscopic data agrees with 
literature values.141 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.30 (dt, 3JHH = 9.0 Hz, 
4JHH = 2.2 Hz, 2H, Ar-H), 8.23 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, Ar-H), 4.97 (d, 4JHH = 
2.5 Hz, 2H, CH2), 2.56 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 164.0, 151.0, 134.9, 131.1, 123.8, 77.1, 75.8, 53.4. 
9.7.1.4 Synthesis of 7.1d 
 
According to General Procedure F1, ester 7.1d was synthesised using propargyl alcohol 
(0.73 ml, 12.5 mmol, 1 equiv) m-nitrobenzoyl chloride (2.77 g, 15 mmol, 1.2 equiv). Yield: 
1.67 g, 8.13 mmol, 65%. Spectroscopic analyses agree with literature values.162 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 8.90 (dd, 4JHH = 2.9, 4JHH = 1.1 Hz, 1H, Ar-H), 8.45 (ddd, 
3JHH = 8.2, 4JHH = 2.3, 4JHH = 1.1 Hz, 1H, Ar-H), 8.43 – 8.38 (m, 1H, Ar-H), 7.72 – 7.65 
(m, 1H, Ar-H), 4.99 (d, 4JHH = 2.5 Hz, 2H, CH2), 2.57 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 163.9, 148.4, 135.6, 131.3, 129.9, 127.9, 125.0, 
77.1, 75.9, 53.4. 
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9.7.1.5 Synthesis of 7.1e 
 
According to General Procedure F1, ester 7.1e was synthesised using 2-methylbut-3- 
yn-2-ol (1.21 ml, 12.5 mmol, 1 equiv) and benzoyl chloride (1.74 ml, 15 mmol, 1.2 equiv). 
Yield: 0.352 g, 1.89 mmol, 15%. Spectroscopic data agrees with literature known 
values.163 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.05 – 8.01 (m, 2H, Ar-H), 7.57 – 
7.52 (m, 1H, Ar-H), 7.46 – 7.40 (m, 2H, Ar-H), 2.59 (s, 1H, ≡CH), 1.82 (s, 3H, CH3). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.0, 133.1, 130.9, 129.8, 128.4, 84.8, 72.7, 
72.4, 29.2. 
9.7.1.6 Synthesis of 7.1f 
 
According to General Procedure F1, ester 7.1f was synthesised using 2-methylbut-3- yn-
2-ol (1.21 ml, 12.5 mmol, 1 equiv) and 4-toluoyl chloride (1.98 ml, 15 mmol, 1.2 equiv). 
Yield: 1.31 g, 6.5 mmol, 52%. Spectroscopic data agrees with literature known values.30 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.90 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.21 (d, 3JHH 
= 8.1 Hz, 2H, Ar-H), 2.57 (s, 1H, ≡CH), 2.38 (s, 3H, Ar-CH3), 1.80 (s, 6H, CH3). 13C NMR 
(101 MHz, CDCl3, 298 K) δ/ppm: 164.0, 142.6, 128.7, 128.0, 127.1, 83.9, 71.5, 71.0, 
28.1, 20.7. 
9.7.1.7 Synthesis of 7.1g 
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According to General Procedure F1, ester 7.1g was synthesised using 2-methylbut-3- 
yn-2-ol (1.21 ml, 12.5 mmol, 1 equiv) and 4-fluorobenzoyl chloride (1.77 ml, 15 mmol, 
1.2 equiv). Yield: 1.78 g, 8.62 mmol, 69%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
8.05 – 8.01 (m, 2H, Ar-H), 7.11 – 7.06 (m, 2H, Ar-H), 2.59 (s, 1H, ≡CH), 1.81 (s, 6H, 
CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.8 (d, 1JCF = 253.7 Hz), 164.0, 132.3 
(d, 3JCF = 9.3 Hz), 127.1 (d, 4JCF = 3.0 Hz), 115.5 (d, 2JCF = 22.0 Hz), 84.7, 72.8, 72.5, 
29.1. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -105.8 (s). 
9.7.1.8 Synthesis of 7.1h 
 
Deuterated ester 7.1h was synthesised according to literature procedure. WA30 resin 
(38 mg) was added to a solution of 7.1a (0.336 g, 2.1 mmol) in D2O and stirred for 18 h 
at room temperature. The suspension was filtered and the filtrate was extracted with 
Et2O (4 x 10 ml) and the combined organic layers were concentrated under vacuum to 
yield desired product 7.1h as colourless oil. Yield: 0.267 g, 1.87 mmol, 88%. 
Spectroscopic data agrees with literature values.142 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 8.02 – 7.97 (m, 2H, Ar-H), 7.53 – 7.48 (m, 1H, Ar-H), 7.40 – 7.34 (m, 2H, Ar-H), 
4.85 (s, 2H, CH2). 2H NMR (61 MHz, CDCl3, 298 K) δ/ppm: 2.53 (s, ≡CD). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 165.9, 133.5, 130.0, 129.5, 128.6, 77.5, 74.9 (t, 1JCD = 39 
Hz), 52.6. 
9.7.2 General procedure F2 to synthesise 1,3-haloborated products 7.2 
PhBCl2 (32 mg, 0.2 mmol, 26 μl, 1 equiv) was added to a solution of alkyne 7.1 (0.2 
mmol, 1 equiv) in CDCl3. 
9.7.2.1 Synthesis of 7.2a 
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According to General Procedure F2, ester 7.2a was synthesised using 7.1a (32 mg, 0.2 
mmol). 1H NMR Conversion: >95%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.09 – 
8.00 (m, 3H, Ar), 7.59 – 7.51 (m, 2H, Ar), 7.46 – 7.36 (m, 5H, Ar), 6.44 (s, 1H, =CH), 
4.55 (s, 2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 164.3, 160.0, 137.2, 136.6, 
134.7, 134.1, 130.4, 128.8, 128.4, 128.0, 119.1 (br. s), 41.8. 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: 59.5 (br. s). 
9.7.2.2 Synthesis of 7.2c 
 
According to General Procedure F2, ester 7.2c was synthesised using 7.1b (36 mg, 0.2 
mmol). 1H NMR Conversion: >95%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.11 – 
8.06 (m, 2H, Ar), 8.02 – 7.99 (m, 2H, Ar), 7.55 – 7.53 (m, 1H, Ar), 7.41 – 7.36 (m, 2H, 
Ar), 7.11 – 7.06 (m, 2H, Ar), 6.42 (s, 1H, =CH), 4.53 (s, 2H, CH2). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 166.5 (d, 1JCF = 255.9 Hz, Ar), 163.3, 159.7, 136.9, 136.6, 134.7, 
133.1 (d, 3JCF = 9.6 Hz, Ar), 128.4, 125.3 (d, 4JCF = 3.0 Hz, Ar), 119.1 (br. s), 116.1 (d, 
2JCF = 22.1 Hz, Ar), 41.8. 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -103.5 (s). 11B NMR 
(128 MHz, CDCl3, 298 K) δ/ppm: 59.3 (br. s) 
9.7.2.3 Synthesis of 7.2d 
 
According to General Procedure F2, ester 7.2d was synthesised using 7.1c (41 mg, 0.2 
mmol). 1H NMR Conversion: >95%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.27 – 
8.25 (m, 4H, Ar), 8.12 – 8.10 (m, Hz, 2H, Ar), 7.67 – 7.63 (m, 1H, Ar), 7.53 – 7.48 (m, 
2H, Ar), 6.55 (s, 1H, =C), 4.63 (s, 2H, -CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
162.4, 158.7, 151.1, 136.6, 134.9, 134.4, 131.5, 128.4, 123.9, 119.6 (br. s), 41.6. 11B 
NMR (128 MHz, CDCl3, 298 K) δ/ppm: 59.9 (br. s). 
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9.7.2.4 Synthesis of 7.2e 
 
According to General Procedure F2, ester 7.2e was synthesised using 7.1d (41 mg, 0.2 
mmol). 1H NMR Conversion: >95%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 9.03 – 
8.94 (m, 1H, Ar), 8.52 – 8.48 (m, 2H, Ar), 8.14 – 8.10 (m, 2H, Ar), 7.77 – 7.73 (m, 1H, 
Ar), 7.68 – 7.63 (m, 1H, Ar), 7.54 – 7.49 (m, 2H, Ar), 6.55 (s, 1H, =CH), 4.65 (s, 2H, -
CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 162.2, 158.8, 148.5, 137.0, 136.7, 
135.9, 134.9, 130.8, 130.2, 128.5, 128.3, 125.3, 119.7 (br. s), 41.6. 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 60.0 (br. s). 
9.7.3 General Procedure F3 to synthesise 1,1-carboborated products 7.3 
PhBCl2 (32 mg, 0.2 mmol, 26 μl, 1 equiv) was added to a solution of methyl substituted 
alkynes 7.1. The resulting mixture was heated to 45 °C in a sealed NMR tube. After 
allowing the reaction mixture to cool to room temperature all volatiles have been removed 
and the residue was washed with hexane (3 x 1 ml) and recrystallised in a CH2Cl2/hexane 
solution at -40 °C to yield the desired carboborated product 7.3. 
9.7.3.1 Synthesis of 7.3a 
 
According to General Procedure F3, ester 7.3a was synthesised using 7.1e (37 mg, 0.2 
mmol, 1 equiv). Yield: 57 mg, 0.16 mmol, 82%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
8.22 (d, 3JHH = 7.5 Hz. 2H, Ar), 7.78 (t, 3JHH = 7.5 Hz, 1H, Ar), 7.55 (t, 3JHH = 7.9 Hz, 2H, 
Ar), 7.12 (t, 3JHH = 7.5, 2H, Ar), 7.05 (t, 3JHH = 7.3 Hz, 1H, Ar), 6.97 (d, 3JHH = 7.4 Hz, 2H, 
Ar), 3.82 (s, 1H, B-CH), 1.95 (s, 3H, -CH3), 1.77 (s, 3H, -CH3). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 171.4, 147.8, 141.1, 138.1, 131.6, 129.8, 128.4, 127.5, 125.9, 124.7, 
122.5, 39.51 (br. s,), 18.7, 17.7. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 8.7 (s). IR 
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νmax (cm-1): 3201 (w), 2993 (w), 2916 (w). 1689 (m), 1597 (m), 1535 (s), 1496 (m), 1450 
(m), 1404 (s), 1311 (m), 1242 (m), 1180 (s), 1056 (m), 1026 (w), 987 (w), 933 (w), 879 
(w), 833 (w), 802 (m), 740 (s), 694 (s). 
9.7.3.2 Synthesis of 7.3b 
 
According to General Procedure F3, ester 7.3b was synthesised using 7.1f (40 mg, 0.2 
mmol, 1 equiv). Yield: 67 mg, 0.17 mmol, 87%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
8.20 (d, 3JHH = 8.3 Hz, 2H, Ar), 7.44 (d, 3JHH = 8.1 Hz, 2H, Ar), 7.21 (t, 3JHH = 7.5 Hz, 2H, 
Ar), 7.14 (t, 3JHH = 7.3 Hz, 1H, Ar), 7.06 (d, 3JHH = 7.4 Hz, 2H, Ar), 3.90 (s, 1H, B-CH), 
2.53 (s, 3H, Ph-CH3), 2.03 (s, 3H, CH3), 1.86 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 171.3, 150.4, 147.6, 141.2, 131.7, 130.6, 128.4, 127.5, 125.9, 122.0, 
121.8, 39.6 (br. s), 22.5, 18.6 (br. s), 17.7. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
8.6 (s). IR νmax (cm-1): 2160 (w), 1666 (w), 1605 (w), 1581 (w), 1527 (s), 1504 (m), 1412 
(s), 1296 (m), 1249 (m), 1172 (m), 1134 (m), 1080 (m), 1049 (m), 972 (w), 933 (w), 910 
(w), 879 (w), 833 (m), 763 (s), 740 (s), 648 (m). 
9.7.3.3 Synthesis of 7.3c 
 
According to General Procedure F3, ester 7.3c was synthesised using 7.1g (41 mg, 0.2 
mmol, 1 equiv). Yield: 58 mg, 16 mmol, 79%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
8.37 – 8.34 (m, 2H, Ar), 7.33 (t, 3JHF = 8.5 Hz, 2H, Ar), 7.22 (t, 3JHH = 7.4 Hz, 2H, Ar), 
7.15 (t, 3JHH = 7.3 Hz, 1H, Ar), 7.05 (d, 3JHH = 7.3 Hz, 2H, Ar), 3.91 (s, 1H, B-CH), 2.03 
(s, 3H, CH3), 1.86 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 170.3,, 168.9 
(d, 1JCF = 264.1 Hz, Ar), 147.9, 140.9, 134.8 (d, 3JCF = 10.6 Hz, Ar), 128.5, 127.5, 126.0, 
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122.6, 121.0 (d, 4JCF = 2.7 Hz, Ar), 117.6 (d, 2JCF = 22.6 Hz, Ar), 39.6 (br. s,), 18.7 (s,), 
17.7 (br. s,). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 8.8 (s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: - 94.6 – -94.5 (m, 1F, p-F). IR νmax (cm-1): 3201 (w), 3086 (w), 2916 
(w), 1697 (w), 1597 (m), 1535 (m), 1504 (m), 1404 (s), 1311 (m), 1242 (s), 1157 (s), 1049 
(m), 972 (w), 933 (w), 910 (w), 879 (w), 833 (m), 763 (s), 725 (s), 695 (s), 648 (m). 
9.7.4 Crystallographic data for 7.2d and 7.3a 
Compound 7.2d 7.3a 
Empirical Formula C16H12BCl2NO4 C18H17BCl2O2 
Space Group P-1 P21/n 
a/Å 7.1918(4) 13.1814(5) 
b/Å 10.3441(6) 8.4219(4) 
c/Å 13.0804(7) 15.3446(8) 
α/° 96.791(4) 90 
β/° 100.323(5) 97.278(4) 
ϒ/° 92.295(4) 90 
Volume/Å3 948.75(9) 1689.71(13) 
Z 2 4 
T/K 150 150 
Dc/g·cm-3 1.274 1.364 
R (reflections) 0.0401 0.0457 
wR2 (reflections) 0.0930 0.1304 
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